This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3

4.3.14.31 Code System http://dicom.nema.org/resources/ontology/DCM

Vocabulary

Work Group

Maturity Level: 0

Informative

Use Context: Any

This is a code system defined at http://medical.nema.org/medical/dicom/current/output/chtml/part16/chapter_D.html .

Summary

Defining URL:

http://dicom.nema.org/resources/ontology/DCM

Version:

Name:

DICOM Controlled Terminology Definitions

Title:

Definition:

DICOM Code Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")

Committee:

OID:

1.2.840.10008.2.16.4 (for OID based terminology systems)

These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright © 2011 by the National Electrical Manufacturers Association.

Source Resource

XML / JSON

This Code system is used in the following value sets:

ValueSet: Audit Event ID (Event Types for Audit Events - defined by DICOM with some FHIR specific additions.)
ValueSet: SecurityRoleType (This example FHIR value set is comprised of example Actor Type codes, which can be used to value FHIR agents, actors, and other role elements such as those specified in financial transactions. The FHIR Actor value set is based on DICOM Audit Message, C402; ASTM Standard, E1762-95 [2013]; selected codes and derived actor roles from HL7 RoleClass OID 2.16.840.1.113883.5.110; HL7 Role Code 2.16.840.1.113883.5.111, including AgentRoleType; HL7 ParticipationType OID: 2.16.840.1.113883.5.90; and HL7 ParticipationFunction codes OID: 2.16.840.1.113883.5.88. This value set includes, by reference, role codes from external code systems: NUCC Health Care Provider Taxonomy OID: 2.16.840.1.113883.6.101; North American Industry Classification System [NAICS]OID: 2.16.840.1.113883.6.85; IndustryClassificationSystem 2.16.840.1.113883.1.11.16039; and US Census Occupation Code OID: 2.16.840.1.113883.6.243 for relevant recipient or custodian codes not included in this value set. If no source is indicated in the definition comments, then these are example FHIR codes. It can be extended with appropriate roles described by SNOMED as well as those described in the HL7 Role Based Access Control Catalog and the HL7 Healthcare (Security and Privacy) Access Control Catalog. In Role-Based Access Control (RBAC), permissions are operations on an object that a user wishes to access. Permissions are grouped into roles. A role characterizes the functions a user is allowed to perform. Roles are assigned to users. If the user's role has the appropriate permissions to access an object, then that user is granted access to the object. FHIR readily enables RBAC, as FHIR Resources are object types and the CRUDE events (the FHIR equivalent to permissions in the RBAC scheme) are operations on those objects. In Attribute-Based Access Control (ABAC), a user requests to perform operations on objects. That user's access request is granted or denied based on a set of access control policies that are specified in terms of attributes and conditions. FHIR readily enables ABAC, as instances of a Resource in FHIR (again, Resources are object types) can have attributes associated with them. These attributes include security tags, environment conditions, and a host of user and object characteristics, which are the same attributes as those used in ABAC. Attributes help define the access control policies that determine the operations a user may perform on a Resource (in FHIR) or object (in ABAC). For example, a tag (or attribute) may specify that the identified Resource (object) is not to be further disclosed without explicit consent from the patient.)
ValueSet: Media Type Code (Media Type Code)
ValueSet: Audit Event Sub-Type (More detailed code concerning the type of the audit event - defined by DICOM with some FHIR specific additions.)
ValueSet: ParticipationRoleType (This FHIR value set is comprised of Actor participation Type codes, which can be used to value FHIR agents, actors, and other role elements. The FHIR Actor participation type value set is based on DICOM Audit Message, C402; ASTM Standard, E1762-95 [2013]; selected codes and derived actor roles from HL7 RoleClass OID 2.16.840.1.113883.5.110; HL7 Role Code 2.16.840.1.113883.5.111, including AgentRoleType; HL7 ParticipationType OID: 2.16.840.1.113883.5.90; and HL7 ParticipationFunction codes OID: 2.16.840.1.113883.5.88. This value set includes, by reference, role codes from external code systems: NUCC Health Care Provider Taxonomy OID: 2.16.840.1.113883.6.101; North American Industry Classification System [NAICS]OID: 2.16.840.1.113883.6.85; IndustryClassificationSystem 2.16.840.1.113883.1.11.16039; and US Census Occupation Code OID: 2.16.840.1.113883.6.243 for relevant recipient or custodian codes not included in this value set. If no source is indicated in the definition comments, then these are example FHIR codes.)

4.3.14.31.1 Content

Properties

Code

URL

Type

Description

status

http://hl7.org/fhir/concept-properties#status

code

This code system http://dicom.nema.org/resources/ontology/DCM defines the following codes:

Code	Display	Definition	status
ARCHIVE	Archive	Archive device
AR	Autorefraction	Autorefraction device
AS	Angioscopy	Angioscopy device	deprecated
AU	Audio	Audio object
BDUS	Ultrasound Bone Densitometry	Ultrasound Bone Densitometry (modality)
BI	Biomagnetic imaging	Biomagnetic imaging device
BMD	Bone Mineral Densitometry	Bone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA)
CAD	Computer Assisted Detection/Diagnosis	Computer Assisted Detection/Diagnosis device
CAPTURE	Image Capture	Image Capture Device, includes video capture
CD	Color flow Doppler	Color flow Doppler	deprecated
CF	Cinefluorography	Cinefluorography	deprecated
COMP	Computation Server	Computation Server; includes radiotherapy planning
CP	Culposcopy	Culposcopy	deprecated
CR	Computed Radiography	Computed Radiography device
CS	Cystoscopy	Cystoscopy	deprecated
CT	Computed Tomography	Computed Tomography device
DD	Duplex Doppler	Duplex Doppler	deprecated
DF	Digital fluoroscopy	Digital fluoroscopy	deprecated
DG	Diaphanography	Diaphanography device
DM	Digital microscopy	Digital microscopy	deprecated
DOCD	Document Digitizer Equipment	Equipment that digitized hardcopy documents and imported them
DS	Digital Subtraction Angiography	Digital Subtraction Angiography	deprecated
DSS	Department System Scheduler	Department System Scheduler, workflow manager; includes RIS
DX	Digital Radiography	Digital Radiography device
EC	Echocardiography	Echocardiography	deprecated
ECG	Electrocardiography	Electrocardiography device
EPS	Cardiac Electrophysiology	Cardiac Electrophysiology device
ES	Endoscopy	Endoscopy device
F	Female	Female sex
FA	Fluorescein angiography	Fluorescein angiography	deprecated
FC	Female changed to Male	Female sex changed to Male sex
FILMD	Film Digitizer	Film Digitizer
FP	Female Pseudohermaphrodite	Female Pseudohermaphrodite
FS	Fundoscopy	Fundoscopy	deprecated
GM	General Microscopy	General Microscopy device
H	Hermaphrodite	Hermaphrodite
HC	Hard Copy	Hard Copy
HD	Hemodynamic Waveform	Hemodynamic Waveform acquisition device
IO	Intra-oral Radiography	Intra-oral Radiography device
IVOCT	Intravascular Optical Coherence Tomography	An acquisition device, process or method that performs intravascular optical coherence tomography
IVUS	Intravascular Ultrasound	Intravascular Ultrasound device
KER	Keratometry	Keratometry device
KO	Key Object Selection	Key Object Selection object
LEN	Lensometry	Lensometry device
LOG	Procedure Logging	Procedure Logging device; includes cath lab logging
LP	Laparoscopy	Laparoscopy	deprecated
LS	Laser surface scan	Laser surface scan device
M	Male	Male sex
MA	Magnetic resonance angiography	Magnetic resonance angiography	deprecated
MC	Male changed to Female	Male sex changed to Female sex
MCD	Media Creation Device	A device that creates DICOM PS3.10 interchange media; e.g. a CD creator that is managed by the Media Creation Management Service Class
MEDIM	Portable Media Importer Equipment	Equipment that retrieved and imported objects from interchange Media
MG	Mammography	Mammography device
MP	Male Pseudohermaphrodite	Male Pseudohermaphrodite
MR	Magnetic Resonance	Magnetic Resonance device
MS	Magnetic resonance spectroscopy	Magnetic resonance spectroscopy	deprecated
NEARLINE	Nearline	Instances need to be retrieved from relatively slow media such as optical disk or tape
NM	Nuclear Medicine	Nuclear Medicine device
OAM	Ophthalmic Axial Measurements	Measurements of the axial length of the eye, which are done by various devices
OCT	Optical Coherence Tomography	Modality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies
OFFLINE	Offline	Instances need to be retrieved by manual intervention
ONLINE	Online	Instances are immediately available
OP	Ophthalmic photography	Ophthalmic photography modality
OPM	Ophthalmic Mapping	Modality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps
OPR	Ophthalmic Refraction	Modality device that measures the refractive characteristics of the eye
OPT	Ophthalmic Tomography	Tomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded
OPV	Ophthalmic Visual Field	Modality device that measures visual fields and perform visual perimetry
OSS	Optical Survace Scanner	An acquisition device, process or method that performs optical surface scanning
OT	Other Modality	Other Modality device
PR	Presentation State	Presentation State object
PRINT	Hard Copy Print Server	Hard Copy Print Server; includes printers with embedded DICOM print server
PT	Positron emission tomography	Positron emission tomography (PET) device
PX	Panoramic X-Ray	Panoramic X-Ray device
REG	Registration	Registration
RF	Radiofluoroscopy	Radiofluoroscopy device
RG	Radiographic imaging	Radiographic imaging (conventional film/screen)
RT	Radiation Therapy Device	Radiation Therapy Device; includes linear accelerator, proton therapy
RTDOSE	Radiotherapy Dose	Radiotherapy Dose
RTIMAGE	Radiotherapy Image	Radiotherapy Imaging device; includes portal imaging
RTPLAN	Radiotherapy Plan	Radiotherapy Plan
RTRECORD	Radiotherapy Treatment Record	Radiotherapy Treatment Record
RTSTRUCT	Radiotherapy Structure Set	Radiotherapy Structure Set
SEG	Segmentation	Segmentation
SM	Slide Microscopy	Slide Microscopy
SMR	Stereometric Relationship	Stereometric image pairing modality
SR	Structured Report Document	Structured Report Document
SRF	Subjective Refraction	Subjective Refraction device
ST	Single-photon emission computed tomography	Single-photon emission computed tomography (SPECT) device	deprecated
TG	Thermography	Thermography device
U	Unknown Sex	Unknown Sex
UNAVAILABLE	Unavailable	Instances cannot be retrieved
US	Ultrasound	Ultrasound device
VA	Visual Acuity	Visual Acuity device
VF	Videofluorography	Videofluorography	deprecated
VIDD	Video Tape Digitizer Equipment	Equipment that digitizes video tape and imports it
WSD	Workstation	Workstation
XA	X-Ray Angiography	X-Ray Angiography device
XC	External-camera Photography	External-camera Photography device
109001	Digital timecode (NOS)	A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology
109002	ECG-based gating signal, processed	A signal that is generated for each detection of a heart beat
109003	IRIG-B timecode	A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks
109004	X-Ray Fluoroscopy On Signal	A signal that indicated that X-Ray source has been activated for fluoroscopy use
109005	X-Ray On Trigger	A signal that indicated that the X-Ray source has been activated for image recording
109006	Differential signal	An electrical signal derived from two electrodes
109007	His bundle electrogram	An electrophysiological recording from the HIS nerve bundle
109008	Monopole signal	An electrical signal from one electrode relative to an indifferent potential
109009	Pacing (electrical) stimulus, voltage	The voltage stimulus during cardiac pacing
109010	Radio frequency ablation, power	The power injected during RF ablation procedure
109011	Voltage measurement by basket catheter	Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes
109012	Voltage measurement by mapping catheter	Electrophysiological signals acquired using a steerable catheter
109013	Voltage measurement, NOS	A voltage measurement not otherwise specified
109014	35% of thermal CO	A signal point that is 35% of the peak thermal cardiac output signal
109015	70% of thermal CO	A signal point that is 70% of the peak thermal cardiac output signal
109016	A wave peak pressure	The peak pressure of each heart beat in the atrium caused by the atrial contraction
109017	A wave pressure, average	The average of several A wave pressure measurements
109018	Beat detected (accepted)	An identified cardiac beat used in the determination of a measurement
109019	Beat detected (rejected)	An identified cardiac beat not used in the determination of a measurement
109020	Diastolic pressure, average	The average of several diastolic pressure measurements	deprecated
109021	Diastolic pressure nadir	The lowest pressure value excluding any undershoot artifact	deprecated
109022	End diastole	The moment at the end of the diastolic phase of the cardiac cycle	deprecated
109023	End of expiration	The moment at the end of respiratory expiration
109024	End of inspiration	The moment at the end of respiratory inspiration
109025	Max dp/dt	The maximum positive rate of change of pressure
109026	Max neg dp/dt	The maximum negative rate of change of pressure
109027	Mean blood pressure	The average blood pressure value, generally over 2 or more seconds	deprecated
109028	Peak of thermal cardiac output bolus	The peak change in blood temperature during a thermal cardiac output measurement
109029	Start of expiration	The moment respiratory expiration begins
109030	Start of inspiration	The moment of respiratory inspiration begins
109031	Start of thermal cardiac output bolus	The first discernible blood temperature change following the injectate during a thermal cardiac output measurement
109032	Systolic pressure, average	The average of several systolic blood pressure measurements	deprecated
109033	Systolic peak pressure	The highest systolic blood pressure value excluding any overshoot artifact	deprecated
109034	V wave peak pressure	The peak pressure of each heart beat in the atrium caused by the filling of the atrium
109035	V wave pressure, average	The average of several V wave pressure measurements
109036	Valve close	The moment at which a heart valve closes
109037	Valve open	The moment at which a heart valve opens
109038	Ablation off	The moment when RF ablation current is turned off
109039	Ablation on	The moment when RF ablation current is turned on
109040	HIS bundle wave	The moment in the cardiac cycle when the HIS bundle nerves depolarize
109041	P wave	The surface electrocardiogram of the atrial contraction
109042	Q wave	The first negative deflection of the electrocardiogram caused by ventricular depolarization
109043	R wave	The first positive deflection the electrocardiogram caused by ventricular depolarization
109044	S wave	The first negative deflection after the R wave
109045	Start of atrial contraction	The beginning of the atrial contraction
109046	Start of atrial contraction (subsequent)	The beginning of the second atrial contraction of two consecutive beats
109047	Stimulation at rate 1 interval	The stimulation interval during cardiac stimulation first used in a pacing train
109048	Stimulation at rate 2 interval	The stimulation interval different from the first stimulation interval used in a pacing train
109049	Stimulation at rate 3 interval	A stimulation interval different from and subsequent to the second interval in a pacing train
109050	Stimulation at rate 4 interval	Describes a stimulation interval different from and subsequent to the third interval in a pacing train
109051	T wave	The electrocardiogram deflection caused by ventricular repolarization
109052	V wave	The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium
109053	V wave of next beat	The second V wave measurement of two consecutive beats
109054	Patient State	A description of the physiological condition of the patient
109055	Protocol Stage	The exercise level during a progressive cardiac stress test
109056	Stress Protocol	A series of physiological challenges designed to progressively increase the work of the heart
109057	Catheterization Procedure Phase	A subpart of a cardiac catheterization procedure	deprecated
109058	Contrast Phase	The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient
109059	Physiological challenges	Physical changes administered to a patient in order to elicit an physiological response
109060	Procedure Step Number	Enumeration of a subpart of a catheterization procedure
109061	EP Procedure Phase	A subpart of an electrophysiological procedure
109063	Pulse train definition	A means of defining a series of cardiac stimulation pulses
109070	End of systole	End of the contraction phase of the cardiac cycle	deprecated
109071	Indicator mean transit time	Time for a median particle to travel from point of injection to point of detection
109072	Tau	The time constant of isovolumic pressure fall
109073	V max myocardial	Maximum velocity of myocardial contractility
109080	Real time acquisition	Total time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037)
109081	Prospective gating	Certain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037)
109082	Retrospective gating	Certain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037)
109083	Paced	There is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037); e.g. Pacemaker
109091	Cardiac Stress State	Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means	deprecated
109092	Reinjection State	Imaging after injection of additional tracer under resting conditions
109093	Redistribution State	Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection
109094	Delayed Redistribution State	Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection
109095	Peak stress state	Peak cardiac stress state	deprecated
109096	Recovery state	Recovery from cardiac stress	deprecated
109101	Acquisition Equipment	Equipment that originally acquired the data stored within composite instances; e.g. a CT, MR or Ultrasound modality
109102	Processing Equipment	Equipment that has processed composite instances to create new composite instances; e.g. a 3D Workstation
109103	Modifying Equipment	Equipment that has modified existing composite instances (without creating new composite instances); e.g. a QA Station or Archive
109104	De-identifying Equipment	Equipment that has modified an existing composite instance to remove patient identifying information
109105	Frame Extracting Equipment	Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance
109106	Enhanced Multi-frame Conversion Equipment	Equipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity
109110	Voice	The sound of a human's speech, recorded during a procedure
109111	Operator's narrative	The voice of a device operator, recorded during a procedure
109112	Ambient room environment	The ambient sound recorded during a procedure, which may or may not include voice and other types of sound
109113	Doppler audio	The Doppler waveform recorded as an audible signal
109114	Phonocardiogram	The sound of the human heart beating
109115	Physiological audio signal	Any sound made by the human body
109116	Arterial Pulse Waveform	A digitized signal from the patient arterial system collected through pulse oximetry or other means
109117	Respiration Waveform	A digitized signal from the patient respiratory system representing respiration
109120	On admission to unit	The occasion on which a procedure was performed on admission to a specialist unit; e.g. intensive care
109121	On discharge	The occasion on which a procedure was performed on discharge from hospital as an in-patient
109122	On discharge from unit	The occasion on which a procedure was performed on discharge from a specialist unit; e.g. intensive care
109123	Pre-intervention	The occasion on which a procedure was performed immediately prior to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109124	Post-intervention	The occasion on which a procedure was performed immediately after to non-surgical intervention; e.g, percutaneous angioplasty, biopsy
109125	At last appointment	The occasion on which a procedure was performed at the most recent outpatient visit
109132	Joint position method	The active or passive joint positioning during acquisition
109133	Physical force	A physical force applied during acquisition
109134	Prior to voiding	Prior to voiding
109135	Post voiding	Post voiding
109136	Neutral musculoskeletal position	Neutral musculoskeletal position
109200	America Kennel Club	America Kennel Club
109201	America's Pet Registry Inc.	America's Pet Registry Inc
109202	American Canine Association	American Canine Association
109203	American Purebred Registry	American Purebred Registry
109204	American Rare Breed Association	American Rare Breed Association
109205	Animal Registry Unlimited	Animal Registry Unlimited
109206	Animal Research Foundation	Animal Research Foundation
109207	Canadian Border Collie Association	Canadian Border Collie Association
109208	Canadian Kennel Club	Canadian Kennel Club
109209	Canadian Livestock Records Association	Canadian Livestock Records Association
109210	Canine Federation of Canada	Canine Federation of Canada
109211	Continental Kennel Club	Continental Kennel Club
109212	Dog Registry of America	Dog Registry of America
109213	Federation of International Canines	Federation of International Canines
109214	International Progressive Dog Breeders' Alliance	International Progressive Dog Breeders' Alliance
109215	National Kennel Club	National Kennel Club
109216	North American Purebred Dog Registry	North American Purebred Dog Registry
109217	United All Breed Registry	United All Breed Registry
109218	United Kennel Club	United Kennel Club
109219	Universal Kennel Club International	Universal Kennel Club International
109220	Working Canine Association of Canada	Working Canine Association of Canada
109221	World Kennel Club	World Kennel Club
109222	World Wide Kennel Club	World Wide Kennel Club
109701	Overall image quality evaluation	Evaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1]
109702	Grayscale resolution evaluation	Visual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1]
109703	Luminance response evaluation	Visual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1]
109704	Luminance uniformity evaluation	Visual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1]
109705	Chromaticity evaluation	Visual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1]
109706	Pixel faults evaluation	Visual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1]
109707	Veiling glare evaluation	Visual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1]
109708	Geometrical image evaluation	Visual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1]
109709	Angular viewing evaluation	Visual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1]
109710	Clinical evaluation	Visual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1]
109801	TG18-QC Pattern	AAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03]
109802	TG18-BR Pattern	AAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03]
109803	TG18-PQC Pattern	AAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03]
109804	TG18-CT Pattern	AAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03]
109805	TG18-LN8-01 Pattern	The 1st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109806	TG18-LN8-02 Pattern	The 2nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109807	TG18-LN8-03 Pattern	The 3rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109808	TG18-LN8-04 Pattern	The 4th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109809	TG18-LN8-05 Pattern	The 5th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109810	TG18-LN8-06 Pattern	The 6th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109811	TG18-LN8-07 Pattern	The 7th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109812	TG18-LN8-08 Pattern	The 8th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109813	TG18-LN8-09 Pattern	The 9th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109814	TG18-LN8-10 Pattern	The 10th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03]
109815	TG18-LN8-11 Pattern	The 11th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109816	TG18-LN8-12 Pattern	The 12th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109817	TG18-LN8-13 Pattern	The 13th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109818	TG18-LN8-14 Pattern	The 14th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109819	TG18-LN8-15 Pattern	The 15th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109820	TG18-LN8-16 Pattern	The 16th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109821	TG18-LN8-17 Pattern	The 17th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]
109822	TG18-LN8-18 Pattern	The 18th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03]
109823	TG18-LN12-01 Pattern	The 1st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109824	TG18-LN12-02 Pattern	The 2 nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109825	TG18-LN12-03 Pattern	The 3rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109826	TG18-LN12-04 Pattern	The 4th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109827	TG18-LN12-05 Pattern	The 5th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109828	TG18-LN12-06 Pattern	The 6th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109829	TG18-LN12-07 Pattern	The 7th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109830	TG18-LN12-08 Pattern	The 8th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109831	TG18-LN12-09 Pattern	The 9th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109832	TG18-LN12-10 Pattern	The 10th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109833	TG18-LN12-11 Pattern	The 11th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109834	TG18-LN12-12 Pattern	The 12th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109835	TG18-LN12-13 Pattern	The 13th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109836	TG18-LN12-14 Pattern	The 14th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109837	TG18-LN12-15 Pattern	The 15th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109838	TG18-LN12-16 Pattern	The 16th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109839	TG18-LN12-17 Pattern	The 17th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109840	TG18-LN12-18 Pattern	The 18th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]
109841	TG18-UN10 Pattern	The AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109842	TG18-UN80 Pattern	The AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]
109843	TG18-UNL10 Pattern	The AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03]
109844	TG18-UNL80 Pattern	The AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03]
109845	TG18-AD Pattern	The AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03]
109846	TG18-MP Pattern	The AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03]
109847	TG18-RH10 Pattern	The AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03]
109848	TG18-RH50 Pattern	The AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03]
109849	TG18-RH89 Pattern	The AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03]
109850	TG18-RV10 Pattern	The AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03]
109851	TG18-RV50 Pattern	The AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03]
109852	TG18-RV89 Pattern	The AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03]
109853	TG18-PX Pattern	The AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03]
109854	TG18-CX Pattern	The AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03]
109855	TG18-LPH10 Pattern	The AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109856	TG18-LPH50 Pattern	The AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109857	TG18-LPH89 Pattern	The AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109858	TG18-LPV10 Pattern	The AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]
109859	TG18-LPV50 Pattern	The AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03]
109860	TG18-LPV89 Pattern	The AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]
109861	TG18-AFC Pattern	The AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03]
109862	TG18-NS10 Pattern	The AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109863	TG18-NS50 Pattern	The AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109864	TG18-NS89 Pattern	The AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]
109865	TG18-GV Pattern	The TG18-GV Pattern used to assess display veiling. See [AAPM OR 03]
109866	TG18-GVN Pattern	The TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109867	TG18-GQ Pattern	The TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03]
109868	TG18-GQN Pattern	TG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]
109869	TG18-GQB Pattern	The TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03]
109870	TG18-GA03 Pattern	The TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03]
109871	TG18-GA05 Pattern	The TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03]
109872	TG18-GA08 Pattern	The TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03]
109873	TG18-GA10 Pattern	The TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03]
109874	TG18-GA15 Pattern	The TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15
109875	TG18-GA20 Pattern	The TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03]
109876	TG18-GA25 Pattern	The TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03]
109877	TG18-GA30 Pattern	The TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03]
109878	TG18-CH Image	The AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03]
109879	TG18-KN Image	The AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03]
109880	TG18-MM1 Image	The AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109881	TG18-MM2 Image	The AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03]
109901	OIQ Pattern	The IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1]
109902	ANG Pattern	The IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1]
109903	GD Pattern	The IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1]
109904	BN01 Pattern	The IEC BN01 Pattern is used as analternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109905	BN02 Pattern	The IEC BN02 Pattern is used as analternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109906	BN03 Pattern	The IEC BN03 Pattern is used as analternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109907	BN04 Pattern	The IEC BN04 Pattern is used as analternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109908	BN05 Pattern	The IEC BN05 Pattern is used as analternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109909	BN06 Pattern	The IEC BN06 Pattern is used as analternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109910	BN07 Pattern	The IEC BN07 Pattern is used as analternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109911	BN08 Pattern	The IEC BN08 Pattern is used as analternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109912	BN09 Pattern	The IEC BN09 Pattern is used as analternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109913	BN10 Pattern	The IEC BN10 Pattern is used as analternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109914	BN11 Pattern	The IEC BN11 Pattern is used as analternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109915	BN12 Pattern	The IEC BN12 Pattern is used as analternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109916	BN13 Pattern	The IEC BN13 Pattern is used as analternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109917	BN14 Pattern	The IEC BN14 Pattern is used as analternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109918	BN15 Pattern	The IEC BN15 Pattern is used as analternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109919	BN16 Pattern	The IEC BN16 Pattern is used as analternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109920	BN17 Pattern	The IEC BN17 Pattern is used as analternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109921	BN18 Pattern	The IEC BN18 Pattern is used as analternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]
109931	DIN Grayscale Pattern	Test image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57]
109932	DIN Geometry Pattern	Test image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57]
109933	DIN Resolution Pattern	Test image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57]
109941	White Pattern	An alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value
109943	SMPTE Pattern	A standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif
109991	CRT Display	A Display Device that displays images on a Cathode Ray Tube
109992	Liquid Crystal Display	A Display Device that displays images on a Liquid Crystal Display
109993	Plasma Display	A Display Device that displays images on a Plasma Display
109994	OLED	A Display Device that displays images on an Organic Light Emitting Diode based display
109995	DLP Rear Projection System	A Display Device that projects images on a surface from behind using a Digital Light Processing Projector
109996	DLP Front Projection System	A Display Device that projects images on a surface from in front using a Digital Light Processing Projector
109997	CRT Rear Projection System	A Display Device that projects images on a surface from behind using a Cathode Ray Tube
109998	CRT Front Projection System	A Display Device that projects images on a surface from in front using a Cathode Ray Tube
109999	Other Projection System	A Display Device that projects images on a surface from an unspecified direction using an unspecified means
110001	Image Processing	Image processing work item
110002	Quality Control	Quality control work item
110003	Computer Aided Diagnosis	Computer aided diagnosis work item
110004	Computer Aided Detection	Computer aided detection work item
110005	Interpretation	Interpretation work item
110006	Transcription	Transcription work item
110007	Report Verification	Report verification work item
110008	Print	Print work item
110009	No subsequent Workitems	There will be no more work items scheduled
110010	Film	Film type of output
110011	Dictation	Dictation type of output
110012	Transcription	Transcription type of output
110013	Media Import	The procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available
110020	Sheet Film Digitized	Digitization of Sheet Film
110021	Cine Film Digitized	Digitization of Cine Film
110022	Video Tape Digitized	Digitization of Video Tape
110023	Paper Digitized	Digitization of pages of a paper document (Units may be specified as Pages, Documents)
110024	CD Imported	Importation of CD
110025	DVD Imported	Importation of DVD
110026	MOD Imported	Importation of MOD
110027	Studies Imported	Importation of DICOM Studies
110028	Instances Imported	Importation of DICOM Composite Instances
110030	USB Disk Emulation	A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies
110031	Email	Email and email attachments used as a media for data transport
110032	CD	CD-R, CD-ROM, and CD-RW media used for data transport
110033	DVD	DVD, DVD-RAM, and other DVD formatted media used for data transport
110034	Compact Flash	Media that comply with the Compact Flash standard
110035	Multi-media Card	Media that comply with the Multi-media Card standard
110036	Secure Digital Card	Media that comply with the Secure Digital Card standard
110037	URI	URI Identifier for network or other resource, see RFC 3968
110038	Paper Document	Any paper or similar document
110100	Application Activity	Audit event: Application Activity has taken place
110101	Audit Log Used	Audit event: Audit Log has been used
110102	Begin Transferring DICOM Instances	Audit event: Storage of DICOM Instances has begun
110103	DICOM Instances Accessed	Audit event: DICOM Instances have been created, read, updated, or deleted
110104	DICOM Instances Transferred	Audit event: Storage of DICOM Instances has been completed
110105	DICOM Study Deleted	Audit event: Entire Study has been deleted
110106	Export	Audit event: Data has been exported out of the system
110107	Import	Audit event: Data has been imported into the system
110108	Network Entry	Audit event: System has joined or left network
110109	Order Record	Audit event: Order has been created, read, updated or deleted
110110	Patient Record	Audit event: Patient Record has been created, read, updated, or deleted
110111	Procedure Record	Audit event: Procedure Record has been created, read, updated, or deleted
110112	Query	Audit event: Query has been made
110113	Security Alert	Audit event: Security Alert has been raised
110114	User Authentication	Audit event: User Authentication has been attempted
110120	Application Start	Audit event: Application Entity has started
110121	Application Stop	Audit event: Application Entity has stopped
110122	Login	Audit event: User login has been attempted
110123	Logout	Audit event: User logout has been attempted
110124	Attach	Audit event: Node has been attached
110125	Detach	Audit event: Node has been detached
110126	Node Authentication	Audit event: Node Authentication has been attempted
110127	Emergency Override Started	Audit event: Emergency Override has started
110128	Network Configuration	Audit event: Network configuration has been changed
110129	Security Configuration	Audit event: Security configuration has been changed
110130	Hardware Configuration	Audit event: Hardware configuration has been changed
110131	Software Configuration	Audit event: Software configuration has been changed
110132	Use of Restricted Function	Audit event: A use of a restricted function has been attempted
110133	Audit Recording Stopped	Audit event: Audit recording has been stopped
110134	Audit Recording Started	Audit event: Audit recording has been started
110135	Object Security Attributes Changed	Audit event: Security attributes of an object have been changed
110136	Security Roles Changed	Audit event: Security roles have been changed
110137	User security Attributes Changed	Audit event: Security attributes of a user have been changed
110138	Emergency Override Stopped	Audit event: Emergency Override has Stopped
110139	Remote Service Operation Started	Audit event: Remote Service Operation has Begun
110140	Remote Service Operation Stopped	Audit event: Remote Service Operation has Stopped
110141	Local Service Operation Started	Audit event: Local Service Operation has Begun
110142	Local Service Operation Stopped	Audit event: Local Service Operation Stopped
110150	Application	Audit participant role ID of software application
110151	Application Launcher	Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application
110152	Destination Role ID	Audit participant role ID of the receiver of data
110153	Source Role ID	Audit participant role ID of the sender of data
110154	Destination Media	Audit participant role ID of media receiving data during an export
110155	Source Media	Audit participant role ID of media providing data during an import
110180	Study Instance UID	ParticipantObjectID type: Study Instance UID
110181	SOP Class UID	ParticipantObjectID type: SOP Class UID
110182	Node ID	ID of a node that is a participant object of an audit message
110190	Issuer of Identifier	System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.)
110500	Doctor canceled procedure	Procedure order canceled by requesting physician or other authorized physician
110501	Equipment failure	Equipment failure prevented completion of procedure
110502	Incorrect procedure ordered	Procedure discontinued due to incorrect procedure being ordered
110503	Patient allergic to media/contrast	Procedure discontinued due to patient allergy to media/contrast (reported or reaction)
110504	Patient died	Procedure discontinued due to death of Patient
110505	Patient refused to continue procedure	Procedure discontinued due to patient refusal to continue procedure
110506	Patient taken for treatment or surgery	Procedure discontinued due to patient being taken for treatment or surgery
110507	Patient did not arrive	Patient did not arrive for procedure
110508	Patient pregnant	Procedure discontinued due to patient pregnancy (reported or determined)
110509	Change of procedure for correct charging	Procedure discontinued to restart with new procedure code for correct charging
110510	Duplicate order	Procedure discontinued due to duplicate orders received for same procedure
110511	Nursing unit cancel	Procedure order canceled by nursing unit
110512	Incorrect side ordered	Procedure discontinued due to incorrect side (laterality) being ordered
110513	Discontinued for unspecified reason	Procedure discontinued for unspecified reason
110514	Incorrect worklist entry selected	Procedure discontinued due to incorrect patient or procedure step selected from modality worklist
110515	Patient condition prevented continuing	Patient condition prevented continuation of procedure
110516	Equipment change	Procedure step is discontinued to change to other equipment or modality
110518	Patient Movement	A movement of the patient affecting test quality
110519	Operator Error	An error of the operator affecting test quality
110521	Objects incorrectly formatted	One or more of the objects is malformed
110522	Object Types not supported	Receiving System is unable to accept the object type
110523	Object Set incomplete	One or more objects associated with the object set is missing
110524	Media Failure	The contents of the Media could not be accessed properly
110526	Resource pre-empted	Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure
110527	Resource inadequate	Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure
110528	Discontinued Procedure Step rescheduled	A new Procedure Step has been scheduled to replace the Discontinued Procedure Step
110529	Discontinued Procedure Step rescheduling recommended	It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step
110700	Ventral Diencephalon	Ventral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html
110701	White Matter T1 Hypointensity	Area(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images
110702	White Matter T2 Hyperintensity	Area(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images
110703	superior longitudinal fasciculus I	The dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110704	superior longitudinal fasciculus II	The major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110705	superior longitudinal fasciculus III	The ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186
110706	Perilesional White Matter	White matter that surrounds a lesion of interest; e.g. to identify the otherwise unclassified white matter that surrounds a tumor to be surgically resected
110800	Spin Tagging Perfusion MR Signal Intensity	Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer
110801	Contrast Agent Angio MR Signal Intensity	Signal intensity of a Contrast Agent Angio MR image
110802	Time Of Flight Angio MR Signal Intensity	Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins
110803	Proton Density Weighted MR Signal Intensity	Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'
110804	T1 Weighted MR Signal Intensity	Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times
110805	T2 Weighted MR Signal Intensity	Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest
110806	T2* Weighted MR Signal Intensity	Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies
110807	Field Map MR Signal Intensity	Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image
110808	Fractional Anisotropy	Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values
110809	Relative Anisotropy	Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image
110810	Volumetric Diffusion Dxx Component	Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis
110811	Volumetric Diffusion Dxy Component	Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions
110812	Volumetric Diffusion Dxz Component	Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions
110813	Volumetric Diffusion Dyy Component	Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis
110814	Volumetric Diffusion Dyz Component	Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions
110815	Volumetric Diffusion Dzz Component	Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis
110816	T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels
110817	T2 Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain
110818	T2* Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain
110819	Blood Oxygenation Level	Signal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR)
110820	Nuclear Medicine Projection Activity	Accumulated decay event counts in a nuclear medicine projection image
110821	Nuclear Medicine Tomographic Activity	Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET)
110822	Spatial Displacement X Component	Spatial Displacement along axis X of a non-linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient
110823	Spatial Displacement Y Component	Spatial Displacement along axis Y of a non-linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient
110824	Spatial Displacement Z Component	Spatial Displacement along axis Z of a non-linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient
110825	Hemodynamic Resistance	Measured resistance to the flow of blood; e.g. through the vasculature or through a heart value
110826	Indexed Hemodynamic Resistance	Measured resistance to the flow of blood; e.g. through the vasculature or through a heart value, normalized to a particular indexed scale
110827	Tissue Velocity	Velocity of tissue based on Doppler measurements
110828	Flow Velocity	Velocity of blood flow based on Doppler measurements
110829	Flow Variance	Statistical variance of blood velocity relative to mean
110830	Elasticity	Scalar value related to the elastic properties of the tissue
110831	Perfusion	Scalar value related to the volume of blood perfusing into tissue
110832	Speed of sound	Speed of sound in tissue
110833	Ultrasound Attenuation	Reduction in strength of ultrasound signal as the wave
110834	RGB R Component	Red component of a true color image (RGB)
110835	RGB G Component	Green component of a true color image (RGB)
110836	RGB B Component	Blue component of a true color image (RGB)
110837	YBR FULL Y Component	Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000
110838	YBR FULL CB Component	CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000
110839	YBR FULL CR Component	CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000
110840	YBR PARTIAL Y Component	Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000
110841	YBR PARTIAL CB Component	CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110842	YBR PARTIAL CR Component	CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000
110843	YBR ICT Y Component	Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110844	YBR ICT CB Component	CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110845	YBR ICT CR Component	CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000
110846	YBR RCT Y Component	Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110847	YBR RCT CB Component	CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110848	YBR RCT CR Component	CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000
110849	Echogenicity	The ability of a material to create an ultrasound return echo
110850	X-Ray Attenuation	Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering
110851	X-Ray Attenuation Coefficient	Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms	deprecated
110852	MR signal intensity	Signal intensity of an MR image, not otherwise specified
110853	Binary Segmentation	Binary value denoting that the segmented property is present
110854	Fractional Probabilistic Segmentation	Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel
110855	Fractional Occupancy Segmentation	Percentage of the voxel area occupied by the segmented property
110856	Linear Displacement	Spatial dimension, denoting a linear displacement
110857	Photon Energy	Dimension denoting the energy (frequency or wavelength) of photons
110858	Time	Dimension used to sequence events, to compare the duration of events and the intervals between events
110859	Angle	Spatial dimension, denoting an angle
110860	Left-Right Axis	A spatial dimension axis running along a line between the patient's left and right side
110861	Head-Foot Axis	A spatial dimension axis running along a line between the patient's head and foot
110862	Anterior-Posterior Axis	A spatial dimension axis running along a line between the patient's anterior and posterior sides
110863	Apex-Base Axis	A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber
110864	Anterior-Inferior Axis	A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber
110865	Septum-Wall Axis	A spatial dimension axis running along a line between the septum and wall of a chamber
110866	Right To Left	Orientation of a spatial dimension where increasing values run from the right to the left side of the patient
110867	Left To Right	Orientation of a spatial dimension where increasing values run from the left to the right side of the patient
110868	Head To Foot	Orientation of a spatial dimension where increasing values run from the head to the foot of the patient
110869	Foot To Head	Orientation of a spatial dimension where increasing values run from the foot to the head of the patient
110870	Anterior To Posterior	Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient
110871	Posterior To Anterior	Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient
110872	Apex To Base	Orientation of a spatial dimension where increasing values run from the apex to the base
110873	Base To Apex	Orientation of a spatial dimension where increasing values run from the base to the apex
110874	Anterior To Inferior	Orientation of a spatial dimension where increasing values run from the anterior to the inferior
110875	Inferior To Anterior	Orientation of a spatial dimension where increasing values run from the inferior to the anterior
110876	Septum To Wall	Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall
110877	Wall To Septum	Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber
110901	Image Position (Patient) X	The x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110902	Image Position (Patient) Y	The y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110903	Image Position (Patient) Z	The z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system
110904	Image Orientation (Patient) Row X	The x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110905	Image Orientation (Patient) Row Y	The y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110906	Image Orientation (Patient) Row Z	The z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system
110907	Image Orientation (Patient) Column X	The x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110908	Image Orientation (Patient) Column Y	The y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110909	Image Orientation (Patient) Column Z	The z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system
110910	Pixel Data Rows	Number of rows in the pixel data of the image
110911	Pixel Data Columns	Number of columns in the pixel data of the image
111001	Algorithm Name	The name assigned by a manufacturer to a specific software algorithm
111002	Algorithm Parameters	The input parameters used by a manufacturer to configure the behavior of a specific software algorithm
111003	Algorithm Version	The software version identifier assigned by a manufacturer to a specific software algorithm
111004	Analysis Performed	The type of correlation applied to detection results; e.g. temporal, spatial
111005	Assessment Category	Assignment of intermediate or overall interpretation results to a general category
111006	Breast composition	Assessment of annotating tissues in breast; generally including fatty, mixed or dense	deprecated
111007	Breast Outline including Pectoral Muscle Tissue	Purpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue
111008	Calcification Distribution	The type of distribution associated with detected calcifications
111009	Calcification Type	Identification of the morphology of detected calcifications
111010	Center	Purpose of reference for an SCOORD content item that identifies the central point of a finding or feature
111011	Certainty of Feature	The likelihood that the feature analyzed is in fact the type of feature identified
111012	Certainty of Finding	The likelihood that the finding detected is in fact the type of finding identified
111013	Certainty of Impression	The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty
111014	Clockface or region	A location identifier based on clock-face numbering or anatomic sub-region
111015	Composite Feature	An item that is an inferred correlation relating two or more individual findings or features
111016	Composite type	The inferred relationship between the findings or features making up a composite feature
111017	CAD Processing and Findings Summary	General assessment of whether or not CAD processing was successful, and whether any findings resulted
111018	Content Date	The date the data creation started
111019	Content Time	The time the data creation started
111020	Depth	A location identifier based on a feature's inferred distance from the surface of the associated anatomy
111021	Description of Change	A textual description of the change that occurred over time in a qualitative characteristic of a feature
111022	Detection Performed	The type of finding sought after by a specific algorithm applied to one image
111023	Differential Diagnosis/Impression	A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure
111024	Failed Analyses	A group of analysis algorithms that were attempted, but failed
111025	Failed Detections	A group of detection algorithms that were attempted, but failed
111026	Horizontal Pixel Spacing	For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel
111027	Image Laterality	Laterality of (possibly paired) body part contained in an image
111028	Image Library	A container that references all image data used as evidence to produce a report
111029	Image Quality Rating	A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality
111030	Image Region	Purpose of reference for an SCOORD content item that identifies a specific region of interest within an image
111031	Image View	The projection of the anatomic region of interest on an image receptor
111032	Image View Modifier	Modifier for Image View
111033	Impression Description	Free-form text describing the overall or an individual impression
111034	Individual Impression/Recommendation	A container for a group of related results from interpretation of one or more images and associated clinical information
111035	Lesion Density	The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue
111036	Mammography CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information
111037	Margins	The characteristic of the boundary, edges or border of a detected lesion
111038	Number of calcifications	The quantity of calcifications detected within an identified group or cluster
111039	Object type	A non-lesion object identified within one or more images
111040	Original Source	Purpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report
111041	Outline	Purpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature
111042	Pathology	The inferred type of disease associated with an identified feature
111043	Patient Orientation Column	The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom)
111044	Patient Orientation Row	The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right)
111045	Pectoral Muscle Outline	Purpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only
111046	Percent Fibroglandular Tissue	Percent of breast area that is mammographically dense, excluding pectoralis muscle
111047	Probability of cancer	The likelihood that an identified finding or feature is cancerous
111048	Quadrant location	A location identifier based on the division of an area into four regions
111049	Qualitative Difference	A qualitative characteristic of a feature that has changed over time
111050	Quality Assessment	The effect of the quality of an image on its usability
111051	Quality Control Standard	The quality control standard used to make a quality assessment
111052	Quality Finding	A specific quality related deficiency detected within an image
111053	Recommended Follow-up	Recommended type of follow-up to an imaging procedure, based on interpreted results
111054	Recommended Follow-up Date	Recommended follow-up date to an imaging procedure, based on interpreted results
111055	Recommended Follow-up Interval	Recommended follow-up interval to an imaging procedure, based on interpreted results
111056	Rendering Intent	The recommendation of the producer of a content item regarding presentation of the content item by recipients of the report
111057	Scope of Feature	An indication of how widespread the detection of a feature is within the analyzed image data set
111058	Selected Region Description	A textual description of the contents of a selected region identified within an image
111059	Single Image Finding	An item that was detected on one image
111060	Study Date	Date on which the acquisition of the study information was started
111061	Study Time	Time at which the acquisition of the study information was started
111062	Successful Analyses	A group of analysis algorithms that were attempted and completed successfully
111063	Successful Detections	A group of detection algorithms that were attempted and completed successfully
111064	Summary of Detections	An overall indication of whether the CAD detection algorithms applied were completed successfully
111065	Summary of Analyses	An overall indication of whether the CAD analysis algorithms applied were completed successfully
111066	Vertical Pixel Spacing	For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel
111069	Crosstable	A radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other; e.g. may describe a cross-table cervical spine, chest or pelvis X-Ray image
111071	CAD Operating Point	One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point
111072	Maximum CAD Operating Point	The maximum value of CAD Operating Point for the specific CAD algorithm used
111081	CAD Operating Point Description	The intended interpretation of a CAD Operating Point
111086	False Markers per Image	The number of false CAD markers per image. Correlates to inverse of Image Specificity
111087	False Markers per Case	The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity
111088	Case Sensitivity	The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view
111089	Lesion Sensitivity	The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view
111090	Case Specificity	The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case
111091	Image Specificity	The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image
111092	Recommended CAD Operating Point	The CAD operating point that is recommended for initial display by the creator of the structured report
111093	CAD Operating Point Table	A list of CAD operating points including their corresponding characteristics
111099	Selected region	A specific area of interest noted within an image
111100	Breast geometry	The surface shape of all or a portion of breast related anatomy
111101	Image Quality	Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling
111102	Non-lesion	A finding or feature that is identified as a non-anatomic foreign object
111103	Density	A space-occupying lesion identified in a single image or projection	deprecated
111104	Individual Calcification	A single identified calcification	deprecated
111105	Calcification Cluster	Multiple calcifications identified as occupying a small area of tissue (less than 2 cc)	deprecated
111111	Cooper's ligament changes	Straightening or thickening of Cooper's ligaments
111112	Mass in the skin	An abnormality noted at imaging within the dermis of the breast
111113	Mass on the skin	An abnormality noted at imaging on the epidermis of the breast
111120	Post Procedure Mammograms for Marker Placement	An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure
111121	Follow-up post biopsy as directed by clinician	An indication that the patient should seek post procedural follow-up directives from a clinical health care provider
111122	Known biopsy proven malignancy - take appropriate action	A recommendation on a patient with known cancer to take steps appropriate to the diagnosis
111123	Marker placement	Positioning of a radiopaque marker
111124	Personal history of breast cancer with mastectomy	Patient has previous diagnosis of breast cancer resulting in mastectomy
111125	Known biopsy proven malignancy	Patient has had biopsy containing proven malignancy
111126	Image detected mass	Patient has a finding of mass reported on a prior imaging exam
111127	Targeted	A breast imaging procedure performed on a specific area of the breast
111128	Survey	A breast imaging procedure performed on the entire breast
111129	Clustered microcysts	A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components
111130	Complicated cyst	A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound
111135	Additional projections	Views not inclusive of MLO and CC (BI-RADS®)
111136	Spot magnification view(s)	A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue
111137	Ultrasound	Use of sound waves to visualize muscles, tendons, and many internal organs, to capture their size, structure and any pathological lesions with real time tomographic images.	deprecated
111138	Old films for comparison	Obtain previous mammography studies to compare to present study
111139	Ductography	A medical procedure used for the sampling of mammary duct tissue	deprecated
111140	Normal interval follow-up	Follow up study at 12 months for women 40 years of age having a prior negative study and no mitigating risk factors for breast cancer
111141	Any decision to biopsy should be based on clinical assessment	Any decision to perform tissue acquisition should be based on clinical assessment
111142	Follow-up at short interval (1-11 months)	Follow-up at short interval (1-11 months)
111143	Biopsy should be considered	Tissue acquisition should be considered
111144	Needle localization and biopsy	Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly
111145	Histology using core biopsy	Pathologic analysis of breast tissue and lesions using core tissue samples
111146	Suggestive of malignancy - take appropriate action	Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy
111147	Cytologic analysis	Cellular analysis of specimen
111148	Biopsy should be strongly considered	Tissue acquisition should be strongly considered
111149	Highly suggestive of malignancy - take appropriate action	Lesions have a high probability of being cancer, which require additional action
111150	Presentation Required: Rendering device is expected to present	The producer of a report intends for a recipient of the report to present or display the associated content item
111151	Presentation Optional: Rendering device may present	The producer of a report considers the presentation or display of the associated content item by a recipient to be optional
111152	Not for Presentation: Rendering device expected not to present	The producer of a report intends for a recipient of the report NOT to present or display the associated content item
111153	Target content items are related temporally	The associated content items are identified as being the same finding or feature at different points in time
111154	Target content items are related spatially	The associated content items are identified as being the same finding or feature on different projections taken at the same point in time
111155	Target content items are related contra-laterally	The associated content items are identified as being related side-to-side
111156	Feature detected on the only image	There is one image in the interpreted data set
111157	Feature detected on only one of the images	There is more than one image of the same modality in the interpreted data set
111158	Feature detected on multiple images	There is more than one image of the same modality in the interpreted data set
111159	Feature detected on images from multiple modalities	The interpreted data set contains images from multiple modalities
111168	Scar tissue	The fibrous tissue replacing normal tissues destroyed by disease or injury	deprecated
111170	J Wire	A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy	deprecated
111171	Pacemaker	A medical appliance used for regulating cardiac rhythms	deprecated
111172	Paddle	A compression device used for obtaining mammographic images	deprecated
111173	Collimator	A device used for restricting an X-Ray beam	deprecated
111174	ID Plate	An area designated on a radiographic film for facility and patient ID information	deprecated
111175	Other Marker	Site specific markers
111176	Unspecified	The value of the concept is not specified
111177	View and Laterality Marker is missing	Image quality deficiency according to MQSA
111178	View and Laterality Marker does not have both view and laterality	Image quality deficiency according to MQCM
111179	View and Laterality Marker does not have approved codes	Image quality deficiency according to MQCM
111180	View and Laterality Marker is not near the axilla	Image quality deficiency according to MQCM
111181	View and Laterality Marker overlaps breast tissue	Image quality deficiency according to MQCM
111182	View and Laterality Marker is partially obscured	Image quality deficiency according to MQCM
111183	View and Laterality Marker is incorrect	Image quality deficiency
111184	View and Laterality Marker is off image	Image quality deficiency
111185	Flash is not near edge of film	Image quality deficiency according to MQCM
111186	Flash is illigible, does not fit, or is lopsided	Image quality deficiency according to MQSA
111187	Flash doesn't include patient name and additional patient id	Image quality deficiency according to MQCM
111188	Flash doesn't include date of examination	Image quality deficiency according to MQCM
111189	Flash doesn't include facility name and location	Image quality deficiency according to MQSA
111190	Flash doesn't include technologist identification	Image quality deficiency according to MQCM
111191	Flash doesn't include cassette/screen/detector identification	Image quality deficiency according to MQCM
111192	Flash doesn't include mammography unit identification	Image quality deficiency according to MQCM
111193	Date sticker is missing	Image quality deficiency according to MQCM
111194	Technical factors missing	Image quality deficiency according to MQCM
111195	Collimation too close to breast	Image quality deficiency according to MQCM
111196	Inadequate compression	Image quality deficiency according to MQCM
111197	MLO Insufficient pectoral muscle	Image quality deficiency according to MQCM
111198	MLO No fat is visualized posterior to fibroglandular tissues	Image quality deficiency according to MQCM
111199	MLO Poor separation of deep and superficial breast tissues	Image quality deficiency according to MQCM
111200	MLO Evidence of motion blur	Image quality deficiency according to MQCM
111201	MLO Inframammary fold is not open	Image quality deficiency according to MQCM
111202	CC Not all medial tissue visualized	Image quality deficiency according to MQCM
111203	CC Nipple not centered on image	Image quality deficiency according to MQCM
111204	CC Posterior nipple line does not measure within 1 cm of MLO	Image quality deficiency according to MQCM
111205	Nipple not in profile	Image quality deficiency
111206	Insufficient implant displacement incorrect	Image quality deficiency according to MQCM
111207	Image artifact(s)	Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information
111208	Grid artifact(s)	Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity
111209	Positioning	Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image
111210	Motion blur	Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure
111211	Under exposed	Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest
111212	Over exposed	An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector
111213	No image	No evidence of a patient exposure
111214	Detector artifact(s)	Superposed features or flaws of the detector
111215	Artifact(s) other than grid or detector artifact	Features or discontinuities arising from causes other than the anti-scatter grid and image detector
111216	Mechanical failure	Failure of the device to operate according to mechanical design specifications
111217	Electrical failure	Failure of a device to operate according to electrical design specifications
111218	Software failure	Attributable to software used in generation or handling of image
111219	Inappropriate image processing	Images processed inappropriately, not following appropriate protocol
111220	Other failure	Failure that is not mechanical or electrical or otherwise described
111221	Unknown failure	Unidentified or unknown cause of failure
111222	Succeeded	The attempted process was completely successful
111223	Partially Succeeded	The attempted process succeeded in some ways, but failed in others
111224	Failed	The attempted process completely failed
111225	Not Attempted	No process was performed
111233	Individual Impression / Recommendation Analysis	Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation
111234	Overall Impression / Recommendation Analysis	Analysis of all groups of findings or features, to produce a single impression and/or recommendation
111235	Unusable - Quality renders image unusable	The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111236	Usable - Does not meet the quality control standard	The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111237	Usable - Meets the quality control standard	The usability of an image for diagnostic interpretation or CAD, based on a quality control standard
111238	Mammography Quality Control Manual 1999, ACR	An image quality control standard specified by the American College of Radiology
111239	Title 21 CFR Section 900, Subpart B	An image quality control standard in the US Code of Federal Regulations
111240	Institutionally defined quality control standard	An image quality control standard specified or adopted by the institution responsible for the document
111241	All algorithms succeeded; without findings	No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111242	All algorithms succeeded; with findings	One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis
111243	Not all algorithms succeeded; without findings	No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111244	Not all algorithms succeeded; with findings	One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process
111245	No algorithms succeeded; without findings	All of the attempted computer-aided detection and/or analysis failed, so there could be no findings
111248	Adenolipoma	A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts	deprecated
111249	Ductal hyperplasia	Hyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. Based on the pattern of the cells, hyperplasia may be called usual or atypical. In usual hyperplasia, the pattern of cells is very close to normal. Atypical hyperplasia (or hyperplasia with atypia) is a term used when the cells are more distorted. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia	deprecated
111250	Adenomyoepithelioma	Neoplasms composed of myoepithelial cells	deprecated
111251	Normal axillary node	Axillary node that is normal in appearance with no associated pathology
111252	Axillary node with calcifications	Axillary node containing calcifications
111253	Axillary node hyperplasia	Excessive proliferation of normal tissue arrangement of the axillary node
111254	Asynchronous involution		deprecated
111255	Benign cyst with blood	Cyst with benign morphology containing blood
111256	Benign Calcifications	Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy
111257	Intracystic papilloma	Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes	deprecated
111258	Ductal adenoma	Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple
111259	Diabetic fibrous mastopathy	The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus
111260	Extra abdominal desmoid	A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize	deprecated
111262	Epidermal inclusion cyst	A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin	deprecated
111263	Fibroadenomatoid hyperplasia	Excessive proliferation of fibroadenoma tissue
111264	Fibroadenolipoma	A lipoma with an abundant stroma of fibrous tissue
111265	Foreign body (reaction)		deprecated
111269	Galactocele	Retention cyst caused by occlusion of a lactiferous duct	deprecated
111271	Hemangioma - nonparenchymal, subcutaneous	A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous	deprecated
111273	Hyperplasia, usual	Hyperplasia is also known as epithelial hyperplasia or proliferative breast disease. It's an overgrowth of the cells that line the ducts or the lobules. Based on how the cells look under a microscope, the hyperplasia is called either ductal hyperplasia (also called duct epithelial hyperplasia) or lobular hyperplasia. FROM: http://www.cancer.org/healthy/findcancerearly/womenshealth/non-cancerousbreastconditions/non-cancerous-breast-conditions-hyperplasia	deprecated
111277	Juvenile papillomatosis	A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma
111278	Lactating adenoma	Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct	deprecated
111279	Lactational change	Changes related to the process of lactation
111281	Large duct papilloma	A papilloma pertaining to large mammary duct
111283	Myofibroblastoma	Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts	deprecated
111284	Microglandular adenosis	Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation
111285	Multiple Intraductal Papillomas	Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems
111286	No abnormality	No abnormality
111287	Normal breast tissue	Normal breast tissue
111288	Neurofibromatosis	Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas	deprecated
111290	Oil cyst (fat necrosis cyst)	A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst
111291	Post reduction mammoplasty	Breast tissue with characteristics of a benign nature, following breast reduction surgery
111292	Pseudoangiomatous stromal hyperplasia	A benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation
111293	Radial scar	An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia	deprecated
111294	Sclerosing adenosis	Prominent interductal fibrosis of the terminal ductules	deprecated
111296	Silicone granuloma	Nodular inflammatory lesions due to the presence of silicone in the breast tissue
111297	Nipple Characteristic	The morphologic status of the nipple
111298	Virginal hyperplasia	Spontaneous excessive proliferation of breast tissue, usually found in younger women
111299	Peripheral duct papillomas	Papilloma(s) pertaining the peripheral ducts
111300	Axillary node with lymphoma	Axillary node with lymphoid tissue neoplasm
111301	Axillary nodal metastases	Metastatic disease to the axillary node
111302	Angiosarcoma	A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts	deprecated
111303	Blood vessel (vascular) invasion	Histological changes to the vascular system related to an invasive process
111304	Carcinoma in children	Carcinoma of the breast found in patients less than 20 years of age
111305	Carcinoma in ectopic breast	A carcinoma found in supernumerary breasts and aberrant breast tissue
111306	Carcinoma with endocrine differentiation	A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast
111307	Basal cell carcinoma of nipple	A basal cell carcinoma that arises in the nipple of the breast
111308	Carcinoma with metaplasia	Metaplastic carcinoma is cancer that begins in cells that have changed into another cell type (for example, a squamous cell of the esophagus changing to resemble a cell of the stomach). In some cases, metaplastic changes alone may mean there is an increased chance of cancer developing at the site. Metaplastic carcinoma is a relatively uncommon type of cancer with treatment generally similar to that of invasive ductal carcinoma of no special type.[1] FROM: https://en.wikipedia.org/wiki/Metaplastic_carcinoma	deprecated
111309	Cartilaginous and osseous change	Tissue changes to bones and cartilage
111310	Carcinoma in pregnancy and lactation	Carcinoma of the breast presenting during pregnancy or lactation
111311	Carcinosarcoma	A malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue	deprecated
111312	Intraductal comedocarcinoma with necrosis	Comedocarcinoma of a duct with areas of necrotic tissue
111313	Intraductal carcinoma, low grade	A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior
111314	Intraductal carcinoma micro-papillary	Papillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3	deprecated
111315	Intracystic papillary carcinoma	A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst
111316	Invasive and in-situ carcinoma	Carcinoma with both characteristics of localized and spreading disease
111317	Invasive lobular carcinoma	Invasive lobular carcinoma is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. Invasive cancer means the cancer cells have broken out of the lobule where they began and have the potential to spread to the lymph nodes and other areas of the body. Invasive lobular carcinoma typically doesn't form a lump, which is common in breast cancer. Instead, there is a change in the breast that feels like a thickening or fullness in one part of the breast and is different from the surrounding breast tissue. FROM: http://www.mayoclinic.org/diseases-conditions/invasive-lobular-carcinoma/basics/definition/con-20033968	deprecated
111318	Leukemic infiltration	Mammary infiltrates as a secondary manifestation in patients with established leukemia
111320	Lympathic vessel invasion	Histological changes to the lymphatic system related to an invasive process
111321	Lymphoma	A heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems	deprecated
111322	Occult carcinoma presenting with axillary lymph node metastases	A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes
111323	Metastatic cancer to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm
111324	Metastatic cancer to the breast from the colon	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon
111325	Metastatic cancer to the breast from the lung	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung
111326	Metastatic melanoma to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma
111327	Metastatic cancer to the breast from the ovary	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary
111328	Metastatic sarcoma to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma
111329	Multifocal intraductal carcinoma	Multiple foci of non-invasive carcinoma restricted to the glandular lumen
111330	Metastatic disease to axillary node	A malignant lesion in an axillary node arising from a non-axillary neoplasm
111331	Malignant fibrous histiocytoma	Pleomorphic undifferentiated sarcoma (abbreviated PUS), also undifferentiated pleomorphic sarcoma and previously malignant fibrous histiocytoma (abbreviated MFH), is a type of soft tissue sarcoma. FROM: https://en.wikipedia.org/wiki/Pleomorphic_undifferentiated_sarcoma	deprecated
111332	Multifocal invasive ductal carcinoma	Multiple sites of ductal carcinoma
111333	Metastasis to an intramammary lymph node	A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm
111334	Malignant melanoma of nipple	A malignant melanoma of the skin that arises in the nipple of the breast
111335	Neoplasm of the mammary skin		deprecated
111336	Papillary carcinoma in-situ	Papillary and micropapillary Ductal Carcinoma In Situ (DCIS): the cancer cells arrange themselves in a fern-like pattern within the affected breast ducts; micropapillary DCIS cells are smaller than papillary DCIS cells. FROM: http://www.imaginis.com/breast-cancer-diagnosis/ductal-carcinoma-in-situ-dcis-3	deprecated
111338	Recurrent malignancy	Recurrent malignancy
111340	Squamous cell carcinoma of the nipple	Squamous cell carcinoma to the terminal portion of the alveolar
111341	Intraductal carcinoma, high grade	A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior
111342	Invasive cribriform carcinoma	Invasive tumor with cribriform pattern similar to cribriform DCIS. Low grade, cribriform appearance (well defined spaces formed by arches of cells) similar to cribriform DCIS but with larger cells, more cytoplasm and more vesicular nuclei: Tumor cells are small, often have apical snouts, mild/moderate nuclear pleomorphism; Also stromal invasion by islands of cells, often angulated; May have predominantly solid appearance; Associated with cribriform DCIS; Often mixed with tubular carcinoma. FROM: http://www.pathologyoutlines.com/topic/breastmalignantcribriform.html	deprecated
111343	Angular margins	An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles
111344	Fine pleomorphic calcification	Calcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter
111345	Macrocalcifications	Coarse calcifications that are 0.5 mm or greater in size
111346	Calcifications within a mass	An indicator that calcifications are imbedded within a mass
111347	Calcifications outside of a mass	An indicator that calcifications are imaged outside of a mass finding
111350	Breast background echotexture	Tissue composition of the breast noted on sonography
111351	Homogeneous fat echotexture	Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue
111352	Homogeneous fibroglandular echotexture	A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat
111353	Heterogeneous echotexture	The breast texture is characterized by multiple small areas of increased and decreased echogenicity
111354	Orientation	Referential relationship of the finding to the imaging device as noted on sonography
111355	Parallel	The long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation)
111356	Not parallel	The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension
111357	Lesion boundary	The lesion boundary describes the transition zone between themas and the surrounding tissue
111358	Abrupt interface	The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness
111359	Echogenic halo	There is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone
111360	Echo pattern	An imaging characteristic of resonance noted during sonography
111361	Anechoic	Without internal echoes
111362	Hyperechoic	Having increased echogenicity relative to fat or equal to fibroglandular tissue
111363	Complex	Mass contains both anechoic and echogenic components
111364	Hypoechoic	Defined relative to fat; masses are characterized by low-level echoes throughout; e.g. appearance of a complicated cyst or fibroadenoma
111365	Isoechoic	Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic)
111366	Posterior acoustic features	The attenuation characteristics of a mass with respect to its acoustic transmission
111367	No posterior acoustic features	No posterior shadowing or enhancement
111368	Posterior enhancement	Increased posterior echoes
111369	Posterior shadowing	Decreased posterior echoes; edge shadows are excluded
111370	Combined posterior enhancement and shadowing	More than one pattern of posterior attenuation, both shadowing and enhancement
111371	Identifiable effect on surrounding tissues	Sonographic appearance of adjacent structures relative to a mass finding
111372	Vascularity	Characterization of vascularization in region of interest
111373	Vascularity not present	Vascularity not evident, such as on ultrasound
111374	Vascularity not assessed	Vascularity not evaluated
111375	Vascularity present in lesion	Vascularity on imaging is seen within a lesion
111376	Vascularity present immediately adjacent to lesion	Vascularity on imaging is seen immediately adjacent to a lesion
111377	Diffusely increased vascularity in surrounding tissue	Vascularity on imaging is considered diffusely elevated within the surrounding breast tissue
111380	Correlation to other Findings	Relationship of the new anomaly to other clinical or imaging anomalies
111381	Correlates to physical exam findings	An indication that the current imaging finding relates to a finding from a clinical breast exam
111382	Correlates to mammography findings	An indication that the current imaging finding relates to a finding from a mammography exam
111383	Correlates to MRI findings	An indication that the current imaging finding relates to a finding from a breast MRI exam
111384	Correlates to ultrasound findings	An indication that the current imaging finding relates to a finding from a breast ultrasound exam
111385	Correlates to other imaging findings	An indication that the current imaging finding relates to a finding from an imaging exam
111386	No correlation to other imaging findings	An indication that the current imaging finding has no relation to findings from any other imaging exam
111387	No correlation to clinical findings	An indication that the current imaging finding has no relation to any other clinical findings
111388	Malignancy Type	Classification of the cancer as invasive, DCIS, or other
111389	Invasive breast carcinoma	A malignancy that has spread beyond an area of focus
111390	Other malignancy type	A breast cancer with malignant pathology findings that are not classified as invasive or in situ
111391	Menstrual Cycle Phase	A specific timeframe during menses
111392	1st week	In the first week of the menstrual cycle phase, that is, one week following menses
111393	2nd week	In the second week of the menstrual cycle phase, that is, two weeks following menses
111394	3rd week	In the third week of the menstrual cycle phase, that is, three weeks following menses
111395	Estimated Timeframe	An estimated period of time
111396	< 3 months ago	An event occurred less than 3 months ago
111397	4 months to 1 year ago	An event occurred between 4 months and 1 year ago
111398	> 1 year ago	An event occurred longer than 1 year ago
111399	Timeframe uncertain	The timing of an event is not recalled
111400	Breast Imaging Report	Report title for the diagnostic report for one or more breast imaging or intervention procedures
111401	Reason for procedure	Concept name for the description of why a procedure has been performed
111402	Clinical Finding	A finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge
111403	Baseline screening mammogram	First screening mammogram taken for patient that is used as a comparison baseline for further examinations
111404	First mammogram ever	First mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure
111405	Implant type	Concept name for the material of which a breast prosthetic device is constructed
111406	Number of similar findings	A numeric count of findings classified as similar in nature
111407	Implant finding	Concept name for the status of a breast prosthetic device as noted by imaging
111408	Film Screen Mammography	Mammogram using traditional X-Ray film
111409	Digital Mammography	Mammogram using a digital image acquisition system
111410	Surgical consult	Referred for evaluation by a surgeon
111411	Mammography CAD	Computer aided detection and/or computer aided diagnosis for mammography
111412	Narrative Summary	Concept name for a text-based section of a report
111413	Overall Assessment	A title for a report section that summarizes all interpretation results for a report with one overriding assessment; e.g. benign or negative
111414	Supplementary Data	Concept name for a collection of supporting evidence for a report
111415	Additional evaluation requested from prior study	Prior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region
111416	Follow-up at short interval from prior study	The prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months)
111417	History of breast augmentation, asymptomatic	Prior breast augmentation (breast enlargement) and is not presenting with any symptoms
111418	Review of an outside study	Review or second opinion made on an image performed outside of the facility
111419	Additional evaluation requested from abnormal screening exam	Additional breast imaging performed at the time of the patient's screening mammogram
111420	History of benign breast biopsy	Patient has had previous benign breast biopsies
111421	Personal history of breast cancer with breast conservation therapy	Patient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains
111423	Physical Examination Results	The results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion
111424	Comparison to previous findings	The result of assessing the current imaging exam in comparison to previous imaging exams
111425	Intraluminal filling defect	An abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained
111426	Multiple filling defect	During ductography an observation of more than one filling abnormality within the breast ductal system
111427	Abrupt duct termination	An abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion
111428	Extravasation	Abnormal flowage of contrast media within the breast noted on ductography
111429	Duct narrowing	An abnormality observed during ductography where the ductal system within the breast appears narrow
111430	Cyst fill	During ductography an observation of the contrast media filling a cyst within the breast
111431	Instrument Approach	The area and line within the anatomy through which a needle or instrument passes during an interventional procedure
111432	Inferolateral to superomedial	The line within the anatomy from the lower outer to the upper inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111433	Inferomedial to superolateral	The line within the anatomy from the lower inner to the upper outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111434	Superolateral to inferomedial	The line within the anatomy from the upper outer to the lower inner aspect; e.g. through which a needle or instrument passes in an interventional procedure
111435	Superomedial to inferolateral	The line within the anatomy from the upper inner to the lower outer aspect; e.g. through which a needle or instrument passes in an interventional procedure
111436	Number of passes	The number of times a biopsy instrument is passed through an area of interest
111437	Number of specimens	The number of biopsy specimens obtained from an interventional procedure
111438	Needle in target	An indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest
111439	Number of needles around target	The number of localizing needles placed around the area of interest in an interventional procedure
111440	Incision made	An indicator of whether or not an incision was made in the anatomy during an interventional procedure
111441	Microclip placed	An indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure	deprecated
111442	Confirmation of target	An indicator of the degree of success of an interventional procedure
111443	Target completely contained in the specimen	An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111444	Target partially obtained in the specimen	An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111445	Target not in the specimen	An indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen
111446	Calcifications seen in the core	An indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen
111447	Lesion completely removed	An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen
111448	Lesion partially removed	An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen
111449	Fluid obtained	An indicator that during an interventional procedure fluid was successfully aspirated
111450	Light brown color	Color that is a light shade of brown
111451	Dark red color	Color that is a dark shade of red
111452	Dark brown color	Color that is a dark shade of brown
111453	Bright red color	Color that is a bright shade of red
111454	Blood tinged color	Color that is tinged with the color of blood
111455	Occult blood test result	An indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells
111456	Action on fluid	An indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded
111457	Sent for analysis	An indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis
111458	Discarded	An indicator that fluid obtained during an interventional procedure was discarded
111459	Mass with calcifications	A radiopaque density noted during diagnostic imaging that has associated calcific densities
111460	Complex cyst	A fluid-filled sac with greater than normal characteristics
111461	Intracystic lesion	A tumor within a cyst
111462	Solid mass	A tumor or lesion
111463	Supplementary Data for Intervention	Supporting evidence for interpretation results of an interventional procedure
111464	Procedure Modifier	A descriptor that further qualifies or characterizes a type of procedure
111465	Needle Gauge	Needle size (diameter) characterization; e.g. of a biopsy needle
111466	Severity of Complication	An indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed
111467	Needle Length	Distance from the hub or bushing to the tip of the needle
111468	Pathology Results	The collection of observations and findings from pathologic analysis
111469	Sampling DateTime	The date and time that the sample was collected from the patient
111470	Uninvolved	Indicates that the margin of the biopsy specimen was not involved with the tumor
111471	Involved	Indicates that the margin of the biopsy specimen was involved with the tumor
111472	Nipple involved	Indicates whether the nipple was involved in an interventional procedure or pathologic analysis
111473	Number of nodes removed	Indicates the number of lymph nodes removed
111474	Number of nodes positive	Indicates the number of lymph nodes removed that contain cancer cells
111475	Estrogen receptor	The result of a test for the presence of a protein that binds with estrogen
111476	Progesterone receptor	The result of a test for the presence of a protein that binds with progesterone
111477	S Phase	Indicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates
111478	Non-bloody discharge (from nipple)	The visible emission of non-bloody fluid from the nipple
111479	Difficult physical/clinical examination	The inability to discern normal versus abnormal breast tissue during palpation
111480	Cancer elsewhere	An indication that a patient has or had a malignant occurrence in an area of the body other than the breast
111481	Saline implant	A salt water filled prosthetic device implanted in the breast
111482	Polyurethane implant	A polymer based (plastic) prosthetic device implanted in the breast
111483	Percutaneous silicone injection	The introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction
111484	Combination implant	A prosthetic device that contains more than one material implanted in the breast
111485	Pre-pectoral implant	A breast implant placed in front of the pectoralis major muscle
111486	Retro-pectoral implant	A breast implant placed behind the pectoralis major muscle
111487	Mammographic (crosshair)	Using X-Ray technique and a superimposed set of crossed lines for detection or placement
111488	Mammographic (grid)	Using X-Ray technique and a superimposed aperture for detection or placement
111489	Palpation guided	Using physical touch for detection or placement
111490	Vacuum assisted	The performance of a biopsy procedure using a vacuum device attached to the biopsy needle
111491	Abnormal discharge	Unusual or unexpected emission of fluid
111492	No complications	Having experienced no adverse medical conditions related to or resulting from an interventional procedure
111494	Stage 0	TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0
111495	Stage I	TNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0
111496	Stage IIA	TNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0
111497	Stage IIB	TNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0
111498	Stage IIIA	TNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0
111499	Stage IIIB	TNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0
111500	Stage IIIC	TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0
111501	Stage IV	TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1
111502	Bloom-Richardson Grade	Histologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count)
111503	Normal implants	Breast prosthetic devices are intact, not leaking, and are in a normal shape and form
111504	Asymmetric implants	Breast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral)
111505	Calcified implant	Fibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device
111506	Distorted implant	Breast prosthetic device is twisted out of normal shape or form
111507	Silicone-laden lymph nodes	Silicone from breast prosthetic device found in lymphatic tissue
111508	Free silicone	Silicone found in breast tissue outside of the prosthetic capsule or implant membrane
111509	Herniated implant	Protrusion of part of the structure normally encapsulating the content of the breast prosthetic device
111510	Explantation	Evidence of removal of a breast prosthetic device
111511	Relevant Patient Information for Breast Imaging	Historical patient health information of interest to the breast health clinician
111512	Medication History	Information regarding usage by the patient of certain medications, such as hormones	deprecated
111513	Relevant Previous Procedures	Interventional or non-interventional procedures previously performed on the patient, such as breast biopsies
111514	Relevant Indicated Problems	Abnormal conditions experienced by the patient that serve as the reason for performing a procedure, such as a breast exam	deprecated
111515	Relevant Risk Factors	Personal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer
111516	Medication Type	A classification of a medicinal substance, such as hormonal contraceptive or antibiotic
111517	Relevant Patient Information	Historical patient health information for general purpose use
111518	Age when first menstrual period occurred	The age of the patient at the first occurrence of menses
111519	Age at First Full Term Pregnancy	The age of the patient at the time of her first full term pregnancy
111520	Age at Menopause	The age of the patient at the cessation of menses
111521	Age when hysterectomy performed	The age of the patient at the time her uterus was removed
111522	Age when left ovary removed	The age of the patient at the time she had her left ovary removed
111523	Age when right ovary removed	The age of the patient at the time she had her right ovary removed
111524	Age Started	The age of a patient on the first occurrence of an event, such as the first use of a medication
111525	Age Ended	The age of a patient on the last occurrence of an event, such as the last use of a medication
111526	DateTime Started	The date and time of the first occurrence of an event, such as the first use of a medication
111527	DateTime Ended	The date and time of the last occurrence of an event, such as the last use of a medication
111528	Ongoing	An indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure
111529	Brand Name	Product name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer
111530	Risk Factor modifier	A descriptor that further qualifies or characterizes a risk factor
111531	Previous Procedure	A prior non-interventional exam or interventional procedure performed on a patient
111532	Pregnancy Status	Describes the pregnancy state of a referenced subject
111533	Indicated Problem	A symptom experienced by a patient that is used as the reason for performing an exam or procedure
111534	Role of person reporting	The function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend
111535	DateTime problem observed	The date and time that a symptom was noted
111536	DateTime of last evaluation	The date and time of the most recent evaluation of an indicated problem
111537	Family Member with Risk Factor	A patient's biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem
111538	Age at Occurrence	The age at which an individual experienced a specific event, such as breast cancer
111539	Menopausal phase	The current stage of an individual in her gynecological development
111540	Side of Family	An indicator of paternal or maternal relationship
111541	Maternal	Relating to biological female parentage
111542	Unspecified gynecological hormone	A gynecological hormone for which the specific type is not specified; e.g. contraceptive, estrogen, Tamoxifen
111543	Breast feeding history	An indicator of whether or not a patient ever provided breast milk to her offspring
111544	Average breast feeding period	The average length of time that a patient provided breast milk to her offspring
111545	Substance Use History	Information regarding usage by the patient of certain legal or illicit substances
111546	Used Substance Type	A classification of a substance, such as alcohol or a legal or illicit drug
111547	Environmental Exposure History	Information regarding exposure of the patient to potentially harmful environmental factors
111548	Environmental Factor	A classification of a potentially harmful substance or gas in a subject's environment, such as asbestos, lead, or carcinogens
111549	Previous Reports	Previous Structured Reports that could have relevant information for a current imaging service request
111550	Personal breast cancer history	An indication that a patient has had a previous malignancy of the breast
111551	History of endometrial cancer	Indicates a previous occurrence of cancer of the lining of the uterus
111552	History of ovarian cancer	Indicates a previous occurrence of cancer of the lining of the ovary
111553	History of high risk lesion on previous biopsy	Indicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation
111554	Post menopausal patient	A female patient whose menstrual periods have ceased
111555	Late child bearing (after 30)	A female patient whose first child was born after the patient was 30 years old
111556	BRCA1 breast cancer gene	The first level genetic marker indicating risk for breast cancer
111557	BRCA2 breast cancer gene	The second level genetic marker indicating risk for breast cancer
111558	BRCA3 breast cancer gene	The third level genetic marker indicating risk for breast cancer
111559	Weak family history of breast cancer	A patient's biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®
111560	Intermediate family history of breast cancer	A patient's biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111561	Very strong family history of breast cancer	A patient's biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®
111562	Family history of prostate cancer	Previous diagnosis of a malignancy of the prostate gland in a biological relative
111563	Family history unknown	The health record of a patient's biological relatives is not known
111564	Nipple discharge cytology	The study of cells obtained from fluid emitted from the breast
111565	Uterine malformations	A developmental abnormality resulting in an abnormal shape of the uterus
111566	Spontaneous Abortion	A naturally occurring premature expulsion from the uterus of the products of conception - the embryo or a nonviable fetus
111567	Gynecologic condition	An ailment/abnormality or state of the female reproductive tract
111568	Gynecologic surgery	A surgical operation performed on any portion of the female reproductive tract
111569	Previous LBW or IUGR birth	Prior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation
111570	Previous fetal malformation/syndrome	History of at least one prior pregnancy with fetal anatomic abnormality(s)
111571	Previous RH negative or blood dyscrasia at birth	History of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder
111572	History of multiple fetuses	History of at least one pregnancy that contained more than one fetus; e.g. twins, triplets, etc.
111573	Current pregnancy, known or suspected malformations/syndromes	At least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a "marker" is present that suggests the abnormality(s) may be present
111574	Family history, fetal malformation/syndrome	Biological relatives have previously conceived a fetus with an anatomic abnormality(s)
111575	High	A subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects
111576	Medium	A subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects
111577	Low	A subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects
111578	Dose frequency	A measurement of the rate of occurrence of which a patient takes a certain medication
111579	Rate of exposure	The quantity per unit of time that a patient was or is being exposed to an environmental irritant
111580	Volume of use	The quantity per unit of time that a medication or substance was or is being used
111581	Relative dose amount	A qualitative descriptor for the amount of a medication that was or is being taken
111582	Relative amount of exposure	A qualitative descriptor for the amount of present or past exposure to an environmental irritant
111583	Relative amount of use	A qualitative descriptor for the amount of a medication or substance that was or is being used
111584	Relative dose frequency	A qualitative descriptor for the frequency with which a medication was or is being taken
111585	Relative frequency of exposure	A qualitative descriptor for the frequency of present or past exposure to an environmental irritant
111586	Relative frequency of use	A qualitative descriptor for the frequency with which a medication or substance was or is being used
111587	No known exposure	Patient is not known to have been exposed to or used the substance or medication
111590	Recall for technical reasons	Patient returns for additional images to improve the quality of the most recent exam
111591	Recall for imaging findings	Patient returns for additional images to clarify findings from the most recent exam
111592	Recall for patient symptoms/ clinical findings	Patient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent exam
111593	LBW or IUGR	Number of births with low birth weight or intrauterine growth restriction
111601	Green filter	Filter that transmits green light while blocking the other colors, typically centered at 510-540 nm	deprecated
111602	Red filter	Filter that transmits red light while blocking the other colors, typically centered at 630-680 nm	deprecated
111603	Blue filter	Filter that transmits blue while blocking the other colors, typically centered at 460-480 nm	deprecated
111604	Yellow-green filter	A filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculature	deprecated
111605	Blue-green filter	A filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengths	deprecated
111606	Infrared filter	Filter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible light	deprecated
111607	Polarizing filter	A filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filter	deprecated
111609	No filter	No filter used
111621	Field 1 for Joslin 3 field	Joslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc
111622	Field 2 for Joslin 3 field	Joslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2
111623	Field 3 for Joslin 3 field	Joslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc
111625	Diffuse direct illumination	A broad or "soft" light supplied from a single source
111626	Scheimpflug Camera	A slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the "Sheimpflug principle" where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye
111627	Scotopic light	Lighting condition approximately 0.04 lux
111628	Mesopic light	Lighting condition approximately 4 lux
111629	Photopic light	Lighting condition approximately 40 lux
111630	Dynamic light	Acquisition preceded by intense light
111631	Average Glandular Dose	Calculated from values of entrance exposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast
111632	Anode Target Material	The primary material in the anode of an X-Ray source
111633	Compression Thickness	The average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure
111634	Half Value Layer	Thickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two
111635	X-Ray Grid	An anti-scatter device based on radiation absorbing strips above the detector; e.g. in the patient support
111636	Entrance Exposure at RP	Exposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999
111637	Accumulated Average Glandular Dose	Average Glandular Dose to a single breast accumulated over multiple images
111638	Patient Equivalent Thickness	Value of the control variable used to parametrize the Automatic Exposure Control (AEC) closed loop; e.g. "Water Value"
111641	Fixed grid	An X-Ray Grid that does not move during exposure
111642	Focused grid	An X-Ray Grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff
111643	Reciprocating grid	An X-Ray Grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image
111644	Parallel grid	An X-Ray Grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances
111645	Crossed grid	An X-Ray Grid with crossed radiation absorbing strips used for more complete cleanup of scatter radiation
111646	No grid	No X-Ray Grid was used due to low scatter conditions
111671	Spectacle Prescription Report	The spectacle prescription for a patient
111672	Add Near	Refractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription
111673	Add Intermediate	Refractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription
111674	Add Other	Refractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription
111675	Horizontal Prism Power	The power of a prism to bend light in the horizontal direction, in prism diopters
111676	Horizontal Prism Base	Direction of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose)
111677	Vertical Prism Power	The power of a prism to bend light in the vertical direction, in prism diopters
111678	Vertical Prism Base	Direction of the base of a vertical prism -- either up, or down
111679	Distance Pupillary Distance	Distance in mm between the pupils when the patient's object of regard is in the distance
111680	Near Pupillary Distance	Distance in mm between the pupils when the patient's object of regard is at near
111685	Autorefraction Visual Acuity	A patient's vision with the correction measured by an autorefractor in place
111686	Habitual Visual Acuity	A patient's vision with whichever vision correction the patient customarily wears
111687	Prescription Visual Acuity	A patient's vision with the final spectacle prescription in place
111688	Right Eye Rx	The spectacle prescription for the right eye
111689	Left Eye Rx	The spectacle prescription for the left eye
111690	Macular Grid Thickness and Volume Report	A macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.1
111691	Number of Images Used for Macular Measurements	Number of images used for the macular grid measurement
111692	Number of Samples Used per Image	Number of samples used per Image for analysis
111693	Analysis Quality Rating	A numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111694	Image Set Quality Rating	A numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes. Higher numbers indicate greater quality
111695	Interfering Tears or Drops	Tear film or drops affecting test quality
111696	Visual Fixation Quality During Acquisition	The assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition
111697	Visual Fixation Quality Problem	The reason why the patient's visual fixation was not steady or was indeterminate
111698	Ophthalmic Macular Grid Problem	The reason why the macular grid measurements may be questionable
111700	Specimen Container Identifier	Identifier of container (box, block, microscope slide, etc.) for the specimen under observation
111701	Processing type	Type of processing that tissue specimen underwent
111702	DateTime of processing	Date and time of processing step
111703	Processing step description	Description of the individual step in the tissue processing sequence
111704	Sampling Method	Method of sampling used to derive specimen from its parent
111705	Parent Specimen Identifier	Identifier of the parent specimen that gave rise to the current specimen
111706	Issuer of Parent Specimen Identifier	Assigning authority for parent specimen's identifier
111707	Parent specimen type	Parent specimen type that gave rise to current specimen
111708	Position Frame of Reference	Description of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image
111709	Location of sampling site	Reference to image of parent specimen localizing the sampling site; may include referenced Presentation State object
111710	Location of sampling site X offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111711	Location of sampling site Y offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111712	Location of sampling site Z offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111718	Location of Specimen	Description of specimen location, either in absolute terms or relative to the Position Frame of Reference
111719	Location of Specimen X offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the X dimension
111720	Location of Specimen Y offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension
111721	Location of Specimen Z offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension
111723	Visual Marking of Specimen	Description of visual distinguishing identifiers; e.g. ink, or a particular shape of the specimen
111724	Issuer of Specimen Identifier	Assigning authority for specimen identifier
111726	Dissection with entire specimen submission	Dissection of specimen with submission of all its sections for further processing or examination
111727	Dissection with representative sections submission	Dissection of specimen with submission of representative sections for further processing or examination
111729	Specimen storage	A workflow step, during which tissue specimens are stored in a climate-controlled environment
111741	Transmission illumination	Transmission illumination method for specimen microscopy
111742	Reflection illumination	Reflection illumination method for specimen microscopy
111743	Epifluorescence illumination	Epifluorescence illumination method for specimen microscopy
111744	Brightfield illumination	Brightfield illumination method for specimen microscopy
111745	Darkfield illumination	Darkfield illumination method for specimen microscopy
111746	Oblique illumination	Oblique illumination method for specimen microscopy
111747	Phase contrast illumination	Phase contrast illumination method for specimen microscopy
111748	Differential interference contrast	Differential interference contrast method for specimen microscopy
111749	Total internal reflection fluorescence	Total internal reflection fluorescence method for specimen microscopy
111750	Ultrasound Contact	A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea
111751	Ultrasound Immersion	A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient's eye in fluid as he lies in a supine position
111752	Optical	A method of obtaining ophthalmic axial measurements that uses light
111753	Manual Keratometry	Measurements taken of the corneal curvature using a manual keratometer
111754	Auto Keratometry	Measurements taken of the corneal curvature using an automated keratometer
111755	Simulated Keratometry	Simulated Keratometry measurements derived from corneal topography
111756	Equivalent K-reading	Corneal power measurements using Scheimpflug camera
111760	Haigis	The Haigis IOL calculation formula. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73
111761	Haigis-L	The Haigis-L IOL calculation formula. Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63
111762	Holladay 1	The Holladay 1 IOL calculation formula. Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24
111763	Holladay 2	The Holladay 2 IOL calculation formula
111764	Hoffer Q	The Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3
111765	Olsen	The Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472-485
111766	SRKII	The SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41
111767	SRK-T	The SRK-T IOL calculation formula. Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528
111768	ACD Constant	The "ACD Constant" used in IOL calculation
111769	Haigis a0	The "Haigis a0" constant used in IOL calculation
111770	Haigis a1	The "Haigis a1" constant used in IOL calculation
111771	Haigis a2	The "Haigis a2" constant used in IOL calculation
111772	Hoffer pACD Constant	The "Hoffer pACD Constant" used in IOL calculation
111773	Surgeon Factor	The "Surgeon Factor" constant used in IOL calculation
111776	Front Of Cornea To Front Of Lens	Anterior chamber depth defined as the front of the cornea to the front of the lens
111777	Back Of Cornea To Front Of Lens	Anterior chamber depth defined as the back of the cornea to the front of the lens
111778	Single or Anterior Lens	Refers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111779	Posterior Lens	Refers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens
111780	Measurement From This Device	Value obtained from measurements taken by the device creating this SOP Instance
111781	External Data Source	Value obtained by data transfer from an external source - not from measurements taken by the device providing the value
111782	Axial Measurements SOP Instance	Axial Measurements DICOM SOP Instance
111783	Refractive Measurements SOP Instance	Refractive Measurements DICOM SOP Instance
111786	Standard Deviation of measurements used	Standard Deviation is a simple measure of the variability of a data set
111787	Signal to Noise Ratio	Signal to Noise Ratio of the data samples taken to create a measurement
111791	Spherical projection	Projection from 2D image pixels to 3D Cartesian coordinates based on a spherical mathematical model
111792	Surface contour mapping	Mapping from 2D image pixels to 3D Cartesian coordinates based on measurements of the retinal surface; e.g. of the retina, derived via a measurement technology such as Optical Coherence Tomography, Ultrasound etc.
111800	Visual Field 24-2 Test Pattern	Test pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 24° pattern (no longer supported)
111801	Visual Field 10-2 Test Pattern	Test pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart. The "-2" in this case indicates its point layout to be similar to the 30-2 and 24-2
111802	Visual Field 30-2 Test Pattern	Test pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 30° pattern (no longer supported)
111803	Visual Field 60-4 Test Pattern	Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart. The "-4" distinguishes this from a similar 60° pattern having 4 additional points
111804	Visual Field Macula Test Pattern	Test pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart
111805	Visual Field Central 40 Point Test Pattern	Test pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation
111806	Visual Field Central 76 Point Test Pattern	Test pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart
111807	Visual Field Peripheral 60 Point Test Pattern	Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart
111808	Visual Field Full Field 81 Point Test Pattern	Test pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation
111809	Visual Field Full Field 120 Point Test Pattern	Test pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere
111810	Visual Field G Test Pattern	Test pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step
111811	Visual Field M Test Pattern	Test pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10, 5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10, 5° and 60°
111812	Visual Field 07 Test Pattern	Full field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies
111813	Visual Field LVC Test Pattern	Low Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V
111814	Visual Field Central Test Pattern	General test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations
111815	Visual Field SITA-Standard Test Strategy	Swedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models. In: Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 1997, 75: 368-375
111816	Visual Field SITA-SWAP Test Strategy	Adaptation of SITA testing methods to Blue-Yellow testing
111817	Visual Field SITA-Fast Test Strategy	Similar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time. In: Bengtsson B, Hejl A. SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 1998, 76: 431-437
111818	Visual Field Full Threshold Test Strategy	Threshold test algorithm that determines a patient's sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point. The starting values are determined by first thresholding a "primary" point in each quadrant then using the results of each primary point to determine the starting values for neighboring points
111819	Visual Field FastPac Test Strategy	Similar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once. In: Flanagan JG, Wild JM, Trope GE. Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population. Ophthalmology, 1993, 100: 949-954
111820	Visual Field Full From Prior Test Strategy	Identical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy
111821	Visual Field Optima Test Strategy	Similar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation)
111822	Visual Field Two-Zone Test Strategy	Suprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as "seen"; otherwise it is marked as "not seen"
111823	Visual Field Three-Zone Test Strategy	An extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness
111824	Visual Field Quantify-Defects Test Strategy	An extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomas
111825	Visual Field TOP Test Strategy	Tendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%. In: Morales J, Weitzman ML, Gonzalez de la Rosa M. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry. Ophthalmology, 2000, 107: 134-142
111826	Visual Field Dynamic Test Strategy	Dynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%
111827	Visual Field Normal Test Strategy	Traditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve
111828	Visual Field 1-LT Test Strategy	One level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity
111829	Visual Field 2-LT Test Strategy	Two level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value
111830	Visual Field LVS Test Strategy	Low Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V
111831	Visual Field GATE Test Strategy	German Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Investigative Ophthalmology and Visual Science, 2009, 51: 488-494
111832	Visual Field GATEi Test Strategy	Similar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values
111833	Visual Field 2LT-Dynamic Test Strategy	A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy
111834	Visual Field 2LT-Normal Test Strategy	A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy
111835	Visual Field Fast Threshold Test Strategy	Takes neighborhood test point results into account and offers stimuli with an adapted value to save time
111836	Visual Field CLIP Test Strategy	Continuous Luminance Incremental Perimetry, which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold
111837	Visual Field CLASS Strategy	A supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient's visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB)
111838	Age corrected	Mode for determining the starting luminance for screening test points - the starting luminance s is chosen based on the age of the patient
111839	Threshold related	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the results of thresholding a set of "primary" test points (one in each quadrant)
111840	Single luminance	Mode for determining the starting luminance for screening test points - in this case, all starting luminance is set to the same value
111841	Foveal sensitivity related	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of the foveal threshold value
111842	Related to non macular sensitivity	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant)
111843	Automated Optical	Real time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained
111844	Blind Spot Monitoring	A method of monitoring the patient's fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient's blind spot
111845	Macular Fixation Testing	A method of monitoring the patient's fixation by presenting the stimulus to the patient's macula
111846	Observation by Examiner	A method of monitoring the patient's fixation by observation from the examiner of the patient
111847	Outside normal limits	Analysis Results are outside normal limits
111848	Borderline	Analysis Results are borderline
111849	Abnormally high sensitivity	Analysis Results identify abnormally high sensitivity
111850	General reduction in sensitivity	Analysis Results identify general reduction in sensitivity
111851	Borderline and general reduction in sensitivity	Analysis Results identify Borderline and general reduction in sensitivity
111852	Visual Field Index	Index of a patient's remaining visual field normalized for both age and generalized defect
111853	Visual Field Loss Due to Diffuse Defect	Estimate of the portion of a patient's visual field loss that is diffuse (i.e., spread evenly across all portions of the visual field)
111854	Visual Field Loss Due to Local Defect	Estimate of the portion of a patient's visual field loss that is local (i.e., not spread evenly across all portions of the visual field)
111855	Glaucoma Hemifield Test Analysis	An analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma
111856	Optical Fixation Measurements	The data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e., the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation
111900	Macula centered	An image of at least 15° angular subtend that is centered on the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111901	Disc centered	An image of at least 15° angular subtend that is centered on the optic disc; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111902	Lesion centered	An image of any angular subtend that is centered on a lesion located in any region of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111903	Disc-macula centered	An image of at least 15° angular subtend centered midway between the disc and macula and containing at least a portion of the disc and both the disc and the macula; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111904	Mid-peripheral-superior	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and superior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111905	Mid-peripheral-superior temporal	An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111906	Mid-peripheral-temporal	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111907	Mid-peripheral-inferior temporal	An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111908	Mid-peripheral-inferior	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111909	Mid-peripheral-inferior nasal	An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111910	Mid-peripheral-nasal	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111911	Mid-peripheral-superior nasal	An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111912	Peripheral-superior	An image of at least 15° angular subtend positioned between the equator and the ora serrata, and spanning both the superior temporal and superior nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111913	Peripheral-superior temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111914	Peripheral-temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111915	Peripheral-inferior temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-temporal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111916	Peripheral-inferior	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111917	Peripheral-inferior nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111918	Peripheral-nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111919	Peripheral-superior nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-nasal quadrant of the fundus; see Section U.1.8 "Relative Image Position Definitions" in PS3.17
111920	Time domain	Identifies the use of physical signals with respect to time to capture information
111921	Spectral domain	Identifies the use of physical signals with respect to multiple frequencies to capture information
111922	No corneal compensation	No compensation algorithm for corneal birefringence
111923	Corneal birefringence compensation	Algorithm to compensate for variability in corneal birefringence
111924	Retinal topography	Measurement of the retinal surface contour relative to an assigned datum plane
111925	Retinal nerve fiber layer thickness	Measurement approximating the distance related to the structure between the internal limiting membrane (ILM) and the outer boarder of the retinal nerve fiber layer (RNFL); see Section III.6 "Retinal Thickness Definition" in PS3.17
111926	Ganglion cell complex thickness	Measurement approximating the distance related to the structure between the ILM and the outer border of the inner plexiform layer (IPL), called the ganglion cell complex (GCC); see Section III.6 "Retinal Thickness Definition" in PS3.17
111927	Total retinal thickness (ILM to IS-OS)	Measurement approximating the distance related to the structure between the ILM and the inner-outer segment junction (IS-OS); see Section III.6 "Retinal Thickness Definition" in PS3.17
111928	Total retinal thickness (ILM to RPE)	Measurement approximating the distance related to the structure between the ILM and the retinal pigment epithelium (RPE); see Section III.6 "Retinal Thickness Definition" in PS3.17
111929	Total retinal thickness (ILM to BM)	Measurement approximating the distance related to the structure between the ILM and the Bruch's membrane (BM); see Section III.6 "Retinal Thickness Definition" in PS3.17
111930	Absolute ophthalmic thickness	Thickness of a component of the posterior segment of the eye; e.g. thickness of retina, choroid, etc.
111931	Thickness deviation category from normative data	Ophthalmic Thickness map based upon statistical significance category (such as percentile) from a normative data set
111932	Thickness deviation from normative data	Ophthalmic Thickness map based upon deviation (such as microns) from a normative data set
111933	Related ophthalmic thickness map	Ophthalmic Thickness Map related to another Ophthalmic Thickness Map or another SOP Instance
111934	Disc-Fovea	An anatomic point centered midway between the disc and fovea centralis
111935	p>5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is not statistically significant
111936	p<5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 95% unlikely to happen by chance
111937	p<2%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 98% unlikely to happen by chance
111938	p<1%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99% unlikely to happen by chance
111939	p<0.5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99.5% unlikely to happen by chance
111940	Corneal axial power map	A two dimensional representation of the axial curvature of the cornea. Axial curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the corneal topographer axis. Also known as sagittal curvature
111941	Corneal instantaneous power map	A two dimensional representation of the instantaneous curvature of the cornea. Instantaneous curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the center of curvature of that point. Also called tangential curvature
111942	Corneal refractive power map	A two dimensional representation of the refractive power of the cornea. Corneal refractive power is calculated using Snell's Law
111943	Corneal elevation map	A two dimensional representation of the elevation of the cornea. Elevation is calculated as the distance from a point on the corneal surface to a point on a reference surface along a line parallel to the corneal topographer axis. For the purpose of visualization the reference surface is usually a sphere or an ellipse
111944	Corneal wavefront map	A two dimensional representation of a wavefront aberration surface of the cornea. Wavefront aberration surface is calculated from the corneal elevation data fit with either the Zernike polynomial series or the Fourier Series. Maps generally display total aberrations and selectable higher order aberrations
111945	Elevation-based corneal tomographer	A device that measures corneal anterior surface shape using elevation-based methods (stereographic and light slit-based). Rasterstereography images a grid pattern illuminating the fluorescein dyed tear film with 2 cameras to produce 3D. Slit-based devices scan the cornea, usually by rotation about the instrument axis centered on the cornea vertex
111946	Reflection-based corneal topographer	A reflection-based device that projects a pattern of light onto the cornea and an image of the reflection of that pattern from the tear film is recorded in one video frame. Light patterns include the circular mire pattern (Placido disc) and spot matrix patterns. Sequential scanning of light spots reflected from the corneal surface is also used requiring multiple video frames for recording
111947	Interferometry-based corneal tomographer	An Interference-based device that projects a beam of light onto and through the cornea. Light reflected from within the cornea is combined with a reference beam giving rise to an interference pattern. Appropriately scanned, this imaging is used to construct 3-dimensional images of the cornea from anterior to posterior surfaces; e.g. swept source OCT
112000	Chest CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information
112001	Opacity	The shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare]
112002	Series Instance UID	A unique identifier for a series of DICOM SOP instances
112003	Associated Chest Component	A named anatomic region within the chest cavity
112004	Abnormal interstitial pattern	A collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph
112005	Radiographic anatomy	A type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image
112006	Distribution Descriptor	Characteristic of the extent of spreading of a finding or feature
112007	Border definition	Characteristic of the clarity of the boundary or edges of a finding or feature
112008	Site involvement	The part(s) of the anatomy affected or encompassed by a finding or feature
112009	Type of Content	Characteristic of the matter or substance within a finding or feature
112010	Texture Descriptor	Characteristic of the surface or consistency of a finding or feature
112011	Positioner Primary Angle	Position of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive
112012	Positioner Secondary Angle	Position of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive
112013	Location in Chest	The zone, lobe or segment within the chest cavity in which a finding or feature is situated
112014	Orientation Descriptor	Vertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical
112015	Border shape	Characteristic of the shape formed by the boundary or edges of a finding or feature
112016	Baseline Category	Indicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST
112017	Cavity extent as percent of volume	The extent of a detected cavity, represented as the percent of the surrounding volume that it occupies
112018	Calcification extent as percent of surface	The extent of a detected calcification, represented as the percent of the surrounding surface that it occupies
112019	Calcification extent as percent of volume	The extent of a detected calcification, represented as the percent of the surrounding volume that it occupies
112020	Response Evaluation	A heading for the reporting of response evaluation for treatment of solid tumors
112021	Response Evaluation Method	The system applied in the reporting of response evaluation for treatment of solid tumors
112022	RECIST	Response Evaluation Criteria In Solid Tumors; see Normative References
112023	Composite Feature Modifier	A term that further specifies the name of an item that is an inferred correlation relating two or more individual findings or features
112024	Single Image Finding Modifier	A term that further specifies the name of an item that was detected on one image
112025	Size Descriptor	A qualitative descriptor for the extent of a finding or feature
112026	Width Descriptor	A qualitative descriptor for the thickness of tubular structures, such as blood vessels
112027	Opacity Descriptor	A characteristic that further describes the nature of an opacity
112028	Abnormal Distribution of Anatomic Structure	The type of adverse affect that a finding or feature is having on the surrounding anatomy
112029	WHO	Response evaluation method as defined in chapter 5, "Reporting of Response" of the WHO Handbook for Reporting Results for Cancer Treatment; see Normative References
112030	Calcification Descriptor	Identification of the morphology of detected calcifications
112031	Attenuation Coefficient	A quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point. Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms. Usually expressed in Hounsfield units [referred to as CT Number in Fraser and Pare]
112032	Threshold Attenuation Coefficient	An X-Ray attenuation coefficient that is used as a threshold; e.g. in calcium scoring
112033	Abnormal opacity	An opacity that is not expected in a diagnostically normal radiograph
112034	Calculation Description	A textual description of the mathematical method of calculation that resulted in a calculated value
112035	Performance of Pediatric and Adult Chest Radiography, ACR	American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98
112036	ACR Position Statement	American College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv
112037	Non-lesion Modifier	A descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient's body
112038	Osseous Modifier	A concept modifier for an Osseous Anatomy, or bone related, finding
112039	Tracking Identifier	A text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used
112040	Tracking Unique Identifier	A unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time
112041	Target Lesion Complete Response	Disappearance of all target lesions
112042	Target Lesion Partial Response	At least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter
112043	Target Lesion Progressive Disease	At least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions
112044	Target Lesion Stable Disease	Neither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started
112045	Non-Target Lesion Complete Response	Disappearance of all non-target lesions and normalization of tumor marker level
112046	Non-Target Lesion Incomplete Response or Stable Disease	Persistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits
112047	Non-Target Lesion Progressive Disease	Appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions
112048	Current Response	The current response evaluation for treatment of solid tumors, according to a method such as RECIST
112049	Best Overall Response	Best response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST
112050	Anatomic Identifier	A text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as "Rib 1", "Rib 2" or thoracic vertebrae "T1" or "T2"
112051	Measurement of Response	A measured or calculated evaluation of response; e.g. according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions
112052	Bronchovascular	Of or relating to a bronchial (lung) specific channel for the conveyance of a body fluid
112053	Osseous	Of, relating to, or composed of bone
112054	Secondary pulmonary lobule	The smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare]
112055	Agatston scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits
112056	Volume scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3
112057	Mass scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg
112058	Calcium score	A measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries
112059	Primary complex	The combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare]
112060	Oligemia	General or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare]
112061	Abnormal lines (1D)	Linear opacity of very fine width, i.e., a nearly one dimensional opacity
112062	Abnormal lucency	Area of abnormal very low X-Ray attenuation, typically lower than aerated lung when occurring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue
112063	Abnormal calcifications	A calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare]
112064	Abnormal texture	Relatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast
112065	Reticulonodular pattern	A collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare]
112066	Beaded septum sign	Irregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare]
112067	Nodular pattern	A collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare]
112068	Pseudoplaque	An irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare]
112069	Signet-ring sign	A ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a "signet ring" [Fraser and Pare]
112070	Air bronchiologram	Equivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare]
112071	Air bronchogram	Radiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare]
112072	Air crescent	Air in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillusspecies [Fraser and Pare]
112073	Halo sign	Ground-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare]
112074	Target Lesion at Baseline	Flag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST]
112075	Non-Target Lesion at Baseline	Flag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST]
112076	Non-Lesion at Baseline	Flag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST]
112077	Vasoconstriction	Local or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare]
112078	Vasodilation	Local or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare]
112079	Architectural distortion	A manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare]
112080	Mosaic perfusion	A patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare]
112081	Pleonemia	Increased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare]
112082	Interface	The common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare]
112083	Line	A longitudinal opacity no greater than 2 mm in width [Fraser and Pare]
112084	Lucency	The shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare]
112085	Midlung window	A midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare]
112086	Carina angle	The angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare]
112087	Centrilobular structures	The pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare]
112088	Anterior junction line	A vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare]
112089	Posterior junction line	A vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare]
112090	Azygoesophageal recess interface	A space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare]
112091	Paraspinal line	A vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare]
112092	Posterior tracheal stripe	A vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare]
112093	Right tracheal stripe	A vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare]
112094	Stripe	A longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare]
112095	Hiatus	A gap or passage through an anatomical part or organ; especially : a gap through which another part or organ passes
112096	Rib Scalene Tubercle	A small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior
112097	Vertebral Intervertebral Notch	A groove that serves for the transmission of the vertebral artery
112098	Subscapular Fossa	The concave depression of the anterior surface of the scapula
112099	Scapular Spine	A sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below)
112100	Scapular Supraspinatus Fossa	The portion of the dorsal surface of the scapula above the scapular spine
112101	Scapular Infraspinatus Fossa	The portion of the dorsal surface of the scapula below the scapular spine
112102	Aortic knob	The portion of the aortic arch that defines the transition between its ascending and descending limbs
112103	Arch of the Azygos vein	Section of Azygos vein near the fourth thoracic vertebra, where it arches forward over the root of the right lung, and ends in the superior vena cava, just before that vessel pierces the pericardium
112104	Air-fluid level	A local collection of gas and liquid that, when traversed by a horizontal X-Ray beam, creates a shadow characterized by a sharp horizontal interface between gas density above and liquid density below [Fraser and Pare]
112105	Corona radiata	A circumferential pattern of fine linear spicules, approximately 5 mm long, extending outward from the margin of a solitary pulmonary nodule through a zone of relative lucency [Fraser and Pare]
112106	Honeycomb pattern	A number of closely approximated ring shadows representing air spaces 5-10 mm in diameter with walls 2-3 mm thick that resemble a true honeycomb; implies "end-stage" lung [Fraser and Pare]
112107	Fleischner's line(s)	A straight, curved, or irregular linear opacity that is visible in multiple projections; usually situated in the lower half of the lung; vary markedly in length and width [Fraser and Pare]
112108	Intralobular lines	Fine linear opacities present in a lobule when the intralobular interstitium is thickened. When numerous, they may appear as a fine reticular pattern [Fraser and Pare]
112109	Kerley A line	Essentially straight linear opacity 2-6 cm in length and 1-3 mm in width, usually in an upper lung zone [Fraser and Pare]
112110	Kerley B line	A straight linear opacity 1.5-2 cm in length and 1-2 mm in width, usually at the lung base [Fraser and Pare]
112111	Kerley C lines	A group of branching, linear opacities producing the appearing of a fine net, at the lung base [Fraser and Pare]
112112	Parenchymal band	Elongated opacity, usually several millimeters wide and up to about 5 cm long, often extending to the pleura, which may be thickened and retracted at the site of contact [Fraser and Pare]
112113	Reticular pattern	A collection of innumerable small linear opacities that together produce an appearance resembling a net [Fraser and Pare]
112114	Septal line(s)	Usually used in the plural, a generic term for linear opacities of varied distribution produced when the interstitium between pulmonary lobules is thickened [Fraser and Pare]
112115	Subpleural line	A thin curvilinear opacity, a few millimeters or less in thickness, usually less than 1 cm from the pleural surface and paralleling the pleura [Fraser and Pare]
112116	Tramline shadow	Parallel or slightly convergent linear opacities that suggest the planar projection of tubular structures and that correspond in location and orientation to elements of the bronchial tree [Fraser and Pare]
112117	Tubular shadow	Paired, parallel, or slightly convergent linear opacities presumed to represent the walls of a tubular structure seen en face; used if the anatomic nature of a shadow is obscure [Fraser and Pare]
112118	Density	The opacity of a radiographic shadow to visible light; film blackening; the term should never be used to mean an "opacity" or "radiopacity" [Fraser and Pare]
112119	Dependent opacity	Subpleural increased attenuation in dependent lung. The increased attenuation disappears when the region of lung is nondependent; a.k.a. dependent increased attenuation [Fraser and Pare]
112120	Ground glass opacity	Hazy increased attenuation of lung, but with preservation of bronchial and vascular margins; caused by partial filling of air spaces, interstitial thickening, partial collapse of alveoli, normal expiration, or increased capillary blood volume [Fraser and Pare]
112121	Infiltrate	Any ill-defined opacity in the lung [Fraser and Pare]
112122	Micronodule	Discrete, small, round, focal opacity of at least soft tissue attenuation and with a diameter no greater than 7 mm [Fraser and Pare]
112123	Phantom tumor (pseudotumor)	A shadow produced by a local collection of fluid in one of the interlobar fissures, usually elliptic in one radiographic projection and rounded in the other, resembling a tumor [Fraser and Pare]
112124	Shadow	Any perceptible discontinuity in film blackening attributed to the attenuation of the X-Ray beam by a specific anatomic absorber or lesion on or within the body of the patient; to be employed only when more specific identification is not possible [Fraser and Pare]
112125	Small irregular opacities	Term used to define a reticular pattern specific to pneumoconioses [Fraser and Pare]
112126	Small rounded opacities	Term used to define a nodular pattern specific to pneumoconioses [Fraser and Pare]
112127	Tree-in-bud sign	Nodular dilation of centrilobular branching structures that resembles a budding tree and represents exudative bronchiolar dilation [Fraser and Pare]
112128	Granular pattern	Any extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured [Fraser and Pare]
112129	Miliary pattern	A collection of tiny discrete opacities in the lungs, each measuring 2 mm or less in diameter, generally uniform in size and widespread in distribution [Fraser and Pare]
112130	Mosaic pattern	Generalized pattern of relatively well defined areas in the lung having different X-Ray attenuations due to a longstanding underlying pulmonary disease
112131	Extremely small	A qualitative descriptor of a size that is dramatically less than typical
112132	Very small	A qualitative descriptor of a size that is considerably less than typical
112133	Too small	A qualitative descriptor of a size that is so small as to be abnormal versus expected size
112134	Elliptic	Shaped like an ellipse (oval)
112135	Lobulated	A border shape that is made up of, provided with, or divided into lobules (small lobes, curved or rounded projections or divisions)
112136	Spiculated	Radially orientated border shape
112137	Sharply defined	The border of a shadow (opacity) is sharply defined [Fraser and Pare]
112138	Distinctly defined	The border of a shadow (opacity) is distinctly defined [Fraser and Pare]
112139	Well demarcated	The border of a shadow (opacity) is well distinct from adjacent structures [Fraser and Pare]
112140	Sharply demarcated	The border of a shadow (opacity) is sharply distinct from adjacent structures [Fraser and Pare]
112141	Poorly demarcated	The border of a shadow (opacity) is poorly distinct from adjacent structures [Fraser and Pare]
112142	Circumscribed	A shadow (opacity) possessing a complete or nearly complete visible border [Fraser and Pare]
112143	Air	Inspired atmospheric gas. The word is sometimes used to describe gas within the body regardless of its composition or site [Fraser and Pare]
112144	Soft tissue	Material having X-Ray attenuation properties similar to muscle
112145	Calcium	Material having X-Ray attenuation properties similar to calcium, a silver-white bivalent metallic element occurring in plants and animals
112146	Acinar	A pulmonary opacity 4-8 mm in diameter, presumed to represent anatomic acinus, or a collection of opacities in the lung, each measuring 4-8 mm in diameter, and together producing an extended, homogeneous shadow [Fraser and Pare]
112147	Air space	The gas-containing portion of the lung parenchyma, including the acini and excluding the interstitium [Fraser and Pare]
112148	Fibronodular	Sharply defined, approximately circular opacities occurring singly or in clusters, usually in the upper lobes [Fraser and Pare]
112149	Fluffy	A shadow (opacity) that is ill-defined, lacking clear-cut margins [Fraser and Pare]
112150	Linear	A shadow resembling a line; any elongated opacity of approximately uniform width [Fraser and Pare]
112151	Profusion	The number of small opacities per unit area or zone of lung. In the International Labor Organization (ILO) classification of radiographs of the pneumoconioses, the qualifiers 0 through 3 subdivide the profusion into 4 categories. The profusion categories may be further subdivided by employing a 12-point scale [Fraser and Pare]
112152	Silhouette sign	The effacement of an anatomic soft tissue border by either a normal anatomic structure or a pathologic state such as airlessness of adjacent lung or accumulation of fluid in the contiguous pleural space; useful in detecting and localizing an opacity along the axis of the X-Ray beam [Fraser and Pare]
112153	Subpleural	Situated or occurring between the pleura and the body wall
112154	Bat's wing distribution	Spatial arrangement of opacities that bears vague resemblance to the shape of a bat in flight; bilaterally symmetric [Fraser and Pare]
112155	Butterfly distribution	Spatial arrangement of opacities that bears vague resemblance to the shape of a butterfly in flight; bilaterally symmetric [Fraser and Pare]
112156	Centrilobular	Referring to the region of the bronchioloarteriolar core of a secondary pulmonary lobule [Fraser and Pare]
112157	Coalescent	The joining together of a number of opacities into a single opacity [Fraser and Pare]
112158	Lobar	Of or relating to a lobe (a curved or rounded projection or division); e.g. involving an entire lobe of the lung
112159	Hyper-acute	Extremely or excessively acute, as a qualitative measure of severity
112160	Homogeneous (uniform opacity)	Of uniform opacity or texture throughout [Fraser and Pare]
112161	Inhomogeneous	Lack of homogeneity in opacity or texture
112162	Target	Discrete opacity centrally within a larger opacity, as a calcification descriptor
112163	Fibrocalcific	Pertaining to sharply defined, linear, and/or nodular opacities containing calcification(s) [Fraser and Pare]
112164	Flocculent	Calcifications made up of loosely aggregated particles, resembling wool
112165	Difference in border shape	A change in the shape formed by the boundary or edges of a finding or feature	deprecated
112166	Difference in border definition	A change in the clarity of the boundary or edges of a finding or feature	deprecated
112167	Difference in distribution	A change in the extent of spreading of a finding or feature	deprecated
112168	Difference in site involvement	A change in the part(s) of the anatomy affected or encompassed by a finding or feature	deprecated
112169	Difference in Type of Content	A change in the matter or substance within a finding or feature	deprecated
112170	Difference in Texture	A change in the surface or consistency of a finding or feature	deprecated
112171	Fiducial mark	A location in image space, which may or may not correspond to an anatomical reference, which is often used for registering data sets
112172	Portacath	Connected to an injection chamber placed under the skin in the upper part of the chest. When it is necessary to inject some drug, a specific needle is put in the chamber through the skin and a silicon membrane. The advantage of a portacath is that it may be left in place several months contrarily of "classical" catheters
112173	Chest tube	A tube inserted into the chest wall from outside the body, for drainage. Sometimes used for collapsed lung. Usually connected to a receptor placed lower than the insertion site
112174	Central line	A tube placed into the subclavian vein to deliver medication directly into the venous system
112175	Kidney stent	A stent is a tube inserted into another tube. Kidney stent is a tube that is inserted into the kidney, ureter, and bladder, to help drain urine. Usually inserted through a scoping device presented through the urethra
112176	Pancreatic stent	A stent is a tube inserted into another tube. Pancreatic stent is inserted through the common bile duct to the pancreatic duct, to drain bile
112177	Nipple ring	A non-lesion object that appears to be a circular band, attached to the body via pierced nipple
112178	Coin	A non-lesion object that appears to be a flat round piece of metal
112179	Minimum Attenuation Coefficient	The least quantity assignable, admissible, or possible; the least of a set of X-Ray attenuation coefficients
112180	Maximum Attenuation Coefficient	The greatest quantity or value attainable or attained; the largest of a set of X-Ray attenuation coefficients
112181	Mean Attenuation Coefficient	The value that is computed by dividing the sum of a set of X-Ray attenuation coefficients by the number of values
112182	Median Attenuation Coefficient	The value in an ordered set of X-Ray attenuation coefficients, below and above which there is an equal number of values
112183	Standard Deviation of Attenuation Coefficient	For a set of X-Ray attenuation coefficients: 1) a measure of the dispersion of a frequency distribution that is the square root of the arithmetic mean of the squares of the deviation of each of the class frequencies from the arithmetic mean of the frequency distribution; 2) a parameter that indicates the way in which a probability function or a probability density function is centered around its mean and that is equal to the square root of the moment in which the deviation from the mean is squared
112184	Performance of Pediatric and Adult Thoracic CT	American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Thoracic Computed Tomography (CT). In: Standards. Reston, Va: 2001:103-107
112185	Performance of CT for Detection of Pulmonary Embolism in Adults	American College of Radiology. ACR Standard for the Performance of Computed Tomography for the Detection of Pulmonary Embolism in Adults. In: Standards. Reston, Va: 2001:109-113
112186	Performance of High-Resolution CT of the Lungs in Adults	American College of Radiology. ACR Standard for the Performance of High-Resolution Computed Tomography (HRCT) of the Lungs in Adults. In: Standards. Reston, Va: 2001:115-118
112187	Unspecified method of calculation	The method of calculation of a measurement or other type of numeric value is not specified
112188	Two-dimensional method	The calculation method was performed in two-dimensional space
112189	Three-dimensional method	The calculation method was performed in three-dimensional space
112191	Breast tissue density	The relative density of parenchymal tissue as a proportion of breast volume
112192	Volume of parenchymal tissue	The volume of parenchymal tissue
112193	Volume of breast	The volume of the breast
112194	Mass of parenchymal tissue	The mass of parenchymal tissue
112195	Mass of breast	The mass of the breast
112196	Area of Vascular Calcification	A measured or calculated area of vascular calcification
112197	Volume of Vascular Calcification	A measured or calculated volume of vascular calcification
112198	Percentage of Vascular Calcification	A measured or calculated percentage of vascular calcification
112199	Mass of Vascular Calcification	A measured or calculated mass of vascular calcification
112200	Average calcification distance in a calcification cluster	The average nearest neighbor distance of all individual microcalcifications in a cluster
112201	Standard deviation distance of calcifications in a cluster	The standard deviation of nearest neighbor distance of all individual microcalcifications in a cluster
112220	Colon CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to colon imaging and associated clinical information
112222	Colon Overall Assessment	Overall interpretation of the colon using C-RADS categorization system
112224	Image Set Properties	Characteristics of a set of images
112225	Slice Thickness	Nominal slice thickness, in mm
112226	Spacing between slices	Distance between contiguous images, measured from the center-to-center of each image
112227	Frame of Reference UID	Uniquely identifies groups of composite instances that have the same coordinate system that conveys spatial and/or temporal information
112228	Recumbent Patient Position with respect to gravity	Patient orientation with respect to downward direction (gravity)
112229	Identifying Segment	Distinguishes a part of a segmentation
112232	Polyp stalk width	The diameter of a polyp stalk measured perpendicular to the axis of the stalk
112233	Distance from anus	The length of the path following the centerline of the colon from the anus to the area of interest
112238	Anatomic non-colon	A location in the body that is outside the colon
112240	C0 - Inadequate Study/Awaiting Prior Comparisons	An inadequate study or a study that is awaiting prior comparisons. The study may have inadequate preparation and cannot exclude lesions greater than or equal to ten millimeters owing to presence of fluid or feces. The study may have inadequate insufflation where one or more colonic segments collapsed on both views. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112241	C1 - Normal Colon or Benign Lesion	The study has a normal colon or benign lesion, with the recommendation to continue routine screening. The study has no visible abnormalities of the colon. The study has no polyps greater than six millimeters. The study may have lipoma, inverted diverticulum, or nonneoplastic findings, such as colonic diverticula. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112242	C2 - Intermediate Polyp or Indeterminate Finding	The study has an intermediate polyp or indeterminate finding and surveillance or colonoscopy is recommended. There may be intermediate polyps between six and nine millimeters and there are less than three in number. The study may have an intermediate finding and cannot exclude a polyp that is greater than or equal to six millimeters in a technically adequate exam. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112243	C3 - Polyp, Possibly Advanced Adenoma	The study has a polyp, possibly advanced adenoma, and a follow-up colonoscopy is recommended. The study has a polyp greater than or equal to ten millimeters or the study has three or more polyps that are each between six to nine millimeters. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112244	C4 - Colonic Mass, Likely Malignant	The study has a colonic mass, likely malignant, and surgical consultation is recommended. The lesion compromises bowel lumen and demonstrates extracolonic invasion. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9
112248	ACR Guideline, Performance of Adult CT Colonography	American College of Radiology Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:371-376
112249	ACR Standard, CT medical physics performance monitoring	American College of Radiology Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:945-948
112300	AP+45	View Orientation Modifier indicates that the view orientation of the imaging plane is rotated +45° along the cranial-caudal axis
112301	AP-45	View Orientation Modifier indicates that the view orientation of the imaging plane is rotated -45° along the cranial-caudal axis
112302	Anatomical axis of femur	The axis following the shaft of the femur
112303	Acetabular Center of Rotation	Center of Rotation of the natural Acetabulum
112304	Femur Head Center of Rotation	Center of Rotation of the natural femur head
112305	Acetabular Cup Shell	Prosthetic component implanted into the acetabulum. Provides hold for the insert that is mounted inside the cup
112306	Acetabular Cup Insert	Prosthetic pelvic joint component. Inserted into the cup, takes in the femoral head replacement
112307	Acetabular Cup Monoblock	Prosthetic pelvic joint cup including insert
112308	Femoral Head Ball Component	Component for Femoral Head Prosthesis where the conic intake for the stem neck can be exchanged. Combined with a Femoral Head Cone Taper Component
112309	Femoral Head Cone Taper Component	Exchangeable neck intake for composite femoral head prosthesis. Combined with a Femoral Head Ball Component
112310	Femoral Stem	Prosthesis Implanted into the femoral bone to provide force transmission between joint replacement and bone. On the proximal end a conic neck holds the femoral head replacement
112311	Femoral Stem Distal Component	Distal half of a modular stem prosthesis system. Combined with a Stem Proximal Component
112312	Femoral Stem Proximal Component	Proximal half of a modular stem prosthesis system. Combined with a Stem Distal Component
112313	Femoral Stem Component	Stem prosthetic component with a modular insert for an exchangeable neck component. Combined with a Neck Component
112314	Neck Component	Prosthetic Neck to be combined with a Stem Component
112315	Monoblock Stem	Prosthetic Stem and Femoral Head in one piece
112316	Prosthetic Shaft Augment	A proximal attachment to the shaft used to compensate for bone deficiencies or bone loss
112317	Femoral Head Resurfacing Component	Artificial femur head surface needed for the partial replacement of the femoral head where only the surface is replaced
112318	Pinning	Fixation using a pin
112319	Sewing	Fixation sewing several objects together
112320	Bolting	Fixation using a bolt
112321	Wedging	Fixation due to forcing an object into a narrow space
112325	Distal Centralizer	Attachment to the distal end of a cemented stem assuring that the stem is in a central position inside the drilled femoral canal before cementation
112340	Generic 2D Planning	Planning by an unspecified 2D method
112341	Generic 3D Planning	Planning by an unspecified 3D method
112342	Generic Planning for Hip Replacement	Planning of a Hip Replacement, by an unspecified method
112343	Generic Planning for Knee Replacement	Planning of Knee Replacement, by an unspecified method
112344	Müller Method Planning for Hip Replacement	Planning of Hip Replacement according to the procedure of M. E. Müller [Eggli et. al.1998]
112345	Implantation Plan	A Report containing the results of an Implantation Planning Activity
112346	Selected Implant Component	A selection of one Implant Component
112347	Component ID	Identification ID of an Implant Component
112348	Implant Template	An implant template describing the properties (2D/3D geometry and other data) of one Implant Component
112350	Component Connection	A connection of two Connected Implantation Plan Components
112351	Mating Feature Set ID	ID of a Mating Feature Set in an Implant Component
112352	Mating Feature ID	ID of the Mating Feature in a Mating Feature Set in an Implant Component
112353	Spatial Registration	The Spatial Registration of one or more Implant Components
112354	Patient Image	Patient Images used for an implantation planning activity
112355	Assembly	A collection of Component Connections of Implant Components
112356	User Selected Fiducial	Fiducials that are selected by the user and may or may not belong to anatomical landmarks
112357	Derived Fiducial	Fiducials that represent geometric characteristics, such as center of rotation, and are derived from other fiducials
112358	Information used for planning	All parameters and data that were used for the planning activity
112359	Supporting Information	A description of the plan as encapsulated PDF SOP Instance
112360	Implant Component List	A list of all Implant Components selected for an implantation
112361	Patient Data Used During Planning	Reference to objects containing patient data that is used for planning
112362	Degrees of Freedom Specification	A specification of the values from one or more Degrees of Freedom
112363	Degree of Freedom ID	ID of one Degree of Freedom
112364	Related Patient Data Not Used During Planning	Reference to objects containing patient data that were not used for planning but are somehow related
112365	Related Implantation Reports	Implantation Reports that are somehow related; e.g. contemporaneous implantations that are independent
112366	Implant Assembly Template	Implant Assembly Template
112367	Planning Information for Intraoperative Usage	Information that is intended to be used intra-operatively
112368	Implantation Patient Positioning	Position of the patient on the operating room table
112369	Fiducial Intent	Intended use of the fiducial
112370	Component Type	Type of an Implant Component
112371	Manufacturer Implant Template	Implant Template released by the Manufacturer
112372	Derived Planning Images	Images that are created by a planning application
112373	Other Derived Planning Data	Data that is created by a planning application
112374	Connected Implantation Plan Component	One Implant Component that is connected to another Implant Component
112375	Planning Method	The method used for planning
112376	Degree of Freedom Exact Translational Value	Defines the exact value that was planned for translation
112377	Degree of Freedom Minimum Translational Value	Defines the minimum value that was planned for translation
112378	Degree of Freedom Maximum Translational Value	Defines the maximum value that was planned for translation
112379	Degree of Freedom Exact Rotational Translation Value	Defines the exact value that was planned for rotation
112380	Degree of Freedom Minimum Rotational Value	Defines the minimum value that was planned for rotation
112381	Degree of Freedom Maximum Rotational Value	Defines the maximum value that was planned for rotation
112700	Peri-operative Photographic Imaging	Procedure step protocol for photographic imaging of surgical procedures, including photography of specimens collected
112701	Gross Specimen Imaging	Procedure step protocol for imaging gross specimens, typically with a photographic camera (modality XC), and planning further dissection
112702	Slide Microscopy	Procedure step protocol for imaging slide specimens
112703	Whole Slide Imaging	Procedure step protocol for imaging slide specimens using a whole slide scanner
112704	WSI 20X RGB	Procedure step protocol for imaging slide specimens using a whole slide scanner with a 20X nominal objective lens, in full color, with a single imaging focal plane across the image
112705	WSI 40X RGB	Procedure step protocol for imaging slide specimens using a whole slide scanner with a 40X nominal objective lens, in full color, with a single imaging focal plane across the image
112706	Illumination Method	Technique of illuminating specimen
112707	Number of focal planes	Number of focal planes for a microscopy image acquisition
112708	Focal plane Z offset	Nominal distance above a reference plane (typically a slide glass substrate top surface) of the focal plane
112709	Magnification selection	Microscope magnification based on nominal objective lens power
112710	Illumination wavelength	Nominal center wavelength for an imaging spectral band
112711	Illumination spectral band	Name (coded) for an imaging spectral band
112712	Optical filter type	Type of filter inserted into the optical imaging path
112713	Tissue selection method	Technique for identifying tissue to be imaged versus area of slide not to be imaged
112714	Multiple planes	Imaging performed at multiple imaging (focal) planes
112715	5X	Nominal 5 power objective lens, resulting in a digital image at approximately 2 um/pixel spacing
112716	10X	Nominal 10 power objective lens, resulting in a digital image at approximately 1 um/pixel spacing
112717	20X	Nominal 20 power microscope objective lens, resulting in a digital image at approximately 0.5 um/pixel spacing
112718	40X	Nominal 40 power microscope objective lens, with a combined condenser and objective lens numerical aperture of approximately 1.3, resulting in a digital image at approximately 0.25 um/pixel spacing
112719	Nominal empty tile suppression	Equipment-specific nominal or default method for identifying tiles without tissue imaged for suppression from inclusion in image object
112720	High threshold empty tile suppression	Equipment-specific high threshold method for identifying tiles without tissue imaged for suppression from inclusion in image object
112721	No empty tile suppression	Tiles without tissue imaged are not suppressed from inclusion in image object
113000	Of Interest	Of Interest
113001	Rejected for Quality Reasons	Rejected for Quality Reasons
113002	For Referring Provider	For Referring Provider
113003	For Surgery	For Surgery
113004	For Teaching	For Teaching
113005	For Conference	For Conference
113006	For Therapy	For Therapy
113007	For Patient	For Patient
113008	For Peer Review	For Peer Review
113009	For Research	For Research
113010	Quality Issue	Quality Issue
113011	Document Title Modifier	Document Title Modifier
113012	Key Object Description	Key Object Description
113013	Best In Set	A selection that represents the "best" chosen from a larger set of items; e.g. the best images within a Study or Series. The criteria against which "best" is measured is not defined. Contrast this with the more specific term "Best illustration of finding"
113014	Study	A study is a collection of one or more series of medical images, presentation states, and/or SR documents that are logically related for the purpose of diagnosing a patient. A study may include composite instances that are created by a single modality, multiple modalities or by multiple devices of the same modality. [From Section A.1.2.2 "Study IE" in PS3.3 ]
113015	Series	A distinct logical set used to group composite instances. All instances within a Series are of the same modality, in the same Frame of Reference (if any), and created by the same equipment. [See Section A.1.2.3 "Series IE" in PS3.3 ]
113016	Performed Procedure Step	An arbitrarily defined unit of service that has actually been performed (not just scheduled). [From Section 7.3.1.9 "Modality Performed Procedure Step" in PS3.3 ]
113017	Stage-View	An image or set of images illustrating a specific stage (phase in a stress echo exam protocol) and view (combination of the transducer position and orientation at the time of image acquisition)
113018	For Printing	For Printing
113020	For Report Attachment	Selection of information objects for attachment to the clinical report of the Current Requested Procedure
113021	For Litigation	List of objects that are related to litigation and should be specially handled; e.g. may apply if a complaint has been received regarding a patient, or a specific set of images has been the subject of a subpoena, and needs to be sequestered or excluded from automatic purging according to retention policy
113026	Double exposure	Double exposure
113030	Manifest	A list of objects that have been exported out of one organizational domain into another domain. Typically, the first domain has no direct control over what the second domain will do with the objects
113031	Signed Manifest	A signed list of objects that have been exported out of one organizational domain into another domain, referenced securely with either Digital Signatures or MACs. Typically, the first domain has no direct control over what the second domain will do with the objects
113032	Complete Study Content	The list of objects that constitute a study at the time that the list was created
113033	Signed Complete Study Content	The signed list of objects that constitute a study at the time that the list was created, referenced securely with either Digital Signatures or MACs
113034	Complete Acquisition Content	The list of objects that were generated in a single procedure step
113035	Signed Complete Acquisition Content	The signed list of objects that were generated in a single procedure step, referenced securely with either Digital Signatures or MACs
113036	Group of Frames for Display	A list of frames or single-frame or entire multi-frame instances that together constitute a set for some purpose, such as might be displayed together in the same viewport, as distinct from another set that might be displayed in a separate viewport
113037	Rejected for Patient Safety Reasons	List of objects whose use is potentially harmful to the patient; e.g. an improperly labeled image could lead to dangerous surgical decisions
113038	Incorrect Modality Worklist Entry	List of objects that were acquired using an incorrect modality worklist entry, and that should not be used, since they may be incorrectly identified
113039	Data Retention Policy Expired	List of objects that have expired according to a defined data retention policy
113040	Lossy Compression	Lossy compression has been applied to an image
113041	Apparent Diffusion Coefficient	Values are derived by calculation of the apparent diffusion coefficient
113042	Pixel by pixel addition	Values are derived by the pixel by pixel addition of two images
113043	Diffusion weighted	Values are derived by calculation of the diffusion weighting
113044	Diffusion Anisotropy	Values are derived by calculation of the diffusion anisotropy
113045	Diffusion Attenuated	Values are derived by calculation of the diffusion attenuation
113046	Pixel by pixel division	Values are derived by the pixel by pixel division of two images
113047	Pixel by pixel mask	Values are derived by the pixel by pixel masking of one image by another
113048	Pixel by pixel Maximum	Values are derived by calculating the pixel by pixel maximum of two or more images
113049	Pixel by pixel mean	Values are derived by calculating the pixel by pixel mean of two or more images
113050	Metabolite Maps from spectroscopy data	Values are derived by calculating from spectroscopy data pixel values localized in two dimensional space based on the concentration of specific metabolites (i.e, at specific frequencies)
113051	Pixel by pixel Minimum	Values are derived by calculating the pixel by pixel minimum of two or more images
113052	Mean Transit Time	The time required for blood to pass through a region of tissue
113053	Pixel by pixel multiplication	Values are derived by the pixel by pixel multiplication of two images
113054	Negative Enhancement Integral	Values are derived by calculating negative enhancement integral values
113055	Regional Cerebral Blood Flow	The flow rate of blood perfusing a region of the brain as volume per mass per unit of time
113056	Regional Cerebral Blood Volume	The volume of blood perfusing a region of brain as volume per mass
113057	R-Coefficient	Correlation Coefficient, r
113058	Proton Density	Values are derived by calculating proton density values
113059	Signal Change	Values are derived by calculating signal change values
113060	Signal to Noise	Values are derived by calculating the signal to noise ratio
113061	Standard Deviation	Values are derived by calculating the standard deviation of two or more images
113062	Pixel by pixel subtraction	Values are derived by the pixel by pixel subtraction of two images
113063	T1	Values are derived by calculating T1 values
113064	T2*	Values are derived by calculating T2* values
113065	T2	Values are derived by calculating T2 values
113066	Time Course of Signal	Values are derived by calculating values based on the time course of signal
113067	Temperature encoded	Values are derived by calculating values based on temperature encoding
113068	Student's T-Test	Values are derived by calculating the value of the Student's T-Test statistic from multiple image samples
113069	Time To Peak	The time from the start of the contrast agent injection to the maximum enhancement value
113070	Velocity encoded	Values are derived by calculating values based on velocity encoded; e.g. phase contrast
113071	Z-Score	Values are derived by calculating the value of the Z-Score statistic from multiple image samples
113072	Multiplanar reformatting	Values are derived by reformatting in a flat plane other than that originally acquired
113073	Curved multiplanar reformatting	Values are derived by reformatting in a curve plane other than that originally acquired
113074	Volume rendering	Values are derived by volume rendering of acquired data
113075	Surface rendering	Values are derived by surface rendering of acquired data
113076	Segmentation	Values are derived by segmentation (classification into tissue types) of acquired data
113077	Volume editing	Values are derived by selectively editing acquired data (removing values from the volume), such as in order to remove obscuring structures or noise
113078	Maximum intensity projection	Values are derived by maximum intensity projection of acquired data
113079	Minimum intensity projection	Values are derived by minimum intensity projection of acquired data
113080	Glutamate and glutamine	For single-proton MR spectroscopy, the resonance peak corresponding to glutamate and glutamine
113081	Choline/Creatine Ratio	For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peaks
113082	N-acetylaspartate /Creatine Ratio	For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Creatine resonance peaks
113083	N-acetylaspartate /Choline Ratio	For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Choline resonance peaks
113085	Spatial resampling	Values are derived by spatial resampling of acquired data
113086	Edge enhancement	Values are derived by edge enhancement
113087	Smoothing	Values are derived by smoothing
113088	Gaussian blur	Values are derived by Gaussian blurring
113089	Unsharp mask	Values are derived by unsharp masking
113090	Image stitching	Values are derived by stitching two or more images together
113091	Spatially-related frames extracted from the volume	Spatially-related frames in this image are representative frames from the referenced 3D volume data set
113092	Temporally-related frames extracted from the set of volumes	Temporally-related frames in this image are representative frames from the referenced 3D volume data set
113093	Polar to Rectangular Scan Conversion	Conversion of a polar coordinate image to rectangular (Cartesian) coordinate image
113094	Creatine and Choline	For single-proton MR spectroscopy, the resonance peak corresponding to creatine and choline
113095	Lipid and Lactate	For single-proton MR spectroscopy, the resonance peak corresponding to lipid and lactate
113096	Creatine+Choline/ Citrate Ratio	For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peak and the Citrate resonance peak
113097	Multi-energy proportional weighting	Image pixels created through proportional weighting of multiple acquisitions at distinct X-Ray energies
113100	Basic Application Confidentiality Profile	De-identification using a profile defined in PS3.15 that requires removing all information related to the identity and demographic characteristics of the patient, any responsible parties or family members, any personnel involved in the procedure, the organizations involved in ordering or performing the procedure, additional information that could be used to match instances if given access to the originals, such as UIDs, dates and times, and private attributes, when that information is present in the non-Pixel Data Attributes, including graphics or overlays
113101	Clean Pixel Data Option	Additional de-identification according to an option defined in PS3.15 that requires any information burned in to the Pixel Data corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113102	Clean Recognizable Visual Features Option	Additional de-identification according to an option defined in PS3.15 that requires that sufficient removal or distortion of the Pixel Data shall be applied to prevent recognition of an individual from the instances themselves or a reconstruction of a set of instances
113103	Clean Graphics Option	Additional de-identification according to an option defined in PS3.15 that requires that any information encoded in graphics, text annotations or overlays corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113104	Clean Structured Content Option	Additional de-identification according to an option defined in PS3.15 that requires that any information encoded in SR Content Items or Acquisition Context Sequence Items corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113105	Clean Descriptors Option	Additional de-identification according to an option defined in PS3.15 that requires that any information that is embedded in text or string Attributes corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed
113106	Retain Longitudinal Temporal Information Full Dates Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be retained,
113107	Retain Longitudinal Temporal Information Modified Dates Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be modified in a manner that preserves temporal relationships; e.g. Study Date and Time
113108	Retain Patient Characteristics Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any physical characteristics of the patient, which are descriptive rather than identifying information per se, be retained; e.g. Patient's Age, Sex, Size (height) and Weight
113109	Retain Device Identity Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any information that identifies a device be retained; e.g. Device Serial Number
113110	Retain UIDs Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that UIDs be retained; e.g. SOP Instance UID
113111	Retain Safe Private Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that private attributes that are known not to contain identity information be retained; e.g. private SUV scale factor
113500	Radiopharmaceutical Radiation Dose Report	The procedure report is a Radiopharmaceutical Radiation Dose report
113502	Radiopharmaceutical Administration	Information pertaining to the administration of a radiopharmaceutical
113503	Radiopharmaceutical Administration Event UID	Unique identification of a single radiopharmaceutical administration event
113505	Intravenous Extravasation Symptoms	Initial signs or symptoms of extravasation
113506	Estimated Extravasation Activity	The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site
113507	Administered activity	The calculated activity at the Radiopharmaceutical Start Time when the radiopharmaceutical is administered to the patient. The residual activity (i.e. radiopharmaceutical not administered) , if measured, is reflected in the calculated value. The estimated extravasation is not reflected in the calculated value
113508	Pre-Administration Measured Activity	Radioactivity measurement of radiopharmaceutical before or during the administration
113509	Post-Administration Measured Activity	Radioactivity measurement of radiopharmaceutical after the administration
113510	Drug Product Identifier	Registered drug establishment code for product, coding scheme example is NDC or RxNorm
113511	Radiopharmaceutical Dispense Unit Identifier	The human readable identification of the specific radiopharmaceutical dispensed quantity or dose ("dose" as unit of medication delivery, not radiation dose measure) to be administered to the patient
113512	Radiopharmaceutical Lot Identifier	Identifies the vial, batch or lot number from which the individual dispense radiopharmaceutical quantity (dose) is produced. The Radiopharmaceutical Dispense Unit Identifier records the identification for each individual dose
113513	Reagent Vial Identifier	Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical
113514	Radionuclide Vial Identifier	Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical
113516	Prescription Identifier	Administered Product's Prescription Number
113517	Organ Dose Information	Information pertaining to the estimated absorbed radiation dose to an organ
113518	Organ Dose	The absorbed radiation dose to organ
113520	MIRD Pamphlet 1	Reference authority MIRD Pamphlet No.1 (rev) ,Society of Nuclear Medicine, 1976
113521	ICRP Publication 53	Reference authority ICRP, 1988. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18 (1-4)
113522	ICRP Publication 80	Reference authority ICRP, 1998. Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53). ICRP Publication 80. Ann. ICRP 28 (3)
113523	ICRP Publication 106	Reference authority ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2)
113526	MIRDOSE	Reference authority Stabin MG, Sparks RB, Crowe E (1994) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine [Computer program]
113527	OLINDA-EXM	Reference authority Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine [Computer program]
113528	Package Insert	Reference authority The reported organ dose is based on radiopharmaceutical's package insert
113529	Institutionally Approved Estimates	Reference authority The reported organ dose is based on Institutionally approved estimates from the Radioactive Drug Research Committee (RDRC) of the institution itself
113530	Investigational New Drug	Reference authority The reported organ dose is based on an Investigation new drug
113540	Activity Measurement Device	The type of device that performed the activity measurement
113541	Dose Calibrator	The device that measures the radiation activity of the radiopharmaceutical
113542	Infusion System	Radiopharmaceutical Infusion System
113543	Generator	Radioisotope Generator
113550	Fasting Duration	The number hours the patient has gone without food
113551	Hydration Volume	The amount of fluids the patient has consumed before the procedure
113552	Recent Physical Activity	A description of physical activity the patient performed before the start of the procedure, such as that which may affect imaging agent biodistribution
113560	Acute unilateral renal blockage	Blockage in one of the tubes (ureters) that drain urine from the kidneys
113561	Low Thyroid Uptake	5% or less Thyroid Uptake of Iodine
113562	High Thyroid Uptake	25% or higher Thyroid Uptake of Iodine
113563	Severely Jaundiced	The patient exhibits symptoms severe of jaundice and/or has a Bilirubin >10 mg/dL
113568	Extravasation visible in image	Extravasation or paravenous administration of the product is visible in the images
113570	Cockroft-Gault Formula estimation of GFR	The measurement method of the Glomerular Filtration Rate is Cockroft-Gault Formula
113571	CKD-EPI Formula estimation of GFR	The measurement method of the Glomerular Filtration Rate is CKD-EPI Formula
113572	Glomerular Filtration Rate (MDRD)	The measurement method of the Glomerular Filtration Rate is MDRD
113573	Glomerular Filtration Rate non-black (MDRD)	The measurement method of the Glomerular Filtration Rate is non-black MDRD
113574	Glomerular Filtration Rate black (MDRD)	The measurement method of the Glomerular Filtration Rate is black (MDRD)
113575	Glomerular Filtration Rate female (MDRD)	The measurement method of the Glomerular Filtration Rate is female (MDRD)
113576	Glomerular Filtration Rate Cystatin-based formula	The measurement method of the Glomerular Filtration Rate is Cystatin-based formula
113577	Glomerular Filtration Rate Creatinine-based formula (Schwartz)	The measurement method of the Glomerular Filtration Rate is Creatinine-based formula (Schwartz)
113601	Small: < 32.0 cm lateral thickness	Small body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113602	Medium: 32.0-38.0 cm lateral thickness	Medium body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113603	Large: > 38.0 cm lateral thickness	Large body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image
113605	Irradiation Event Label	A human-readable label identifying an irradiation event
113606	Label Type	The type of a human-readable label
113607	Series Number	A number that identifies a Series. Corresponds to (0020,0011) in PS3.3
113608	Acquisition Number	A number that identifies an Acquisition. Corresponds to (0020,0012) in PS3.3
113609	Instance Number	A number that identifies an Instance. Corresponds to (0020,0013) in PS3.3
113611	Stationary Acquisition	Acquisition where the X-Ray source does not move in relation to the patient
113612	Stepping Acquisition	Acquisition where the X-Ray source moves laterally in relation to the patient
113613	Rotational Acquisition	Acquisition where the X-Ray source moves angularly in relation to the patient
113620	Plane A	Primary plane of a Biplane acquisition equipment
113621	Plane B	Secondary plane of a Biplane acquisition equipment
113622	Single Plane	Single plane acquisition equipment
113630	Continuous	Continuous X-Ray radiation is applied during an irradiation event
113631	Pulsed	Pulsed X-Ray radiation is applied during an irradiation event
113650	Strip filter	Filter with uniform thickness
113651	Wedge filter	Filter with variation in thickness from one edge to the opposite edge
113652	Butterfly filter	Filter with two triangular sections
113653	Flat filter	Filter with uniform thickness that is for spectral filtering only; e.g. filter out low energy portion of the X-Ray that would only contribute to skin dose, but not to image
113661	Outline of lobulations	A polyline defining the outline of a lobulated finding
113662	Inner limits of fuzzy margin	A polyline defining the inner limits of a finding with fuzzy margin
113663	Outer limits of fuzzy margin	A polyline defining the outer limits of a finding with fuzzy margin
113664	Outline of spiculations	A polyline defining the outline of the spiculations of a finding
113665	Linear spiculation	A polyline segment graphically indicating the location and direction of a spiculation of a finding
113666	Pixelated spiculations	A collection of points indicating the pixel locations of the spiculations of a finding
113669	Orthogonal location arc	Connected line segments indicating the center of location of a finding on an orthogonal view
113670	Orthogonal location arc inner margin	Connected line segments indicating the inner margin of the location of a finding on an orthogonal view
113671	Orthogonal location arc outer margin	Connected line segments indicating the outer location of a finding on an orthogonal view
113680	Quality Control Intent	This procedure is intended to gather data that is used for calibration or other quality control purposes
113681	Phantom	An artificial subject of an imaging study
113682	ACR Accreditation Phantom - CT	A phantom acceptable for the ACR Computed Tomography Accreditation program
113683	ACR Accreditation Phantom - MR	A phantom acceptable for the ACR Magnetic Resonance Imaging Accreditation program
113684	ACR Accreditation Phantom - Mammography	A phantom acceptable for the ACR Mammography Accreditation program
113685	ACR Accreditation Phantom - Stereotactic Breast Biopsy	A phantom acceptable for the ACR Stereotactic Breast Biopsy Accreditation program
113686	ACR Accreditation Phantom - ECT	A phantom acceptable for the ACR SPECT Accreditation program (but not for PET)
113687	ACR Accreditation Phantom - PET	A phantom acceptable for the ACR PET Accreditation program (but not for SPECT)
113688	ACR Accreditation Phantom - ECT/PET	A SPECT phantom with a PET faceplate acceptable for both the ACR SPECT and PET Accreditation programs
113689	ACR Accreditation Phantom - PET Faceplate	A PET faceplate (made to fit an existing flangeless or flanged ECT phantom) acceptable for the ACR PET Accreditation program
113690	IEC Head Dosimetry Phantom	A phantom used for CTDI measurement in head modes according to IEC 60601-2-44, Ed.2.1 (Head 16 cm diameter Polymethyl methacrylate PMMA)
113691	IEC Body Dosimetry Phantom	A phantom used for CTDI measurement in body modes according to IEC 60601-2-44, Ed.2.1 (Body 32cm diameter Polymethyl methacrylate PMMA)
113692	NEMA XR21-2000 Phantom	A phantom in accordance with NEMA standard XR-21-2000
113701	X-Ray Radiation Dose Report	X-Ray Radiation Dose Report
113702	Accumulated X-Ray Dose Data	X-Ray dose data accumulated over multiple irradiation events; e.g. for a study or a performed procedure step
113704	Projection X-Ray	Imaging using a point X-Ray source with a diverging beam projected onto a 2 dimensional detector
113705	Scope of Accumulation	Entity over which dose accumulation values are integrated
113706	Irradiation Event X-Ray Data	X-Ray dose data for a single Irradiation Event
113710	Niobium or Niobium compound	Material containing Niobium or a Niobium compound	deprecated
113711	Europium or Europium compound	Material containing Europium or a Europium compound	deprecated
113720	Calibration Protocol	Describes the method used to derive the calibration factor
113721	Irradiation Event Type	Denotes the type of irradiation event recorded
113722	Dose Area Product Total	Total calculated Dose Area Product (in the scope of the including report)
113723	Calibration Date	Last calibration Date for the integrated dose meter or dose calculation
113724	Calibration Responsible Party	Individual or organization responsible for calibration
113725	Dose (RP) Total	Total Dose related to Reference Point (RP). (in the scope of the including report)
113726	Fluoro Dose Area Product Total	Total calculated Dose Area Product applied in Fluoroscopy Modes (in the scope of the including report)
113727	Acquisition Dose Area Product Total	Total calculated Dose Area Product applied in Acquisition Modes (in the scope of the including report)
113728	Fluoro Dose (RP) Total	Dose applied in Fluoroscopy Modes, related to Reference Point (RP). (in the scope of the including report)
113729	Acquisition Dose (RP) Total	Dose applied in Acquisition Modes, related to Reference Point (RP). (in the scope of the including report)
113730	Total Fluoro Time	Total accumulated clock time of Fluoroscopy in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated fluoroscopy irradiation events)
113731	Total Number of Radiographic Frames	Accumulated Count of exposure pulses (single or multi-frame encoded) created from irradiation events performed with high dose (acquisition)
113732	Fluoro Mode	Mode of application of X-Rays during Fluoroscopy
113733	KVP	Applied X-Ray Tube voltage at peak of X-Ray generation, in kilovolts; Mean value if measured over multiple peaks (pulses)
113734	X-Ray Tube Current	Mean value of applied Tube Current
113735	Exposure Time	Cumulative time the patient has received X-Ray exposure during the irradiation event	deprecated
113736	Exposure	Mean value of X-Ray Current Time product
113737	Distance Source to Reference Point	Distance to the Reference Point (RP) defined according to IEC 60601-2-43 or equipment defined
113738	Dose (RP)	Dose applied at the Reference Point (RP)
113739	Positioner Primary End Angle	Positioner Primary Angle at the end of an irradiation event. For further definition see (112011, DCM, "Positioner Primary Angle")
113740	Positioner Secondary End Angle	Positioner Secondary Angle at the end of an irradiation event. For further definition see (112012, DCM, "Positioner Secondary Angle")
113742	Irradiation Duration	Clock time from the start of loading time of the first pulse until the loading time trailing edge of the final pulse in the same irradiation event. Note Loading time is defined in IEC 60601-1-3:2008, 3.37, and described in IEC 60601-2-54:2009, 203.4.101.3
113743	Patient Orientation	Orientation of the Patient with respect to Gravity
113744	Patient Orientation Modifier	Enhances or modifies the Patient orientation specified in Patient Orientation
113745	Patient Table Relationship	Orientation of the Patient with respect to the Head of the Table
113748	Distance Source to Isocenter	Distance from the X-Ray Source to the Equipment C-Arm Isocenter.(Center of Rotation)
113750	Distance Source to Detector	Measured or calculated distance from the X-Ray source to the detector plane in the center of the beam
113751	Table Longitudinal Position	Table Longitudinal Position with respect to an arbitrary chosen reference by the equipment. Table motion towards LAO is positive assuming that the patient is positioned supine and its head is in normal position
113752	Table Lateral Position	Table Lateral Position with respect to an arbitrary chosen reference by the equipment. Table motion towards CRA is positive assuming that the patient is positioned supine and its head is in normal position
113753	Table Height Position	Table Height Position with respect to an arbitrary chosen reference by the equipment in (mm). Table motion downwards is positive
113754	Table Head Tilt Angle	Angle of the head-feet axis of the table in degrees relative to the horizontal plane. Positive values indicate that the head of the table is upwards
113755	Table Horizontal Rotation Angle	Rotation of the table in the horizontal plane (clockwise when looking from above the table)
113756	Table Cradle Tilt Angle	Angle of the left-right axis of the table in degrees relative to the horizontal plane. Positive values indicate that the left of the table is upwards
113757	X-Ray Filter Material	X-Ray absorbing material used in the filter
113758	X-Ray Filter Thickness Minimum	The minimum thickness of the X-Ray absorbing material used in the filters
113759	Table Longitudinal End Position	Table Longitudinal Position at the end of an irradiation event; see (113751, DCM, "Table Longitudinal Position")
113760	Table Lateral End Position	Table Lateral Position at the end of an irradiation event; see (113752, DCM, "Table Lateral Position")
113761	Table Height End Position	Table Height Position at the end of an irradiation event; see (113753, DCM, "Table Height Position")
113763	Calibration Uncertainty	Uncertainty of the 'actual' value
113764	Acquisition Plane	Identification of Acquisition Plane with Biplane systems
113766	Focal Spot Size	Nominal Size of Focal Spot of X-Ray Tube
113767	Average X-Ray Tube Current	Average X-Ray Tube Current averaged over time for pulse or for continuous Fluoroscopy
113768	Number of Pulses	Number of pulses applied by X-Ray systems during an irradiation event (acquisition run or pulsed fluoro)
113769	Irradiation Event UID	Unique identification of a single irradiation event
113770	Column Angulation	Angle of the X-Ray beam in degree relative to an orthogonal axis to the detector plane
113771	X-Ray Filters	Devices used to modify the energy or energy distribution of X-Rays
113772	X-Ray Filter Type	Type of filter(s) inserted into the X-Ray beam; e.g. wedges
113773	X-Ray Filter Thickness Maximum	The maximum thickness of the X-Ray absorbing material used in the filters
113780	Reference Point Definition	System provided definition of the Reference Point used for Dose calculations
113788	Collimated Field Height	Distance between the collimator blades in pixel column direction as projected at the detector plane
113789	Collimated Field Width	Distance between the collimator blades in pixel row direction as projected at the detector plane
113790	Collimated Field Area	Collimated field area at image receptor. Area for compatibility with IEC 60601-2-43
113791	Pulse Rate	Pulse rate applied by equipment during Fluoroscopy
113792	Distance Source to Table Plane	Measured or calculated distance from the X-Ray source to the table plane in the center of the beam
113793	Pulse Width	(Average) X-Ray pulse width
113794	Dose Measurement Device	Calibrated device to perform dose measurements
113795	Acquired Image	Image acquired during a specified event
113800	DLP to E conversion via MC computation	Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of Monte Carlo computations
113801	CTDIfreeair to E conversion via MC computation	Effective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of Monte Carlo computations
113802	DLP to E conversion via measurement	Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113803	CTDIfreeair to E conversion via measurement	Effective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom
113804	Sequenced Acquisition	The CT acquisition was performed by acquiring single or multi detector data while rotating the source about the gantry while the table is not moving. Additional slices are acquired by incrementing the table position and again rotating the source about the gantry while the table is not moving
113805	Constant Angle Acquisition	The CT acquisition was performed by holding the source at a constant angle and moving the table to obtain a projection image; e.g. localizer
113806	Stationary Acquisition	The CT acquisition was performed by holding the table at a constant position and acquiring multiple slices over time at the same location
113807	Free Acquisition	The CT acquisition was performed while rotating the source about the gantry while the table movement is under direct control of a human operator or under the control of an analysis application; e.g. fluoro
113808	ICRP Pub 60	Reference authority 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, published as the Annals of the ICRP Vol. 21, No. 1-3, Pergamon Press,1991)
113809	Start of X-Ray Irradiation	Start, DateTime of the first X-Ray Irradiation Event of the accumulation within a Study
113810	End of X-Ray Irradiation	End, DateTime of the last X-Ray Irradiation Event of the accumulation within a Study
113811	CT Accumulated Dose Data	X-Ray dose accumulated over multiple CT irradiation events; e.g. for a study or a performed procedure step
113812	Total Number of Irradiation Events	Total number of events during the defined scope of accumulation
113813	CT Dose Length Product Total	The total dose length product defined scope of accumulation
113814	CT Effective Dose Total	The total Effective Dose at the defined scope of accumulation
113815	Patient Model	Identification of the reference-patient model used when Effective Dose is evaluated via Monte Carlo calculations or from a Dose Length Product conversion factor based on Monte Carlo calculations
113816	Condition Effective Dose measured	References the physical phantom and the type of dosimeter used when measurements are done to establish Effective Dose Conversion Factors (E/DLP) or ratios E/CTDIfreeair
113817	Effective Dose Phantom Type	Type of Effective Dose phantom used
113818	Dosimeter Type	Type of dosimeter used
113819	CT Acquisition	General description of the CT Irradiation event
113820	CT Acquisition Type	Method of the CT acquisition
113821	X-Ray Filter Aluminum Equivalent	Thickness of an equivalent filter in mm in Aluminum
113822	CT Acquisition Parameters	General description of the acquisition parameters
113823	Number of X-Ray Sources	Number of X-Ray sources
113824	Exposure Time	Total time the patient has received X-Ray exposure during the irradiation event
113825	Scanning Length	Length of the table travel during the entire tube loading, according to IEC 60601-2-44 Note Scanning Length might be longer than the programmed acquisition length (Length of Reconstructable Volume)
113826	Nominal Single Collimation Width	The value of the nominal width referenced to the location of the isocenter along the z axis of a single row of acquired data in mm
113827	Nominal Total Collimation Width	The value of the nominal width referenced to the location of the isocenter along the z axis of the total collimation in mm over the area of active X-Ray detection
113828	Pitch Factor	For Spiral scanning: Pitch Factor = (Table Feed per Rotation (mm)) /(Nominal Total Collimation Width (mm)) For Sequenced scanning: Pitch Factor = (Table Feed per single Sequenced scan (mm)) /(Nominal Total Collimation Width (mm))
113829	CT Dose	General description of CT dose values
113830	Mean CTDIvol	"Mean CTDIvol" refers to the average value of the CTDIvol associated with this acquisition
113831	CT X-Ray Source Parameters	Identification, tube-potential, tube-current, and exposure-time parameters associated with an X-Ray source during an acquisition
113832	Identification of the X-Ray Source	Identifies the particular X-Ray source (in a multi-source CT system) for which the set of X-Ray source parameter values is reported
113833	Maximum X-Ray Tube Current	Maximum X-Ray tube current
113834	Exposure Time per Rotation	The exposure time for one rotation of the source around the object in s
113835	CTDIw Phantom Type	A label describing the type of phantom used for CTDIW measurement according to IEC 60601-2-44 (Head 16 cm diameter PMMA, Body 32 cm diameter PMMA)
113836	CTDIfreeair Calculation Factor	The CTDIfreeair Calculation Factor is the CTDIfreeair per mAs, expressed in units of mGy/mAs. The CTDIfreeair Calculation Factor may be used in one method calculating Dose
113837	Mean CTDIfreeair	The average value of the free-in-air CTDI associated with this acquisition
113838	DLP	Dose Length Product (DLP), expressed in mGy-cm, is an index characterizing the product of the CTDIvol and the length scanned. For Spiral scanning, DLP = CTDIvol x Scanning Length. For Sequenced scanning, DLP = CTDIvol x Nominal Total Collimation Width x Cumulative Exposure Time / Exposure Time per Rotation. For Stationary and Free scanning, DLP = CTDIvol x Nominal Total Collimation Width
113839	Effective Dose	Effective dose in mSv
113840	Effective Dose Conversion Factor	Effective Dose per DLP, reference value for Effective Dose calculation, expressed in mSv/mGY.cm
113841	ICRP Pub 103	Effective Dose Reference authority 2007 Recommendations of the International Commission on Radiological Protection (ICRP Publication 103, published as the Annals of the ICRP Vol. 37, No. 2-4, Elsevier, 2007)
113842	X-Ray Modulation Type	The type of exposure modulation used for the purpose of limiting the dose
113845	Exposure Index	Measure of the detector response to radiation in the relevant image region of an image acquired with a digital X-Ray imaging system as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113846	Target Exposure Index	The target value used to calculate the Deviation Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113847	Deviation Index	A scaled representation of the accuracy of the Exposure Index compared to the Target Exposure Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro
113850	Irradiation Authorizing	The clinician responsible for determining that the irradiating procedure was appropriate for the indications
113851	Irradiation Administering	The person responsible for the administration of radiation
113852	Irradiation Event	An irradiation event is the loading of X-Ray equipment caused by a single continuous actuation of the equipment's irradiation switch, from the start of the loading time of the first pulse until the loading time trailing edge of the final pulse. Any automatic on-off switching of the irradiation source during the event is not treated as separate events, rather the event includes the time between start and stop of irradiation as triggered by the user; e.g. a pulsed fluoro X-Ray acquisition shall be treated as a single irradiation event
113853	Irradiation Event UID	Unique Identifier of an Irradiation Event
113854	Source of Dose Information	Method by which dose-related details of an Irradiation Event were obtained
113855	Total Acquisition Time	Total accumulated acquisition clock time in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated acquisition irradiation events)
113856	Automated Data Collection	Direct recording of data by a relevant system
113857	Manual Entry	Recording of data by a human operator, including manual transcription of electronic data
113858	MPPS Content	The data is taken from an MPPS SOP Instance
113859	Irradiating Device	A device exposing a patient to ionizing radiation
113860	15cm from Isocenter toward Source	15cm from the isocenter towards the X-Ray source; See IEC 60601-2-43
113861	30cm in Front of Image Input Surface	30cm in front (towards the tube) of the input surface of the image receptor; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113862	1cm above Tabletop	1cm above the patient tabletop or cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113863	30cm above Tabletop	30cm above the patient tabletop of cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113864	15cm from Table Centerline	15cm from the centerline of the X-Ray table and in the direction of the X-Ray source; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (7)
113865	Entrance exposure to a 4.2 cm breast thickness	Standard breast means a 4.2 centimeter (cm) thick compressed breast consisting of 50 percent glandular and 50 percent adipose tissue. See Department of Health and Human Services, Food and Drug Administration. Mammography quality standards; final rule. Federal Register. Oct. 28, 1997; 68(208):55852-55994; see 900.2(uu)
113866	Copied From Image Attributes	The data is copied from information present in the image attributes; e.g. dose attributes such as CTDIvol (0018,9345)
113867	Computed From Image Attributes	The data is computed from information present in the image attributes; e.g. by using dosimetry information for the specific irradiating device make and model, applied to technique information such as KVP and mAs
113868	Derived From Human-Readable Reports	The data is derived from human-readable reports; e.g. by natural language parsing of text reports, or optical character recognition from reports saved as images by the irradiating device
113870	Person Name	The name of a specific person
113871	Person ID	An identification number or code for a specific person
113872	Person ID Issuer	The organization that issued a Person ID
113873	Organization Name	The name of an organization
113874	Person Role in Organization	The role played by a person in an organization
113875	Person Role in Procedure	The role played by a person in a procedure
113876	Device Role in Procedure	The role played by a device in a procedure
113877	Device Name	The name used to refer to a device; usually locally unique
113878	Device Manufacturer	Manufacturer of a device
113879	Device Model Name	Model Name of a device
113880	Device Serial Number	Serial Number of a device
113890	All Planes	All planes of a multi-plane acquisition equipment
113893	Length of Reconstructable Volume	The length from which images may be reconstructed (i.e., excluding any overranging performed in a spiral acquisition that is required for data interpolation). Value is distinct from (1113825, DCM, "Scanning Length"), which is the actual length of the table travel during the entire tube loading, according to IEC 60601-2-44, and includes overranging. Also distinct from any actual Reconstructed Volume, which may depend on the slice thickness chosen for a particular reconstruction
113895	Top Z Location of Reconstructable Volume	The Z location that is the top (highest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113896	Bottom Z Location of Reconstructable Volume	The Z location that is the bottom (lowest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113897	Top Z Location of Scanning Length	The Z location that is the top (highest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113898	Bottom Z Location of Scanning Length	The Z location that is the bottom (lowest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference
113899	Exposed Range	The range along the z axis of the total volume irradiated, per IEC 60601-2-44, Ed. 3, 203.115(b). The start and stop of loading corresponding to the outer edge of the full width half maximum of the free-in-air dose profile for the beam collimation used
113900	Dose Check Alert Details	Report section about cumulative dose alerts during an examination
113901	DLP Alert Value Configured	Flag denoting whether a DLP Alert Value was configured
113902	CTDIvol Alert Value Configured	Flag denoting whether a CTDIvol Alert Value was configured
113903	DLP Alert Value	Cumulative Dose Length Product value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113904	CTDIvol Alert Value	Cumulative CTDIvol value configured to trigger an alert; see NEMA XR 25-2010 Dose Check Standard
113905	Accumulated DLP Forward Estimate	A forward estimate of the accumulated DLP plus the estimated DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113906	Accumulated CTDIvol Forward Estimate	A forward estimate at a given location of the accumulated CTDIvol plus the estimated CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113907	Reason for Proceeding	Reason provided for proceeding with a procedure that is projected to exceed a configured dose value
113908	Dose Check Notification Details	Report section about dose notifications during a protocol element
113909	DLP Notification Value Configured	Flag denoting whether a DLP Notification Value was configured
113910	CTDIvol Notification Value Configured	Flag denoting whether a CTDIvol Notification Value was configured
113911	DLP Notification Value	Dose Length Product value configured to trigger a notification for a given protocol element
113912	CTDIvol Notification Value	CTDIvol value configured to trigger a notification for a given protocol element
113913	DLP Forward Estimate	A forward estimate of the DLP for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113914	CTDIvol Forward Estimate	A forward estimate of the CTDIvol for the next Protocol Element Group; see NEMA XR 25-2010 Dose Check Standard
113921	Radiation Exposure	The amount of ionizing radiation to which the patient was exposed
113922	Radioactive Substance Administered	Type, amount and route of radioactive substance administered
113923	Radiation Exposure and Protection Information	Exposure to ionizing radiation and associated preventive measures used to reduce the exposure of parts of the body like lead apron or eye, thyroid gland or gonad protection	deprecated
113930	Size Specific Dose Estimation	The Size-Specific Dose Estimate is a patient dose estimate that takes into account the size of the patient, such as described in AAPM Report 204 by using linear dimensions measured on the patient or patient images or estimated from patient age
113931	Measured Lateral Dimension	The side-to-side (left to right) dimension of the body part being scanned (per AAPM Report 204)
113932	Measured AP Dimension	The thickness of the body part being scanned, in the antero-posterior dimension (per AAPM Report 204)
113933	Derived Effective Diameter	The diameter of the patient at a given location along the Z-axis of the patient, assuming that the patient has a circular cross-section (per AAPM Report 204)
113934	AAPM 204 Lateral Dimension	The Size Specific Dose Estimation is computed using Table 1B (32cm phantom) or Table 2B (16cm phantom) of AAPM Report 204
113935	AAPM 204 AP Dimension	The Size Specific Dose Estimation is computed using Table 1C (32cm phantom) or Table 2C (16cm phantom) of AAPM Report 204
113936	AAPM 204 Sum of Lateral and AP Dimension	The Size Specific Dose Estimation is computed using Table 1A (32cm phantom) or Table 2A (16cm phantom) of AAPM Report 204
113937	AAPM 204 Effective Diameter Estimated From Patient Age	The Size Specific Dose Estimation is computed using Table 1D (32cm phantom) or Table 2D (16cm phantom) using an effective diameter estimated from the patient's age using Table 3 of AAPM Report 204
113940	System Calculated	Values calculated from other existing parameters
113941	In Detector Plane	A segmented region of the detector surface within the irradiated area (but might not be near the center of the detector)
113942	X-Ray Reading Device	A device that creates digital images from X-Ray detectors (Direct, Indirect or Storage)
113943	X-Ray Source Data Available	Parameters related to the X-Ray source (generator, tube, etc.) are available to the recording application
113944	X-Ray Mechanical Data Available	Parameters related to the X-Ray Mechanical System (Stand, Table) are available to the recording application
113945	X-Ray Detector Data Available	Parameters related to the X-Ray Detector are available to the recording application
113946	Projection Eponymous Name	Describes the radiographic method of patient, tube and detector positioning to achieve a well described projection or view
113947	Detector Type	Type of Detector used to acquire data; e.g. Images
113948	Direct Detector	Detector that directly transforms the input signal to pixel values
113949	Indirect Detector	Detector that transforms an intermediate signal into pixel values; e.g. a scintillator-based detector
113950	Storage Detector	Storage detector that stores a signal that is later transformed by a reader into pixel values; e.g. a phosphor-based detector
113951	Film	Film that is scanned to create pixel values
113952	Table Mount	The cassette/detector is mounted in the patient table
113953	Unmounted Detector	The cassette/detector is not mounted.; e.g. a cassette placed underneath the patient
113954	Upright Stand Mount	The cassette/detector is mounted in an upright stand
113955	C-Arm Mount	The cassette/detector is mounted on a c-arm
113956	CR/DR Mechanical Configuration	Method of mounting or positioning a CR/DR cassette or detector
113957	Fluoroscopy-Guided Projection Radiography System	An integrated projection radiography system capable of fluoroscopy
113958	Integrated Projection Radiography System	A projection radiography system where the X-Ray detector, X-Ray Source and gantry components are integrated and the managing system is able to access details of each component
113959	Cassette-based Projection Radiography System	A projection radiography system where the X-Ray detector, X-Ray Source and gantry components are not integrated; e.g. cassette-based CR and DR systems
113961	Reconstruction Algorithm	Description of the algorithm used when reconstructing the image from the data acquired during the acquisition process
113962	Filtered Back Projection	An algorithm for reconstructing an image from multiple projections by back-projecting the measured values along the line of the projection and filtering the result to reduce blurring
113963	Iterative Reconstruction	An algorithm for reconstructing an image from multiple projections by starting with an assumed reconstructed image, computing projections from the image, comparing the original projection data and updating the reconstructed image based upon the difference between the calculated and the actual projections
113970	Procedure Step To This Point	The period of time from the start of a Procedure Step until the time point established by the context of the reference
114000	Not a number	Measurement not available: Not a number (per IEEE 754)
114001	Negative Infinity	Measurement not available: Negative Infinity (per IEEE 754)
114002	Positive Infinity	Measurement not available: Positive Infinity (per IEEE 754)
114003	Divide by zero	Measurement not available: Divide by zero (per IEEE 754)
114004	Underflow	Measurement not available: Underflow (per IEEE 754)
114005	Overflow	Measurement not available: Overflow (per IEEE 754)
114006	Measurement failure	Measurement not available: Measurement failure
114007	Measurement not attempted	Measurement not available: Measurement not attempted
114008	Calculation failure	Measurement not available: Calculation failure
114009	Value out of range	Measurement not available: Value out of range
114010	Value unknown	Measurement not available: Value unknown
114011	Value indeterminate	Measurement not available: Value indeterminate
114201	Time of flight	Measures the time-of-flight of a light signal between the camera and the subject for each point of the image
114202	Interferometry	Interferometry is a family of techniques in which waves are superimposed in order to extract depth information about the scanned object
114203	Laser scanning	Laser scanning describes the general method to sample or scan a surface using laser technology
114204	Pattern projection	Projecting a narrow band of light onto a three-dimensionally shaped surface produces a line of illumination that appears distorted from other perspectives than that of the projector. It can be used for an exact geometric reconstruction of the surface shape
114205	Shape from shading	A technique for estimating the surface normal of an object by observing that object under different lighting conditions
114206	Shape from motion	A technique for estimating the surface normal of an object by observing that object under different motions
114207	Confocal imaging	An optical imaging technique used to increase optical resolution and contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane. It enables the reconstruction of 3D structures from the obtained images
114208	Point Cloud Algorithmic	Point cloud that was calculated by an algorithm
114209	Turntable Scan Method	Scanning the object from different views by placing it on a rotating table
114210	High resolution	Higher resolution with a longer acquisition time
114211	Fast mode	Lower resolution with a shorter acquisition time
114213	Iterative Closest Point	An algorithm employed to minimize the difference between two clouds of points. It iteratively revises the transformation (translation, rotation) needed to minimize the distance between the points of two point clouds
114215	Freehand	Human controlled minimization of the distance between the points of two point clouds
114216	Checkerboard	Scanning the object from different views by placing it in front of a checkerboard pattern
121001	Quotation Mode	Type of source for observations quoted from an external source
121002	Quoted Source	Reference to external source of quoted observations
121003	Document	Documentary source of quoted observations
121004	Verbal	Verbal source of quoted observations
121005	Observer Type	Type of observer that created the observations
121006	Person	Human observer created the observations
121007	Device	Automated device created the observations
121008	Person Observer Name	Name of human observer that created the observations
121009	Person Observer's Organization Name	Organization or institution with which the human observer is affiliated for the context of the current observation
121010	Person Observer's Role in the Organization	Organizational role of human observer for the context of the current observation
121011	Person Observer's Role in this Procedure	Procedural role of human observer for the context of the current observation
121012	Device Observer UID	Unique identifier of automated device that created the observations
121013	Device Observer Name	Institution-provided identifier of automated device that created the observations
121014	Device Observer Manufacturer	Manufacturer of automated device that created the observations
121015	Device Observer Model Name	Manufacturer-provided model name of automated device that created the observations
121016	Device Observer Serial Number	Manufacturer-provided serial number of automated device that created the observations
121017	Device Observer Physical Location During Observation	Location of automated device that created the observations whilst the observations were being made
121018	Procedure Study Instance UID	Unique identifier for the Study or Requested Procedure
121019	Procedure Study Component UID	Unique identifier for the Performed Procedure Step
121020	Placer Number	Identifier for the Order (or Service Request) assigned by the order placer system
121021	Filler Number	Identifier for the Order (or Service Request) assigned by the order filler system
121022	Accession Number	Identifier for the Order (or Service Request) assigned by the department information system
121023	Procedure Code	Type of procedure scheduled or performed
121024	Subject Class	Type of observation subject
121025	Patient	A patient is the subject of observations
121026	Fetus	Fetus of patient is the subject of observations
121027	Specimen	Specimen is the subject of observations
121028	Subject UID	Unique Identifier of patient or fetus who is the subject of observations
121029	Subject Name	Name of patient who is the subject of observations
121030	Subject ID	Identifier of patient or fetus who is the subject of observations
121031	Subject Birth Date	Birth Date of patient who is the subject of observations
121032	Subject Sex	Sex of patient who is the subject of observations
121033	Subject Age	Age of patient who is the subject of observations
121034	Subject Species	Species of patient who is the subject of observations
121035	Subject Breed	The breed of the subject
121036	Mother of fetus	Name of mother of fetus that is the subject of observations
121037	Fetus number		deprecated
121038	Number of Fetuses		deprecated
121039	Specimen UID	Unique Identifier of specimen that is the subject of observations
121040	Specimen Accession Number	Accession Number of specimen that is the subject of observations	deprecated
121041	Specimen Identifier	Identifier of specimen that is the subject of observations
121042	Specimen Type	Coded category of specimen that is the subject of observations	deprecated
121043	Slide Identifier	Identifier of specimen microscope slide that is the subject of observations	deprecated
121044	Slide UID	Unique Identifier of specimen microscope slide that is the subject of observations	deprecated
121045	Language	The language of the content, being a language that is primarily used for human communication; e.g. English, French
121046	Country of Language	The country-specific variant of language; e.g. Canada for Candadian French
121047	Language of Value	The language of the value component of a name-value pair
121048	Language of Name and Value	The language of both the name component and the value component of a name-value pair
121049	Language of Content Item and Descendants	The language of the current content item (node in a tree of content) and all its descendants
121050	Equivalent Meaning of Concept Name	The human readable meaning of the name component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded name and its concept modifier children
121051	Equivalent Meaning of Value	The human readable meaning of the value component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded value and its concept modifier children
121052	Presence of property	Whether or not the property concept being modified is present or absent
121053	Present		deprecated
121054	Absent		deprecated
121055	Path	A set of points on an image, that when connected by line segments, provide a polyline from which a linear measurement was inferred
121056	Area outline	A set of points on an image, that when connected by line segments, provide a closed polyline that is the border of a defined region from which an area, or two-dimensional measurement, was inferred
121057	Perimeter outline	A set of points on an image, that when connected by line segments, provide a closed polyline that is a two-dimensional border of a three-dimensional region's intersection with, or projection into the image
121058	Procedure reported	The imaging procedure whose results are reported
121059	Presence Undetermined	Presence or absence of a property is undetermined	deprecated
121060	History		deprecated
121062	Request		deprecated
121064	Current Procedure Descriptions		deprecated
121065	Procedure Description	A description of the imaging procedure
121066	Prior Procedure Descriptions		deprecated
121068	Previous Findings		deprecated
121069	Previous Finding	An observation found on a prior imaging study
121070	Findings		deprecated
121071	Finding	An observation found on an imaging study
121072	Impressions		deprecated
121073	Impression	An interpretation in the clinical context of the finding(s) on an imaging study
121074	Recommendations		deprecated
121075	Recommendation	A recommendation for management or investigation based on the findings and impressions of an imaging study
121076	Conclusions		deprecated
121077	Conclusion	An interpretation in the clinical context of the finding(s) on an imaging study
121078	Addendum		deprecated
121079	Baseline	Initial images used to esyablish a beginning condition that is used for comparison over time to look for changes. [Paraphrases NCI-PT (C1442488, UMLS, "Baseline"), which is defined as "An initial measurement that is taken at an early time point to represent a beginning condition, and is used for comparison over time to look for changes. For example, the size of a tumor will be measured before treatment (baseline) and then afterwards to see if the treatment had an effect. A starting point to which things may be compared."]
121080	Best illustration of finding	A selection of composite instances that best illustrates a particular finding; e.g. an image slice at the location of the largest extent of a tumor
121081	Physician		deprecated
121082	Nurse		deprecated
121083	Technologist		deprecated
121084	Radiographer		deprecated
121085	Intern		deprecated
121086	Resident		deprecated
121087	Registrar		deprecated
121088	Fellow	A medical practitioner undergoing sub-specialty training; e.g. during the period after specialty training (residency)
121089	Attending [Consultant]		deprecated
121090	Scrub nurse		deprecated
121091	Surgeon		deprecated
121092	Sonologist	A medical practitioner with sub-specialty training in Ultrasound
121093	Sonographer		deprecated
121094	Performing	The person responsible for performing the procedure
121095	Referring	The person responsible for referring the patient for the procedure	deprecated
121096	Requesting	The person responsible for requesting the procedure
121097	Recording	The person responsible for recording the procedure or observation
121098	Verifying	The person responsible for verifying the recorded procedure or observation
121099	Assisting	The person responsible for assisting with the procedure
121100	Circulating	The person responsible for making preparations for and monitoring the procedure	deprecated
121101	Standby	The person responsible for standing by to assist with the precedure if required
121102	Other sex	Other sex
121103	Undetermined sex	Sex of subject undetermined at time of encoding
121104	Ambiguous sex	Ambiguous sex
121105	Radiation Physicist	Radiation Physicist	deprecated
121106	Comment	Comment
121109	Indications for Procedure	Indications for Procedure	deprecated
121110	Patient Presentation	Patient condition at the beginning of a healthcare encounter	deprecated
121111	Summary	Summary of a procedure, including most significant findings	deprecated
121112	Source of Measurement	Image or waveform used as source for measurement
121113	Complications	Complications from a procedure	deprecated
121114	Performing Physician	Physician who performed a procedure
121115	Discharge Summary	Summary of patient condition upon Discharge from a healthcare facility
121116	Proximal Finding Site	Proximal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121117	Distal Finding Site	Distal Anatomic Location for a differential measurement; may be considered subtype of term (G-C0E3, SRT, "Finding Site"); e.g. distance or pressure gradient
121118	Patient Characteristics	Patient Characteristics (findings)
121120	Cath Lab Procedure Log	Time-stamped record of events that occur during a catheterization procedure
121121	Room identification	Room identification
121122	Equipment Identification	Equipment identification
121123	Patient Status or Event	A recorded Patient Status or an event involving a patient
121124	Procedure Action Item ID	Identification of a step, action, or phase of a procedure
121125	DateTime of Recording of Log Entry	DateTime of Recording of an Entry in an Event Log
121126	Performed Procedure Step SOP Instance UID	SOP Instance UID of a Performed Procedure Step
121127	Performed Procedure Step SOP Class UID	SOP Class UID of a Performed Procedure Step
121128	Procedure Action Duration	Duration of a step, action, or phase of a procedure
121130	Start Procedure Action Item	Beginning of a step, action, or phase of a procedure
121131	End Procedure Action Item	End of a step, action, or phase of a procedure
121132	Suspend Procedure Action Item	Suspension of a step, action, or phase of a procedure
121133	Resume Procedure Action Item	Resumption of a step, action, or phase of a procedure
121135	Observation DateTime Qualifier	Concept modifier for the DateTime of Recording of an Entry in an Event Log
121136	DateTime Unsynchronized	Recorded DateTime had its source in a system clock not synchronized to other recorded DateTimes
121137	DateTime Estimated	Recorded DateTime is estimated
121138	Image Acquired	Event of the acquisition of an image
121139	Modality	Type of data acquisition device
121140	Number of Frames	Number of Frames in a multi-frame image
121141	Image Type	Descriptor of an Image
121142	Acquisition Duration	Duration of the acquisition of an image or a waveform
121143	Waveform Acquired	Event of the acquisition of an image
121144	Document Title	Document Title
121145	Description of Material	Description of Material used in a procedure
121146	Quantity of Material	Quantity of Material used in a procedure
121147	Billing Code	Billing Code for materials used in a procedure
121148	Unit Serial Identifier	Unit or Device Serial Identifier
121149	Lot Identifier	Lot Identifier
121150	Device Code	Vendor or local coded value identifying a device
121151	Lesion Identifier	Identification of a Lesion observed during an imaging procedure
121152	Person administering drug/contrast	Person administering drug/contrast
121153	Lesion Risk	Assessment of the risk a coronary lesion presents to the health of a patient
121154	Intervention attempt identifier	Identifier for an attempted Intervention
121155	Deployment	Use of a device to deploy another device
121156	Percutaneous Entry Action	Action of a clinical professional at the site of percutaneous access to a patient's cardiovascular system
121157	Begin Circulatory Support	The action or event of beginning circulatory support for a patient
121158	End Circulatory Support	The action or event of ending circulatory support for a patient
121160	Oxygen Administration Rate	Rate of Oxygen Administration
121161	Begin Oxygen Administration	The action or event of beginning administration of oxygen to a patient
121162	End oxygen administration	The action or event of ending administration of oxygen to a patient
121163	By ventilator	Method of administration of oxygen to a patient by ventilator
121165	Patient Assessment Performed	The action or event of assessing the clinical status of a patient
121166	Begin Pacing	The action or event of beginning pacing support for a patient
121167	End Pacing	The action or event of ending pacing support for a patient
121168	Begin Ventilation	The action or event of beginning ventilation support for a patient
121169	End Ventilation	The action or event of ending ventilation support for a patient
121171	Tech Note	Procedural note originated by a technologist
121172	Nursing Note	Procedural note originated by a nurse
121173	Physician Note	Procedural note originated by a Physician
121174	Procedure Note	General procedural note
121180	Key Images	List of references to images considered significant	deprecated
121181	DICOM Object Catalog	List of references to DICOM SOP Instances
121190	Referenced Frames	Individual frames selected as a subset of a multi-frame image
121191	Referenced Segment	Segment selected as a subset of a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the identified segment
121192	Device Subject	A device is the subject of observations
121193	Device Subject Name	Name or other identifier of a device that is the subject of observations
121194	Device Subject Manufacturer	Manufacturer of a device that is the subject of observations
121195	Device Subject Model Name	Model Name of a device that is the subject of observations
121196	Device Subject Serial Number	Serial Number of a device that is the subject of observations
121197	Device Subject Physical Location during observation	Physical Location of a device that is the subject of observations during those observations
121198	Device Subject UID	Unique Identifier of a device that is the subject of observations
121200	Illustration of ROI	Illustration of a region of interest
121201	Area Outline		deprecated
121202	Area of Defined Region		deprecated
121206	Distance	A one dimensional, or linear, numeric measurement
121207	Height	Vertical measurement value
121208	Inter-Marker Distance	Distance between marks on a device of calibrated size; e.g. a ruler
121210	Path		deprecated
121211	Path length	A one dimensional, or linear, numeric measurement along a polyline
121213	Perimeter Outline		deprecated
121214	Referenced Segmentation Frame	Frame selected from a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the segment encompassing the identified frame
121216	Volume estimated from single 2D region	A three-dimensional numeric measurement that is approximate, based on a two-dimensional region in a single image
121217	Volume estimated from three or more non-coplanar 2D regions	A three-dimensional numeric measurement that is approximate, based on three or more non-coplanar two-dimensional image regions
121218	Volume estimated from two non-coplanar 2D regions	A three-dimensional numeric measurement that is approximate, based on two non-coplanar two-dimensional image regions
121219	Volume of bounding three dimensional region	A three-dimensional numeric measurement of the bounding region of a three-dimensional region of interest in an image set
121220	Volume of circumscribed sphere	A three-dimensional numeric measurement of the bounding sphere of a three-dimensional region of interest in an image set
121221	Volume of ellipsoid	A three-dimensional numeric measurement of an ellipsoid shaped three-dimensional region of interest in an image set
121222	Volume of sphere	A three-dimensional numeric measurement of a sphere shaped three-dimensional region of interest in an image set
121230	Path Vertex	Coordinates of a point on a defined path
121231	Volume Surface	Surface of an identified or measured volume
121232	Source series for segmentation	Series of image instances used as source data for a segmentation
121233	Source image for segmentation	Image instances used as source data for a segmentation
121242	Distance from nipple	Indicates the location of the area of interest as measured from the nipple of the breast
121243	Distance from skin	Indicates the location of the area of interest as measured from the most direct skin point of the breast
121244	Distance from chest wall	Indicates the location of the area of interest as measured from the chest wall
121290	Patient exposure to ionizing radiation	Patient exposure to ionizing radiation (procedure)
121291	Results communicated	The act of communicating actionable findings to a responsible receiver
121301	Simultaneous Doppler	Reference is to a Doppler waveform acquired simultaneously with an image
121302	Simultaneous Hemodynamic	Reference is to a Hemodynamic waveform acquired simultaneously with an image
121303	Simultaneous ECG	Reference is to a ECG waveform acquired simultaneously with an image
121304	Simultaneous Voice Narrative	Reference is to a voice narrative recording acquired simultaneously with an image
121305	Simultaneous Respiratory Waveform	A waveform representing chest expansion and contraction due to respiratory activity, measured simultaneously with the acquisition of this Image
121306	Simultaneous Arterial Pulse Waveform	Arterial pulse waveform obtained simultaneously with acquisition of a referencing image
121307	Simultaneous Phonocardiographic Waveform	Phonocardiographic waveform obtained simultaneously with acquisition of a referencing image
121311	Localizer	Image providing an anatomical reference on the patient under examination, for the purpose of defining the location of the ensuing imaging
121312	Biopsy localizer	Image providing an anatomical reference on the patient under examination, for the purpose of planning or documenting a biopsy
121313	Other partial views	Image providing a partial view of the target anatomy, when the target anatomy is too large for a single image
121314	Other image of biplane pair	Image providing a view of the target anatomy in a different imaging plane, typically from a near perpendicular angle
121315	Other image of stereoscopic pair	Image providing a view of the target anatomy in a different imaging plane, typically with a small angular difference
121316	Images related to standalone object	Image related to a non-image information object
121317	Spectroscopy	Image where signals are identified and separated according to their frequencies; e.g. to identify individual chemicals, or individual nuclei in a chemical compound
121318	Spectroscopy Data for Water Phase Correction	MR spectroscopy data acquired to correct the phase of the diagnostic data for the phase signal of the Water
121320	Uncompressed predecessor	An image that has not already been lossy compressed that is used as the source for creation of a lossy compressed image
121321	Mask image for image processing operation	Image used as the mask for an image processing operation, such as subtraction
121322	Source image for image processing operation	Image used as the source for an image processing operation
121323	Source series for image processing operation	Series used as the source for an image processing operation
121324	Source Image	Image used as the source for a derived or compressed image
121325	Lossy compressed image	Image encoded with a lossy compression transfer syntax
121326	Alternate SOP Class instance	SOP Instance encoded with a different SOP Class but otherwise equivalent data
121327	Full fidelity image	Full fidelity image, uncompressed or lossless compressed
121328	Alternate Photometric Interpretation image	Image encoded with a different photometric interpretation
121329	Source image for montage	Image used as a source for a montage (stitched) image
121330	Lossy compressed predecessor	An image that has previously been lossy compressed that is used as the source for creation of another lossy compressed image
121331	Equivalent CDA Document	HL7 Document Architecture (CDA) Document that contains clinical content equivalent to the referencing Instance
121332	Complete Rendering for Presentation	Instance that contains a displayable complete rendering of the referencing Instance
121333	Partial Rendering for Presentation	Instance that contains a displayable partial rendering of the referencing Instance
121334	Extended Rendering for Presentation	Instance that contains a displayable complete rendering of the referencing Instance, plus additional content such as inline rendering of referenced images
121335	Source Document	Document whose content has been wholly or partially transformed to create the referencing document
121338	Anatomic image	Image showing structural anatomic features
121339	Functional image	Image showing physical or chemical activity
121340	Spectral filtered image	Image providing the same view of the target anatomy acquired using only a specific imaging wavelength, frequency or energy
121341	Device localizer	Image providing an anatomical reference on the patient under examination, for the purpose of documenting the location of device such as a diagnostic or therapeutic catheter
121342	Dose Image	Image providing a graphic view of the distribution of radiation dose
121346	Acquisition frames corresponding to volume	The referenced image is the source of spatially-related frames from which the referencing 3D volume data set was derived
121347	Volume corresponding to spatially-related acquisition frames	3D Volume containing the spatially-related frames in the referencing instance
121348	Temporal Predecessor	Instance acquired prior to the referencing instance in a set of consecutively acquired instances
121349	Temporal Successor	Instance acquired subsequent to the referencing instance in a set of consecutively acquired instances
121350	Same acquisition at lower resolution	Image of the same target area at lower resolution acquired in the same acquisition process
121351	Same acquisition at higher resolution	Image of the same target area at higher resolution acquired in the same acquisition process
121352	Same acquisition at different focal depth	Image of the same target area at different focal depth (Z-plane) acquired in the same acquisition process
121353	Same acquisition at different spectral band	Image of the same target area at different spectral band acquired in the same acquisition process
121354	Imaged container label	Image specifically targeting the container label
121358	For Processing predecessor	Source image from which FOR PRESENTATION images were created
121360	Replaced report	The reference is to a predecessor report that has been replaced by the current report
121361	Addended report	The reference is to a predecessor report to which the current report provides and addendum
121362	Preliminary report	A report that precedes the final report and may contain only limited information; it may be time sensitive, and it is not expected to contain all the reportable findings
121363	Partial report	A report that is not complete
121370	Composed from prior doses	The dose object created was calculated by summation of existing, previously calculated, RT Dose instances
121371	Composed from prior doses and current plan	The dose object created was calculated by summation of existing, previously calculated, RT Dose instances and dose newly calculated by the application. The newly calculated dose may or may not exist as an independent object
121372	Source dose for composing current dose	RT Dose Instances used as source for calculated dose
121380	Active Ingredient Undiluted Concentration	Concentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml
121381	Contrast/Bolus Ingredient Opaque	X-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue)
121382	Quantity administered	Number of units of substance administered to a patient; e.g. tablets
121383	Mass administered	Mass of substance administered to a patient
121401	Derivation	Method of deriving or calculating a measured value; e.g. mean, or maximum of set
121402	Normality	Assessment of a measurement relative to a normal range of values; may be considered subtype of term (G-C0F2, SRT, "has interpretation")
121403	Level of Significance	Significance of a measurement
121404	Selection Status	Status of selection of a measurement for further processing or use
121405	Population description	Description of a population of measurements
121406	Reference Authority	Bibliographic or clinical reference for a Description of a population of measurements
121407	Normal Range description	Description of a normal range of values for a measurement concept
121408	Normal Range Authority	Bibliographic or clinical reference for a Description of a normal range of values
121410	User chosen value	Observation value selected by user for further processing or use, or as most representative
121411	Most recent value chosen	Observation value is the recently obtained, and has been selected for further processing or use
121412	Mean value chosen	Observation value is the mean of several measurements, and has been selected for further processing or use
121414	Standard deviation of population	Standard deviation of a measurement in a reference population
121415	Percentile Ranking of measurement	Percentile Ranking of an observation value with respect a reference population
121416	Z-Score of measurement	Z-score of an observation value with respect a reference population, expressed as the dimensionless quantity (x-m) /s, where (x-m) is the deviation of the observation value (x) from the population mean (m), and s is the standard deviation of the population
121417	2 Sigma deviation of population	2 Sigma deviation of a measurement in a reference population
121420	Equation	Formula used to compute a derived measurement
121421	Equation Citation	Bibliographic reference to a formula used to compute a derived measurement; reference may be to a specific equation in a journal article
121422	Table of Values Citation	Bibliographic reference to a Table of Values used to look up a derived measurement
121423	Method Citation	Bibliographic reference to a method used to compute a derived measurement
121424	Table of Values	A Table of Values used to look up a derived measurement
121425	Index	Factor (divisor or multiplicand) for normalizing a measurement; e.g. body surface area used for normalizing hemodynamic measurements
121427	Estimated	Measurement obtained by observer estimation, rather than with a measurement tool or by calculation	deprecated
121428	Calculated	Measurement obtained by calculation	deprecated
121430	Concern	Identified issue about a state or process that has the potential to require intervention or management
121431	DateTime Concern Noted	DateTime concern noted (noted by whom is determined by context of use)
121432	DateTime Concern Resolved	DateTime the concern was resolved
121433	DateTime Problem Resolved	DateTime the problem was resolved
121434	Service Delivery Location	Place at which healthcare services may be provided
121435	Service Performer	Identification of a healthcare provider who performed a healthcare service; may be either a person or an organization
121436	Medical Device Used	Type or identifier of a medical device used on, in, or by a patient
121437	Pharmacologic and exercise stress test	Cardiac stress test using pharmacologic and exercise stressors	deprecated
121438	Paced stress test	Cardiac stress test using an implanted or external cardiac pacing device	deprecated
121439	Correction of congenital cardiovascular deformity	Procedure for correction of congenital cardiovascular deformity	deprecated
121701	RT Patient Setup	Process of placing patient in the anticipated treatment position, including specification and location of positioning aids, and other treatment delivery accessories
121702	RT Patient Position Acquisition, single plane MV	Acquisition of patient positioning information prior to treatment delivery, using single-plane megavoltage imaging
121703	RT Patient Position Acquisition, dual plane MV	Acquisition of patient positioning information prior to treatment delivery, using dual-plane megavoltage imaging
121704	RT Patient Position Acquisition, single plane kV	Acquisition of patient positioning information prior to treatment delivery, using single-plane kilovoltage imaging
121705	RT Patient Position Acquisition, dual plane kV	Acquisition of patient positioning information prior to treatment delivery, using dual-plane kilovoltage imaging
121706	RT Patient Position Acquisition, dual plane kV/MV	Acquisition of patient positioning information prior to treatment delivery, using dual-plane combination kilovoltage and megavoltage imaging
121707	RT Patient Position Acquisition, CT kV	Acquisition of patient positioning information prior to treatment delivery, using kilovoltage CT imaging
121708	RT Patient Position Acquisition, CT MV	Acquisition of patient positioning information prior to treatment delivery, using megavoltage CT imaging
121709	RT Patient Position Acquisition, Optical	Acquisition of patient positioning information prior to treatment delivery, using optical imaging
121710	RT Patient Position Acquisition, Ultrasound	Acquisition of patient positioning information prior to treatment delivery, using ultrasound imaging
121711	RT Patient Position Acquisition, Spatial Fiducials	Acquisition of patient positioning information prior to treatment delivery, using spatial fiducials
121712	RT Patient Position Registration, single plane	Registration of intended and actual patient position prior to treatment delivery, using single-plane images
121713	RT Patient Position Registration, dual plane	Registration of intended and actual patient position prior to treatment delivery, using dual-plane images
121714	RT Patient Position Registration, 3D CT general	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and an unspecified registration approach
121715	RT Patient Position Registration, 3D CT marker-based	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a marker-based registration approach
121716	RT Patient Position Registration, 3D CT volume-based	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a volume-based registration approach
121717	RT Patient Position Registration, 3D on 2D reference	Registration of intended and actual patient position prior to treatment delivery, using 3D verification images and 2D reference images
121718	RT Patient Position Registration, 2D on 3D reference	Registration of intended and actual patient position prior to treatment delivery, using 2D verification images and 3D reference images
121719	RT Patient Position Registration, Optical	Registration of intended and actual patient position prior to treatment delivery, using optical images
121720	RT Patient Position Registration, Ultrasound	Registration of intended and actual patient position prior to treatment delivery, using ultrasound images
121721	RT Patient Position Registration, Spatial Fiducials	Registration of intended and actual patient position prior to treatment delivery, using spatial fiducials
121722	RT Patient Position Adjustment	Adjustment of patient position such that the patient is correctly positioned for treatment
121723	RT Patient Position In-treatment-session Review	Review of patient positioning information in the process of delivering a treatment session
121724	RT Treatment Simulation with Internal Verification	Simulated radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121725	RT Treatment Simulation with External Verification	Simulated radiotherapy treatment delivery using verification by a external Machine Parameter Verifier
121726	RT Treatment with Internal Verification	Radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121727	RT Treatment with External Verification	Radiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121728	RT Treatment QA with Internal Verification	Quality assurance of a radiotherapy treatment delivery using verification integral to the Treatment Delivery System
121729	RT Treatment QA with External Verification	Quality assurance of a radiotherapy treatment delivery using verification by an external Machine Parameter Verifier
121730	RT Machine QA	Quality assurance of a Treatment Delivery Device
121731	RT Treatment QA by RT Plan Dose Check	Perform Quality Assurance on an RT Plan by evaluating dosimetric content of the current RT Plan
121732	RT Treatment QA by RT Plan Difference Check	Perform Quality Assurance on an RT Plan by comparing the content of previously quality-assessed RT Plans with the current RT Plan
121733	RT Treatment QA by RT Ion Plan Dose Check	Perform Quality Assurance on an RT Ion Plan by evaluating dosimetric content of the current RT Ion Plan
121734	RT Treatment QA with RT Ion Plan Difference Check	Perform Quality Assurance on an RT Ion Plan by comparing the content of previously quality-assessed RT Ion Plans with the current RT Ion Plan
121740	Treatment Delivery Type	Indicates whether the treatment to be delivered is a complete fraction or a continuation of previous incompletely treated fraction
122001	Patient called to procedure room	Patient called to procedure room
122002	Patient admitted to procedure room	Patient admitted to procedure room
122003	Patient given pre-procedure instruction	Patient given pre-procedure instruction
122004	Patient informed consent given	Patient informed consent given
122005	Patient advance directive given	Patient advance directive given
122006	Nil Per Os (NPO) status confirmed	Nil Per Os (NPO) status confirmed
122007	Patient assisted to table	Patient assisted to table
122008	Patient prepped and draped	Patient prepped and draped
122009	Patient connected to continuous monitoring	Patient connected to continuous monitoring
122010	Patient transferred to holding area	Patient transferred to holding area
122011	Patient transferred to surgery	Patient transferred to surgery
122012	Patient transferred to CCU	Patient transferred to CCU
122020	Patient disoriented	Patient disoriented
122021	Patient reports nausea	Patient reports nausea
122022	Patient reports discomfort	Patient reports discomfort
122023	Patient reports chest pain	Patient reports chest pain
122024	Patient reports no pain	Patient reports no pain
122025	Patient alert	Patient alert
122026	Patient restless	Patient restless
122027	Patient sedated	Patient sedated
122028	Patient asleep	Patient asleep
122029	Patient unresponsive	Patient unresponsive
122030	Patient has respiratory difficulty	Patient has respiratory difficulty
122031	Patient coughed	Patient coughed
122032	Patient disconnected from continuous monitoring	Patient disconnected from continuous monitoring
122033	Hemostasis achieved	Hemostasis achieved
122034	Hemostasis not achieved - oozing	Hemostasis not achieved - oozing
122035	Hemostasis not achieved - actively bleeding	Hemostasis not achieved - actively bleeding
122036	Patient given post-procedure instruction	Patient given post-procedure instruction
122037	Patient discharged from department	Patient discharged from department or laboratory
122038	Patient pronounced dead	Patient pronounced dead
122039	Patient transferred to morgue	Patient transferred to morgue
122041	Personnel Arrived	Identified personnel or staff arrived in procedure room
122042	Personnel Departed	Identified personnel or staff departed procedure room
122043	Page Sent To	Page sent to identified personnel or staff
122044	Consultation With	Consultation with identified personnel or staff
122045	Office called	Office of identified personnel or staff was called
122046	Equipment failure	Equipment failure	deprecated
122047	Equipment brought to procedure room	Equipment brought to procedure room
122048	Equipment ready	Equipment ready for procedure
122049	Equipment removed	Equipment removed from procedure room
122052	Bioptome	Device for obtaining biopsy sample
122053	Valvular Intervention	Valvular Intervention
122054	Aortic Intervention	Aortic Intervention
122055	Septal Defect Intervention	Septal Defect Intervention
122056	Vascular Intervention	Vascular Intervention
122057	Myocardial biopsy	Myocardial biopsy
122058	Arterial conduit angiography	Arterial conduit angiography
122059	Single plane Angiography	Single plane Angiography
122060	Bi-plane Angiography	Bi-plane Angiography
122061	Percutaneous Coronary Intervention	Percutaneous Coronary Intervention
122062	15-Lead ECG	15-Lead electrocardiography	deprecated
122072	Pre-procedure log	Log of events occurring prior to the current procedure
122073	Current procedure evidence	Analysis or measurements for current procedure (purpose of reference to evidence document)
122075	Prior report for current patient	Prior report for current patient
122076	Consumable taken from inventory	Identifier of Consumable taken from inventory
122077	Consumable returned to inventory	Identifier of Consumable returned to inventory
122078	Remaining consumable disposed	Identifier of consumable whose remaining content has been disposed
122079	Consumable unusable	Identifier of Consumable determined to be unusable
122081	Drug start	Identifier of Drug whose administration has started
122082	Drug end	Identifier of Drug whose administration has ended
122083	Drug administered	Identifier of Drug administered as part of procedure
122084	Contrast start	Identifier of Contrast agent whose administration has started
122085	Contrast end	Identifier of Contrast agent whose administration has ended
122086	Contrast administered	Identifier of Contrast agent administered
122087	Infusate start	Identifier of Infusate whose administration has started
122088	Infusate end	Identifier of Infusate whose administration has ended
122089	Device crossed lesion	Action of a device traversing a vascular lesion
122090	Intervention Action	Action of a clinical professional performed on a patient for therapeutic purpose
122091	Volume administered	Volume of Drug, Contrast agent, or Infusate administered
122092	Undiluted dose administered	Undiluted dose of Drug, Contrast agent, or Infusate administered
122093	Concentration	Concentration of Drug, Contrast agent, or Infusate administered
122094	Rate of administration	Rate of Drug, Contrast agent, or Infusate administration
122095	Duration of administration	Duration of Drug, Contrast agent, or Infusate administration
122096	Volume unadministered or discarded	Volume of Drug, Contrast agent, or Infusate unadministered or discarded
122097	Catheter Curve	Numeric parameter of Curvature of Catheter
122098	Transmit Frequency	Transmit Frequency
122099	ST change from baseline	Measured change of patient electrocardiographic ST level relative to baseline measurement
122101	Aneurysm on cited vessel	Anatomic term modifier indicating aneurysm on cited vessel is the subject of the finding
122102	Graft to cited segment, proximal section	Anatomic term modifier indicating proximal section of graft to cited vessel is the subject of the finding
122103	Graft to cited segment, mid section	Anatomic term modifier indicating mid section of graft to cited vessel is the subject of the finding
122104	Graft to cited segment, distal section	Anatomic term modifier indicating distal section of graft to cited vessel is the subject of the finding
122105	DateTime of Intervention	DateTime of Intervention
122106	Duration of Intervention	Duration of Intervention
122107	Baseline Stenosis Measurement	Lesion stenosis measured prior to any interventional procedure	deprecated
122108	Post-Intervention Stenosis Measurement	Lesion stenosis measured after an interventional procedure	deprecated
122109	Baseline TIMI Flow	Assessment of perfusion across a coronary lesion measured prior to any interventional procedure
122110	Post-Intervention TIMI Flow	Assessment of perfusion across a coronary lesion measured after an interventional procedure
122111	Primary Intervention Device	Indication that device is the primary (first and/or most significant) device used for interventional therapy of a particular pathology; e.g. lesion
122112	Normal Myocardium	Normal Myocardium
122113	Sacrred Myocardial	Sacrred Myocardial
122114	Thinning Myocardium	Thinning Myocardium
122120	Hemodynamics Report	Hemodynamics Report
122121	Atrial pressure measurements	Atrial pressure measurements, report section
122122	Ventricular pressure measurements	Ventricular pressure measurements, report section
122123	Gradient assessment	Gradient assessment, report section
122124	Blood velocity measurements	Blood velocity measurements, report section
122125	Blood lab measurements	Blood lab measurements, report section
122126	Derived Hemodynamic Measurements	Derived Hemodynamic Measurements, report section
122127	Clinical Context	Clinical Context, report section
122128	Patient Transferred From	Location from which the patient was transferred
122129	PCI during this procedure	Indication that the procedure includes a percutaneous coronary intervention
122130	Dose Area Product	Radiation dose times area of exposure
122131	Degree of Thrombus	Finding of probability and/or severity of thrombus
122132	Severity of Calcification	Severity of Calcification, property of lesion
122133	Lesion Morphology	Lesion Morphology; form and/or structural properties of lesion
122134	Vessel Morphology	Vessel Morphology; form and/or structural properties of vessel
122138	Circulatory Support	Technique (device or procedure) of support for patient circulatory system; hemodynamic support
122139	Reason for Exam	Reason for Exam
122140	Comparison with Prior Exam Done	Indication that the current exam data has been compared with prior exam data
122141	Electrode Placement	Electrocardiographic electrode placement technique
122142	Acquisition Device Type	Acquisition Device Type
122143	Acquisition Device ID	Acquisition Device ID
122144	Quantitative Analysis	Quantitative Analysis, report section
122145	Qualitative Analysis	Qualitative Analysis, report section
122146	Procedure DateTime	The date and time on which a procedure was performed on a patient
122147	Clinical Interpretation	Clinical Interpretation, report section
122148	Lead ID	ECG Lead Identifier
122149	Beat Number	Beat Number; ordinal of cardiac cycle within an acquisition
122150	Compound Statement	Complex coded semantic unit, consisting of several coded components
122151	Trend	Trend (temporal progression) of a clinical condition, finding, or disease
122152	Statement	Coded semantic unit
122153	Statement Modifier	Coded modifier for a semantic unit
122154	Conjunctive Term	Conjunctive term between semantic units
122157	Probability	Probability
122158	ECG Global Measurements	ECG Global Measurements, report section
122159	ECG Lead Measurements	ECG Lead Measurements, report section
122160	Derived Area, Non-Valve	Derived cross-sectional area of a vessel or anatomic feature, other than a cardiac valve
122161	Pulmonary Flow	Rate of blood flow through Pulmonary artery
122162	Systemic Flow	Rate of blood flow through the aorta
122163	Discharge DateTime	DateTime of patient discharge from hospital admission
122164	Coronary Artery Bypass During This Admission	Indication that a Coronary Artery Bypass operation was performed during the current hospital admission
122165	Date of Death	Date of Death
122166	Death During This Admission	Indication that the patient died during the current hospital admission
122167	Death During Catheterization	Indication that the patient died during the current Catheterization procedure
122170	Type of Myocardial Infarction	Finding of type of Myocardial Infarction
122171	Coronary lesion > = 50% stenosis	Finding of Coronary lesion with greater than 50% stenosis
122172	Acute MI Present	Finding of Acute Myocardial Infarction Presence as indication for interventional procedure
122173	ST Elevation Onset DateTime	DateTime of first determination of elevated ECG ST segment, as indication of Myocardial Infarction
122175	Number of lesion interventions attempted	Number of lesion interventions attempted during current procedure
122176	Number of lesion interventions successful	Number of lesion interventions successful during current procedure, where the residual post intervention stenosis is less than or equal to 50% of the arterial luminal diameter, TIMI Flow is 3 and the minimal decrease in stenosis was 20%
122177	Procedure Result	Overall success of interventional procedure
122178	Lesion Intervention Information	Lesion Intervention Information, report section
122179	Peri-procedural MI occurred	Indication that Myocardial Infarction occurred during current procedure
122180	CK-MB baseline	Creatine Kinase-MB value at baseline (start of procedure)
122181	CK-MB peak	Creatine Kinase-MB highest value measured during procedure
122182	R-R interval	Time interval between ECG R-wave peaks in subsequent cardiac cycles
122183	Blood temperature	Blood temperature
122185	Blood Oxygen content	Blood Oxygen content
122187	Blood Carbon dioxide saturation	Blood Carbon dioxide saturation
122188	Pulmonary Arterial Content (FCpa)	Pulmonary Arterial Content (FCpa)
122189	Pulmonary Venous Content (FCpv)	Pulmonary Venous Content (FCpv)
122190	Max dp/dt/P	Max dp/dt/P
122191	Ventricular End Diastolic pressure	Ventricular End Diastolic pressure
122192	Indicator appearance time	Elapsed time from injection of an indicator bolus until it is observed at another location
122193	Maximum pressure acceleration	Maximum pressure acceleration
122194	Ventricular Systolic blood pressure	Ventricular Systolic blood pressure
122195	Pulse Strength	Pulse Strength; palpable strength of systolic flow
122196	C wave pressure	The secondary peak pressure in the atrium during atrial contraction
122197	Gradient pressure, average	Gradient pressure, average
122198	Gradient pressure, peak	Gradient pressure, peak
122199	Pressure at dp/dt max	Pressure at dp/dt max
122201	Diastolic blood velocity, mean	Diastolic blood velocity, mean
122202	Diastolic blood velocity, peak	Diastolic blood velocity, peak
122203	Systolic blood velocity, mean	Systolic blood velocity, mean
122204	Systolic blood velocity, peak	Systolic blood velocity, peak
122205	Blood velocity, mean	Blood velocity, mean
122206	Blood velocity, minimum	Blood velocity, minimum
122207	Blood velocity, peak	Blood velocity, peak
122208	x-descent pressure	Venous or atrial pressure minimum during ventricular systole, after A-wave
122209	y-descent pressure	Venous or atrial pressure minimum when tricuspid valve opens during diastole, after V-wave
122210	z-point pressure	Atrial pressure upon closure of tricuspid and mitral valves
122211	Left Ventricular ejection time	Left Ventricular ejection time
122212	Left Ventricular filling time	Left Ventricular filling time
122213	Right Ventricular ejection time	Right Ventricular ejection time
122214	Right Ventricular filling time	Right Ventricular filling time
122215	Total Pulmonary Resistance	Total Pulmonary Resistance
122216	Total Vascular Resistance	Total Vascular Resistance
122217	Coronary Flow reserve	Coronary Flow reserve
122218	Diastolic/Systolic velocity ratio	Diastolic/Systolic velocity ratio
122219	Hyperemic ratio	Hyperemic ratio
122220	Hemodynamic Resistance Index	Hemodynamic Resistance Index
122221	Thorax diameter, sagittal	Thorax diameter, sagittal
122222	Procedure Environmental Characteristics	Environmental characteristics in the procedure room
122223	Room oxygen concentration	Oxygen concentration in the procedure room
122224	Room temperature	Temperature in the procedure room
122225	Room Barometric pressure	Barometric pressure in the procedure room
122227	Left to Right Flow	Left to Right Flow
122228	Right to Left Flow	Right to Left Flow
122229	Arteriovenous difference	Arteriovenous oxygen content difference
122230	10 Year CHD Risk	Framingham Study 10 Year CHD Risk
122231	Comparative Average10 Year CHD Risk	Framingham Study Comparative Average10 Year CHD Risk
122232	Comparative Low10 Year CHD Risk	Framingham Study Comparative Low10 Year CHD Risk
122233	LDL Cholesterol Score Sheet for Men	Framingham Study LDL Cholesterol Score Sheet for Men
122234	LDL Cholesterol Score Sheet for Women	Framingham Study LDL Cholesterol Score Sheet for Women
122235	Total Cholesterol Score Sheet for Men	Framingham Study Total Cholesterol Score Sheet for Men
122236	Total Cholesterol Score Sheet for Women	Framingham Study Total Cholesterol Score Sheet for Women
122237	Corrected Sinus Node Recovery Time	Corrected Sinus Node Recovery Time
122238	Max volume normalized to 50mmHg pulse pressure	Max volume normalized to 50mmHg pulse pressure
122239	Oxygen Consumption	Oxygen Consumption
122240	BSA = 3.207WT^(0.7285-0.0188 log (WT)) HT^0.3	Body Surface Area computed from patient height and weight: BSA = 3.207WT[g]^(0.7285-0.0188 log (WT[g])) HT[cm] ^ 0.3 [Boyd E, The growth of the surface area of the human body. Minneapolis: University of Minnesota Press, 1935, eq. (36) ]
122241	BSA = 0.007184WT^ 0.425HT^0.725	Body Surface Area computed from patient height and weight: BSA = 0.007184* WT[kg] ^ 0.425*HT[cm] ^ 0.725 [Dubois and Dubois, Arch Int Med 1916 17:863-71]
122242	BSA = 0.0235WT^0.51456HT^ 0.42246	Body Surface Area computed from patient height and weight: BSA = 0.0235* WT[kg] ^0.51456*HT[cm]^ 0.42246 [Gehan EA, George SL, 'Estimation of human body surface area from height and weight', Cancer Chemother Rep 1970 54:225-35]
122243	BSA = 0.024265WT^0.5378HT^0.3964	Body Surface Area computed from patient height and weight: BSA = 0.024265 * WT[kg] ^ 0.5378 * HT[cm] ^ 0.3964 [Haycock G.B., Schwartz G.J., Wisotsky D.H. 'Geometric method for measuring body surface area: A height weight formula validated in infants, children and adults.' The Journal of Pediatrics 1978 93:1:62-66]
122244	BSA = (HT * WT/36) ^0.5	Body Surface Area computed from patient height and weight: BSA = (HT[m] * WT[kg] / 36) ^ 0.5 [Mosteller, R.D. 'Simplified Calculation of Body Surface Area.' N Engl J Med 1987 Oct 22;317(17):1098]
122245	BSA = 1321+0.3433*WT	Body Surface Area computed from patient weight:BSA = 1321 + 0.3433 * WT[kg] (for pediatrics 3-30 kg) [Current, J.D. 'A Linear Equation For Estimating The Body Surface Area In Infants And Children', The Internet Journal of Anesthesiology. 1998. 2:2]
122246	BSA = 0.0004688 * WT ^ (0.8168 - 0.0154 * log(WT))	BSA = 0.0004688 * (1000 * WT) ^ (0.8168 - 0.0154 * log(1000 * WT)) Where (WT is weight in kilogram) Units = m2 Boyd, Edith. The Growth of the Surface Area of the Human Body(originally published in 1935 by the University of Minnesota Press), Greenwood Press, Westport, Connecticut, 1975, p. 102.Equation (35)
122247	VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)	Equation for estimated oxygen consumption: VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)
122248	VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)	Equation for estimated oxygen consumption: VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)
122249	VO2 = VeSTPD * 10 * (FIO2 - FE02)	Equation for estimated oxygen consumption: VO2 = VeSTPD * 10 * (FIO2 - FE02)
122250	VO2 = 152 * BSA	Equation for estimated oxygen consumption: VO2 = 152 * BSA
122251	VO2 = 175 * BSA	Equation for estimated oxygen consumption: VO2 = 175 * BSA
122252	VO2 = 176 * BSA	Equation for estimated oxygen consumption: VO2 = 176 * BSA
122253	Robertson & Reid table	Robertson & Reid Table for estimated oxygen consumption
122254	Fleisch table	Fleisch table for estimated oxygen consumption
122255	Boothby table	Boothby table for estimated oxygen consumption
122256	if (prem age< 3days) P50 = 19.9	Estimate of Oxygen partial pressure at 50% saturation for premature infants less than 3 days old: P50 = 19.9
122257	if (age < 1day) P50 = 21.6	Estimate of Oxygen partial pressure at 50% saturation for infants less than 1 day old: P50 = 21.6
122258	if (age < 30day) P50 = 24.6	Estimate of Oxygen partial pressure at 50% saturation for infants less than 30 days old: P50 = 24.6
122259	if (age < 18y) P50 = 27.2	Estimate of Oxygen partial pressure at 50% saturation for patients less than 18 years old: P50 = 27.2
122260	if (age < 40y) P50 = 27.4	Estimate of Oxygen partial pressure at 50% saturation for patients less than 40 years old: P50 = 27.4
122261	if (age > 60y) P50 = 29.3	Estimate of Oxygen partial pressure at 50% saturation for patients more than 60 years old: P50 = 29.3
122262	Area = Flow / 44.5 * sqrt(Gradient[mmHg])	Cardiac valve area computed from flow and pressure gradient: Area = Flow / 44.5 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122263	MVA = Flow / 38.0 * sqrt(Gradient[mmHg])	Mitral valve area computed from flow and pressure gradient: Mitral valve Area = Flow / 38.0 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951]
122265	BMI = Wt / Ht ^ 2	Body Mass Index computed from weight and height: BMI = Wt/Ht^2
122266	BSA = 0.007358 * WT ^ 0.425 * HT ^ 0.725	Body Surface Area computed from patient height and weight: BSA = 0.007358 * WT[kg] ^ 0.425 * HT[cm] ^ 0.725 (for East Asian adult, aged 15+ years) [Kanai Izumi, Masamitsu Kanai, 'Clinical examination method summary']
122267	BSA = 0.010265 * WT ^ 0.423 * HT ^ 0.651	Body Surface Area computed from patient height and weight: BSA = 0.010265 * WT[kg] ^ 0.423 * HT[cm] ^ 0.651 (For East Asian child aged 12-14 years)
122268	BSA = 0.008883 * WT ^ 0.444 * HT ^ 0.663	Body Surface Area computed from patient height and weight: BSA = 0.008883* WT[kg] ^ 0.444 * HT[cm] ^ 0.663 (For East Asian child aged 6-11 years)
122269	BSA = 0.038189 * WT ^ 0.423 * HT ^ 0.362	Body Surface Area computed from patient height and weight: BSA = 0.038189 * WT[kg] ^ 0.423 * HT[cm] ^ 0.362 (For East Asian child aged 1-5 years)
122270	BSA = 0.009568 * WT ^ 0.473 * HT ^ 0.655	Body Surface Area computed from patient height and weight: BSA = 0.009568* WT[kg] ^ 0.473 * HT[cm] ^ 0.655 (For East Asian child aged 0-12 months)
122271	Skin Condition Warm	Skin Condition Warm
122272	Skin Condition Cool	Skin Condition Cool
122273	Skin Condition Cold	Skin Condition Cold
122274	Skin Condition Dry	Skin Condition Dry
122275	Skin Condition Clammy	Skin Condition Clammy
122276	Skin Condition Diaphoretic	Skin Condition Diaphoretic
122277	Skin Condition Flush	Skin Condition Flush
122278	Skin Condition Mottled	Skin Condition Mottled
122279	Skin Condition Pale	Skin Condition Pale
122281	Airway unobstructed	Airway unobstructed
122282	Airway partially obstructed	Airway partially obstructed
122283	Airway severely obstructed	Airway severely obstructed
122288	Not Visualized	Anatomy could not be visualized for the purpose of evaluation
122291	Quantitative Arteriography Report	Quantitative Arteriography Report
122292	Quantitative Ventriculography Report	Quantitative Ventriculography Report
122301	Guidewire crossing lesion unsuccessful	Guidewire crossing lesion unsuccessful
122302	Guidewire crossing lesion successful	Guidewire crossing lesion successful
122303	Angioplasty balloon inflated	Angioplasty balloon inflated
122304	Angioplasty balloon deflated	Angioplasty balloon deflated
122305	Device deployed	Device deployed
122306	Stent re-expanded	Stent re-expanded
122307	Object removed	Object removed
122308	Radiation applied	Radiation applied
122309	Radiation removed	Radiation removed
122310	Interventional device placement unsuccessful	Interventional device placement unsuccessful
122311	Interventional device placed	Interventional device placed
122312	Intervention performed	Intervention performed
122313	Interventional device withdrawn	Interventional device withdrawn
122319	Catheter Size	Catheter Size
122320	Injectate Temperature	Injectate Temperature
122321	Injectate Volume	Injectate Volume
122322	Calibration Factor	Factor by which a measured or calculated value is multiplied to obtain the estimated real-world value
122325	IVUS Report	Intravascular Ultrasound Report
122330	EEM Diameter	External Elastic Membrane (EEM) diameter measured through the center point of the vessel. Center point of the vessel is defined as the center of gravity of the EEM area. The EEM is a discrete interface at the border between the media and the adventitia
122331	Plaque Plus Media Thickness	The distance from intimal leading edge to the external elastic membrane along any line passing through the luminal center, which is defined as the center of gravity of the lumen area
122332	Lumen Perimeter	Planimetered perimeter of the lumen
122333	EEM Cross-Sectional Area	Vessel area measured at the External Elastic Membrane (EEM), a discrete interface at the border between the media and the adventitia
122334	Plaque plus Media Cross-Sectional Area	Area within the EEM occupied by atheroma, regardless of lumen compromise. Plaque plus Media Area = EEM cross-sectional area - vessel lumen cross-sectional area
122335	In-Stent Neointimal Cross-Sectional Area	Measurement of in-stent restenosis. In-Stent Intimal Area = Stent cross-sectional area - vessel lumen cross-sectional area
122336	Vascular Volume measurement length	Longitudinal extent of the Vascular Volume Measurement. This is the distance from the distal edge to the proximal edge of the Volume measurement
122337	Relative position	Longitudinal distance from the closest edge of a fiducial feature or reference location to the start of the vascular measurement. This value will be a positive if the measurement is distal to the fiducial feature or reference location, or negative if the measurement is proximal to the fiducial feature or reference location
122339	Stent Volume Obstruction	In-Stent Neointimal Volume / Stent Volume
122340	Fiducial feature	Reference, normally anatomical, which is used for locating the position of a measurement
122341	Calcium Length	Longitudinal calcium length measurement
122343	Lumen Eccentricity Index	Measurement of vessel lumen eccentricity. Lumen Eccentricity Index = (maximum vessel lumen diameter - minimum vessel lumen diameter) / maximum vessel lumen diameter. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122344	Plaque plus Media Eccentricity Index	Plaque plus Media Eccentricity Index = (maximum Plaque plus media thickness - minimum Plaque plus media thickness) / maximum Plaque plus media thickness
122345	Remodeling Index	Measurement of increase or decrease in EEM area that occurs during the development of atherosclerosis. Remodeling Index = Lesion EEM area / reference EEM area
122346	Stent Symmetry Index	Measurement of stent circularity. Stent Symmetry Index = (maximum stent diameter - minimum stent diameter) / maximum stent diameter
122347	Stent Expansion Index	Measurement of stent area relative to the reference lumen area. Stent Expansion Index = Minimum stent area / reference vessel lumen cross-sectional area
122348	Lumen Shape Index	Measurement of vessel lumen eccentricity. Lumen Shape Index = (2p * sqrt(Vessel lumen cross-sectional area / p) / Lumen Perimeter) 2 Reference: Tobis & Yock, "Intravascular Ultrasound Imaging", Chapter 7
122350	Lumen Diameter Ratio	Lumen diameter ratio = minimum vessel lumen diameter / maximum vessel lumen diameter, measured at the same cross section in the vessel. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area
122351	Stent Diameter Ratio	Stent diameter ratio = Minimum stent diameter / Maximum stent diameter, measured at the same cross section in the vessel. Stent diameters are measured through the center point of the stent, which is defined as the center of gravity of the stent area
122352	EEM Diameter Ratio	EEM diameter ratio = minimum EEM diameter / maximum EEM diameter. Measured at the same cross section in the vessel
122354	Plaque Burden	Fractional area within the External Elastic Membrane (EEM) occupied by atheroma. Plaque Burden = (EEM area - vessel lumen cross-sectional area) / EEM area
122355	Arc of Calcium	Angular measurement of a Calcium deposit with the apex located at the center of the lumen, which is defined as the center of gravity of the lumen area
122356	Soft plaque	Plaque characterized by low density or echogenicity
122357	In-Stent Neointima	Abnormal thickening of the intima within the stented segment
122360	True Lumen	Lumen surrounded by all three layers of the vessel-intima, media, and adventitia
122361	False Lumen	A channel, usually parallel to the true lumen, which does not communicate with the true lumen over a portion of its length
122363	Plaque Rupture	Plaque ulceration with a tear detected in a fibrous cap
122364	Stent Gap	Length of gap between two consecutive stents
122367	T-1 Worst	Worst stenosis - the stenosis with the smallest lumen size within a vessel segment
122368	T-2 Secondary	2nd most severe stenosis within a vessel segment
122369	T-3 Secondary	3rd most severe stenosis within a vessel segment
122370	T-4 Secondary	4th most severe stenosis within a vessel segment
122371	EEM Volume	External Elastic Membrane (EEM) volume measured within a specified region. The EEM is a discrete interface at the border between the media and the Adventitia
122372	Lumen Volume	Lumen volume measured within a specified region
122374	In-Stent Neointimal Volume	The amount of plaque between the lumen and stent, within the stent region; In-stent restenosis. In-Stent Neointimal Volume = Stent Volume - Lumen Volume
122375	Native Plaque Volume	The amount of plaque between the stent and the EEM, within the stent region. Native Plaque Volume = EEM Volume - Stent Volume
122376	Total Plaque Volume	Total amount of plaque between the EEM and the Lumen, over the entire region that is measured. Total Plaque Volume = EEM Volume - Lumen Volume
122380	Proximal Reference	Proximal reference segment measurement site. Typically the site with the largest lumen proximal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122381	Distal Reference	Distal reference segment measurement site. Typically the site with the largest lumen distal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches)
122382	Site of Lumen Minimum	Site of the smallest lumen in a vessel; e.g. due to a stenotic lesion
122383	Entire Pullback	Measurement region that encompasses the entire vessel imaged in a single pullback acquisition
122384	Stented Region	Measurement region occupied by the stent
122385	Proximal Stent Margin	Region starting at the proximal edge of the Stent and extending several millimeters (usually 5 mm) proximal to the Stent edge
122386	Distal Stent Margin	Region starting at the distal edge of the Stent and extending several millimeters (usually 5 mm) distal to the Stent edge
122387	Dissection Classification	Classification of dissections in a vessel
122388	Intra-stent Dissection	Separation of neointimal hyperplasia from stent struts, usually seen only after treatment of in-stent restenosis
122389	Vulnerable Plaque	Plaque with a thin cap fibrous atheroma that is at increased risk of rupture and thrombosis (or re-thrombosis) and rapid stenosis progression
122390	Eroded Plaque	Plaque erosions with no structural defect (beyond endothelial injury) or gap in the plaque
122391	Relative Stenosis Severity	Stenosis severity classifications of multiple lesions in a vessel
122393	Restenotic Lesion	A finding of a previously treated lesion in which stenosis has reoccurred
122394	Fibro-Lipidic Plaque	Loosely packed bundles of collagen fibers with regions of lipid deposition present. Region is cellular and no cholesterol clefts or necrosis are present. Some macrophage infiltration. Increase in extra cellular matrix
122395	Necrotic-Lipidic Plaque	Area within the plaque with very low echogenicity separated from the lumen and surrounded by more echogenic structures (fibrous cap). Highly lipidic necrotic region with remnants of foam cells and dead lymphocytes present. No collagen fibers are visible and mechanical integrity is poor. Cholesterol clefts and micro calcifications are visible
122398	Intimal Dissection	Dissection limited to the intima or atheroma, and not extending to the media
122399	Medial Dissection	Dissection in the arterial Media, extending into the media
122400	Simultaneously Acquired	The referenced information was acquired simultaneously with the information in the object in which the reference occurs
122401	Same Anatomy	Information acquired for the same anatomic region
122402	Same Indication	Information acquired for the same indication; e.g. to elucidate the same diagnostic question
122403	For Attenuation Correction	The referenced information was used to correct the data for differential attenuation through different anatomic tissue
122404	Reconstructed	Value estimated for a vessel in the absence of a stenosis
122405	Algorithm Manufacturer	Manufacturer of application used
122406	Left Atrial Ejection Fraction by Angiography	Left Atrial Ejection Fraction by Angiography
122407	Left Atrial ED Volume	Left Atrial End Diastolic Volume
122408	Left Atrial ES Volume	Left Atrial End Systolic Volume
122410	Contour Realignment	Contour repositioning of End Diastolic relative to End Systolic contour
122411	Threshold Value	The minimum standard deviation to define the hypokinesis and hyperkinesis
122417	Regional Abnormal Wall Motion	Report of differentiation of wall motion compared to normal
122421	Calibration Object	Object used for Calibration
122422	Calibration Method	Method used for Calibration
122423	Calibration Object Size	Size of calibration object
122428	Area Length Method	Method how long axis is positioned
122429	Volume Method	Model for cardiac chamber volume calculation
122430	Reference Method	Method to define original diameter of the artery
122431	Regression Slope ED	Relation between calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122432	Regression Offset ED	Correction factor for the calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used
122433	Regression Slope ES	Relation between calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122434	Regression Offset ES	Correction factor for the calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used
122435	Regression Volume Exponent	Exponent of volume in regression formula
122438	Reference Points	Container for spatial locations or coordinates used for calculation
122445	Wall Thickness	Average thickness of the chamber wall in the current view
122446	Wall Volume	Volume of the chamber wall estimated from the current view
122447	Wall Mass	Mass of the chamber wall (myocardium)
122448	Wall Stress	Peak systolic stress of chamber wall
122449	Centerline Wall Motion Analysis	Method to calculate wall motion [example: Sheehan, 1986]
122450	Normalized Chord Length	The length between End Diastolic and End Systolic contour perpendicular on the centerline normalized by a method dependent ventricular perimeter length. The centerline is the line equidistant between the End Diastolic and End Systolic contour [example: Sheehan, 1986]
122451	Abnormal Region	The report of the boundaries of the abnormal (hyperkinetic, hypokinetic, a-kinetic) regions associated with the territory of the artery [example: Sheehan, 1986]
122452	First Chord of Abnormal Region	The chord number specifying the begin of abnormal region [example: Sheehan, 1986]
122453	Last Chord of Abnormal Region	The chord number specifying the end of abnormal region [example: Sheehan, 1986]
122459	Territory Region Severity	Severity at the regional abnormality extent [example: Sheehan, 1986]
122461	Opposite Region Severity	Severity at the opposite regional abnormality extent [example: Sheehan, 1986]
122464	LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 5 - 85. [Sheehan, 1986]
122465	RCA Region in ROA Projection	Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 25 - 85. [Sheehan, 1986]
122466	Single LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 66 (hypokinetic) and 67 - 80 (hyperkinetic). [Sheehan, 1986]
122467	Single RCA Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 51 - 80 (hypokinetic) and 10 - 50 (hyperkinetic). [Sheehan, 1986]
122468	Multiple LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 58 (hypokinetic) and 59 -80 (hyperkinetic). [Sheehan, 1986]
122469	Multiple RCA Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 59 - 80 (hypokinetic) and 10 - 58 (hyperkinetic). [Sheehan, 1986]
122470	LAD Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 50 -100 (hypokinetic) and 20 - 49 (hyperkinetic). [Sheehan, 1986]
122471	RCA Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 19 - 67 (hypokinetic) and 68 - 100 (hyperkinetic). [Sheehan, 1986]
122472	CFX Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 38 -74 (hypokinetic) and 75 - 100 (hyperkinetic). [Sheehan, 1986]
122473	Circular Method	Method based on assumption that the image object is circular
122474	Densitometric Method	Method based on the gray value distribution of the image
122475	Center of Gravity	End Systolic contour realigned to End Diastolic contour based on the center of gravity
122476	Long Axis Based	End Systolic contour realigned to End Diastolic contour based on the mid point of the long axis. The long axis end-points are defined as the posterior and apex
122477	No Realignment	No Contour Realignment applied
122480	Vessel Lumen Cross-Sectional Area	Calculated Vessel Lumen Cross-Sectional Area based on the referenced method
122481	Contour Start	Location of the beginning of a contour
122482	Contour End	Location of the end of a contour
122485	Sphere	Sphere is used as calibration object
122486	Geometric Isocenter	Object of interest in isocenter of image and pixel separation is calculated from geometric data
122487	Geometric Non-Isocenter	Object of interest not in isocenter of image and pixel separation is calculated from geometric data and out of isocenter distances
122488	Calibration Object Used	Object used for calibration; e.g. sphere
122489	Curve Fitted Reference	Application dependent method to calculate the reference diameter based on the multiple diameter values
122490	Interpolated Local Reference	Application dependent method to calculate reference by interpolation, based on the diameter of two or more user defined reference positions
122491	Mean Local Reference	Application dependent method to calculate by averaging the reference, based on the diameter of one or more user defined reference positions
122493	Radial Based Wall Motion Analysis	Method to calculate wall motion based on the lengths of the radials in the predefined regions [Ingels]
122495	Regional Contribution to Ejection Fraction	Contribution of Region to global Ejection factor based on radial or landmark based wall motion method
122496	Radial Shortening	The reduction of area between End Systolic and End Diastolic based on radial wall motion analysis
122497	Landmark Based Wall Motion Analysis	Method to calculate wall motion based on the move of landmarks on the wall [Slager]
122498	Slice Contribution to Ejection Fraction	Contribution to the ejection fraction of a specific slice region [Slager]
122499	Frame to Frame Analysis	Method to calculate volumes of heart chambers for every image in a range
122501	Area of closed irregular polygon	The area is derived by considering a set of coordinates as a closed irregular polygon, accounting for inner angles. The exact method, such as by decomposition into triangles or quadrilaterals, is not specified, since it does not affect the numeric result, apart from the effect of numeric precision during computation of intermediate results
122502	Area of a closed NURBS	The area is derived by using a set of coordinates as control points for a Non Uniform Rational B-Spline (NURBS)
122503	Integration of sum of closed areas on contiguous slices	The volume derived by integrating the sum of the areas on adjacent slices across the slice interval; each area is defined by a regular planar shape or by considering a set of coordinates as a closed irregular polygon, accounting for inner angles
122505	Calibration	Procedure used to calibrate measurements or measurement devices
122507	Left Contour	Left contour of lumen (direction proximal to distal)
122508	Right Contour	Right contour of lumen (direction proximal to distal)
122509	Diameter Graph	Ordered set of diameters values derived from contours (direction proximal to distal)
122510	Length Luminal Segment	Length Luminal Segment
122511	Graph Increment	Increment value along X-axis in Diameter Graph
122516	Site of Maximum Luminal	Location of the maximum lumen area in a lesion or vessel
122517	Densitometric Luminal Cross-sectional Area Graph	Ordered set of cross-sectional Vessel Lumen Cross-Sectional Area values derived from contours (direction proximal to distal) based on densitometric method
122528	Position of Proximal Border	Position of proximal border of segment relative to the contour start (proximal end of analysis area)
122529	Position of Distal Border	Position of distal border of segment relative to the contour start (proximal end of analysis area)
122542	Plaque Area	Longitudinal cross sectional area of plaque
122544	Diameter Symmetry	Symmetry of stenosis (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122545	Area Symmetry	Symmetry of plaque (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 "Definition of Diameter Symmetry with Arterial Plaques" in PS3.17
122546	Inflow Angle	The average slope of the diameter function between the position of the minimum luminal diameter and the position of the proximal border of the segment
122547	Outflow Angle	The average slope of the diameter function between the position of the minimum luminal diameter and the position of the distal border of the segment
122548	Stenotic Flow Reserve	The relation between coronary pressure and coronary flow
122549	Poiseuille Resistance	Poiseuille Resistance at the location of the stenosis
122550	Turbulence Resistance	Turbulence Resistance at the location of the stenosis
122551	Pressure Drop at SFR	Pressure drop over the stenosis at maximum heart output
122554	Segmentation Method	Method for selection of vessel sub-segments
122555	Estimated Normal Flow	Estimate of the volume of blood flow in the absence of stenosis
122558	Area Length Kennedy	Area Length method defined by Kennedy [Kennedy, 1970]
122559	Area Length Dodge	Area Length method defined by Dodge [Dodge, 1960]
122560	Area Length Wynne	Area Length method defined by Wynne [Wynne]
122562	Multiple Slices	Volume method based on multiple slice
122563	Boak	Volume method defined by Boak [Boak]
122564	TS Pyramid	Volume method defined by Ferlinz [Ferlinz]
122565	Two Chamber	Volume method defined by Graham [Graham]
122566	Parallelepiped	Volume method defined by Arcilla [Arcilla]
122572	BSA^1.219	Corrected Body Surface area for indexing the hemodynamic measurements for a pediatric patient
122574	Equidistant method	Method for selecting sub-segments that are all of the same length
122575	User selected method	Manually selected start and end of sub-segment
122582	Left ventricular posterobasal segment	Left ventricular posterobasal segment
122600	Cardiovascular Analysis Report	Report of a Cardiovascular Analysis, typically from a CT or MR study
122601	Ventricular Analysis	Ventricular Analysis
122602	Myocardial Perfusion Analysis	Myocardial Perfusion Analysis
122603	Calcium Scoring Analysis	Calcium Scoring Analysis
122604	Flow Quantification	Flow Quantification Analysis
122605	Vascular Morphological Analysis	Vascular Morphological Analysis
122606	Vascular Functional Analysis	Vascular Functional Analysis
122607	Thickening Analysis	Analysis of myocardial wall thickening
122608	Absolute Values Of Ventricular Measurements	Section Heading for absolute values of ventricular measurements
122609	Normalized Values Of Ventricular Measurements	Results of normalizing ventricular measurements
122611	Reference Point	Reference Point of a measurement
122612	Central breathing position	Central breathing position between inspiration and expiration
122616	Peak Ejection Rate	Peak of the ventricular ejection rate
122617	Peak Ejection Time	Time of the peak of ventricular ejection
122618	Peak Filling Rate	Peak of the fluid filling rate
122619	Peak Filling Time	Time interval until time of peak filling from a given reference point; e.g. end systole
122620	Papillary Muscle Excluded	Papillary muscle was excluded from the measurement
122621	Papillary Muscle Included	Papillary muscle was included in the measurement
122624	Wall Thickness Ratio end-systolic to end-diastolic	The ratio of the end-systolic wall thickness compared to the end-diastolic wall thickness
122627	Curve Fit Method	The method to smooth a ventricular volume as a function of time
122628	Baseline Result Correction	Baseline correction used in the calculation of the results
122631	Signal Earliest Peak Time	The time in a dynamic set of images at which the first peak of the signal is observed for the analyzed myocardial wall segments
122633	Signal Increase Start Time	This is the time at which the signal begins to increase
122634	Signal Time to Peak	Time interval between the beginning of the signal increase to the time at which the signal intensity reaches its first maximum in a dynamic set of images
122635	MR Perfusion Peak	Peak of the MR perfusion signal
122636	MR Perfusion Slope	Signal intensity as a function of time. It is the change in the signal intensity divided by the change in the time
122637	MR Perfusion Time Integral	MR perfusion time integral from baseline (foot time) to earliest peak
122638	Signal Baseline Start	First time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122639	Signal Baseline End	Last time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment
122640	Image Interval	The time delta between images in a dynamic set of images
122642	Velocity Encoding Minimum Value	The minimum velocity encoded by the phase encoding gradient
122643	Velocity Encoding Maximum Value	The maximum velocity encoded by the phase encoding gradient
122645	Net Forward Volume	Forward volume-reverse volume
122650	Area Based Method	Area Based Method for estimating volume or area
122651	Diameter Based Method	Diameter Based Method for estimating volume, area or diameter
122652	Volume Based Method	Volume Based Method for estimating volume
122655	NASCET	A method of diameter measurements according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)
122656	ECST	A method of diameter measurements according to ECST (European Carotid Surgery Trial)
122657	Agatston Score Threshold	Agatston Score Threshold
122658	Calcium Mass Threshold	Calcium Mass Threshold
122659	Calcium Scoring Calibration	Calcium Scoring Calibration
122660	Calcium Volume	Calcium Volume
122661	Calcium Mass	Calcium Mass
122664	Late Contrast Enhancement	Delayed hyperenhancement of a tissue observed in an image acquired after injection of contrast media
122665	Time interval since injection of contrast media	Time interval since injection of contrast media
122666	Time relative to R-wave peak	Time relative to R-wave peak
122667	Blood velocity vs. time of cardiac cycle	Relationship between blood velocity and time relative to R-wave peak
122668	Time interval since detection of contrast bolus	Time interval since detection of contrast bolus
122670	Papillary Muscle Included/Excluded	Indicates if the papillary muscle was included or excluded in the measurement
122675	Anterior-Posterior	Anterior to Posterior direction
122680	endoleak	Persistent flow of blood into the stent-grafting
122683	Stent Fracture	Fracture of a stent
122684	Stent Disintegration	Disintegration of a stent
122685	Stent Composition	Material that a stent consists of
122686	Parent Vessel Finding	Finding about the characteristics of the parent vessel of a vessel
122687	Site of Lumen Maximum	Site of Maximal lumen diameter of a vessel
122698	X-Concept	The physical domain (time, space, etc.) to the horizontal axis of the graphical presentation
122699	Y-Concept	The physical domain (time, space, etc.) to the vertical axis of the graphical presentation
122700	Indications for Pharmacological Stress	Indications for Pharmacological Stress
122701	Procedure time base	Reference time for measurement of elapsed time in a procedure
122702	Treadmill speed	Treadmill speed
122703	Treadmill gradient	Treadmill gradient
122704	Ergometer power	Ergometer power
122705	Pharmacological Stress Agent Dose Rate	Pharmacological Stress Agent Dose Rate
122706	Rating of Perceived Exertion	Rating of Perceived Exertion
122707	Number of Ectopic Beats	Number of ectopic beats during a period of collection
122708	Double Product	Heart rate times systolic blood pressure
122709	Activity workload	Physical activity workload (intensity) measurement
122710	Time since start of stage	Elapsed time at stage
122711	Exercise duration after stress agent injection	Exercise duration after stress agent injection
122712	Imaging Start Time	Imaging Start Time
122713	Attenuation correction method	Attenuation correction method
122715	Pharmacological Stress Agent Dose	Pharmacological Stress Agent Dose
122716	Maximum Power Output Achieved	Maximum power output achieved during course of procedure
122717	Peak activity workload	Peak physical activity intensity measurement during course of procedure
122718	Peak Double Product	Peak Double Product measurement during course of procedure
122720	OSEM algorithm	Ordered subsets expectation maximization reconstruction algorithm
122721	Chang method	Chang attenuation correction method
122726	Algorithmic attenuation correction	Attenuation correction not based on image-based attenuation maps
122727	NM transmission attenuation correction	NM transmission attenuation correction
122728	CT-based attenuation correction	CT-based attenuation correction
122729	No Attenuation Correction	No attenuation correction
122730	Bazett QTc Algorithm	Bazett QT Correction Algorithm; QT/(RR ^ 0.5); Bazett HC. "An analysis of the time-relations of electrocardiograms" Heart7:353-370 (1920)
122731	Hodges QTc Algorithm	Hodges QT Correction Algorithm; QT + 1.75 (heart rate-60); Hodges M, Salerno Q, Erlien D. "Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better." J Am Coll Cardiol1:694 (1983)
122732	Fridericia QTc Algorithm	Fridericia QT Correction Algorithm; QT/(RR ^ 0.333); Fridericia LS. "The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease" Acta Med Scand53:469-486 (1920)
122733	Framingham QTc Algorithm	Framingham QT Correction Algorithm; QT + 0.154 (1- RR); Sagie A, Larson MG, Goldberg RJ, et al. "An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)." Am J Cardiol70:797-801(1992)
122734	Borg RPE Scale	Borg Rating of Perceived Exertion Scale, range 6:20
122735	Borg CR10 Scale	Borg category ratio scale, open ended range with nominal range 0:10
122739	Overall study quality	Overall study quality
122740	Excellent image quality	Excellent image quality
122741	Good image quality	Good image quality
122742	Poor image quality	Poor image quality
122743	Body habitus attenuation	Image attenuation due to body physique (overweight)
122744	Breast attenuation	Image attenuation due to breast tissue
122745	Diaphragmatic attenuation	Image attenuation due to diaphragm
122748	False positive defect finding	Finding of a defect is incorrect; e.g. from automated analysis
122750	Non-diagnostic - low heart rate	ECG is non-diagnostic due to low heart rate
122751	Non-diagnostic - resting ST abnormalities	ECG is non-diagnostic due to resting ST abnormalities
122752	Non-diagnostic - ventricular pacing or LBBB	ECG is non-diagnostic due to ventricular pacing or Left Bundle Branch Block
122753	Non-diagnostic ECG	ECG is non-diagnostic for presence of acute coronary syndrome
122755	Strongly positive	Strongly positive finding
122756	Strongly positive - ST elevation	Strongly positive finding - ST elevation
122757	ST Depression - Horizontal	Finding of ST segment depression with no slope
122758	ST Depression - Upsloping	Finding of ST segment depression with upslope
122759	ST Depression - Downsloping	Finding of ST segment depression with downslope
122760	Stress test score	Stress test score
122762	Number of diseased vessel territories	Number of diseased vessel territories
122764	Weight exceeds equipment limit	Patient weight exceeds equipment limit
122768	Difference in Ejection Fraction	Difference in Ejection Fraction
122769	Difference in ED LV Volume	Difference in End Diastolic Left Ventricular Volume
122770	Ratio of achieved to predicted maximal oxygen consumption	Ratio of achieved to predicted maximal oxygen consumption
122771	Ratio of achieved to predicted functional capacity	Ratio of achieved to predicted functional capacity
122772	Aerobic index	Workload (Watts) at target heart rate divided by body weight
122773	ST/HR Index	ST depression at peak exercise divided by the exercise-induced increase in heart rate [Kligfield P, Ameisen O, Okin PM. "Heart rate adjustment of ST segment depression for improved detection of coronary artery disease." Circulation 1989;79:245-55.]
122775	Agreement with prior findings	Agreement with prior findings
122776	Disagreement with prior findings	Disagreement with prior findings
122781	Rest thallium/stress technetium procedure	Nuclear Medicine Rest thallium/stress technetium procedure
122782	Rest technetium/stress technetium 1 day procedure	Nuclear Medicine Rest technetium/stress technetium 1 day procedure
122783	Rest technetium/stress technetium 2 day procedure	Nuclear Medicine Rest technetium/stress technetium 2 day procedure
122784	Stress technetium/rest technetium 1 day procedure	Nuclear Medicine Stress technetium/rest technetium 1 day procedure
122785	NM Myocardial Viability procedure	Nuclear Medicine Myocardial Viability procedure
122791	PET Myocardial Perfusion, Rest only	Positron Emission Tomography Perfusion Imaging procedure, rest only
122792	PET Myocardial Perfusion, Stress only	Positron Emission Tomography Perfusion Imaging procedure, stress only
122793	PET Myocardial Perfusion, Rest and Stress	Positron Emission Tomography Perfusion Imaging procedure, rest and stress
122795	PET Myocardial Viability, Rest only	Positron Emission Tomography Myocardial Viability procedure, rest only
122796	PET Myocardial Viability, Stress only	Positron Emission Tomography Myocardial Viability procedure, stress only
122797	PET Myocardial Viability, Rest and Stress	Positron Emission Tomography Myocardial Viability procedure, rest and stress
122799	Anginal Equivalent	Group of symptoms heralding angina pectoris that does not include chest pain (dyspnea, diaphoresis, profuse vomiting in a diabetic patient, or arm or jaw pain)
123001	Radiopharmaceutical	Active ingredient (molecular) used for radioactive tracing	deprecated
123003	Radiopharmaceutical Start Time	Time of radiopharmaceutical administration to the patient for imaging purposes
123004	Radiopharmaceutical Stop Time	Ending time of radiopharmaceutical administration to the patient for imaging purposes
123005	Radiopharmaceutical Volume	Volume of radiopharmaceutical administered to the patient
123006	Radionuclide Total Dose	Total amount of radionuclide administered to the patient at Radiopharmaceutical Start Time
123007	Radiopharmaceutical Specific Activity	Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
123009	Radionuclide Syringe Counts	Pre-injection syringe acquisition count rate
123010	Radionuclide Residual Syringe Counts	Syringe acquisition count rate following patient injection
123011	Contrast/Bolus Agent	Contrast or bolus agent
123012	Pre-Medication	Medication to be administered at the beginning of the Scheduled Procedure Step
123014	Target Region	Anatomic Region to be imaged
123015	Imaging Direction	Direction of imaging (includes view, transducer orientation, patient orientation, and/or projection)
123016	Imaging Conditions	Imaging condition for refinement of protocol (includes secondary posture, instruction, X-Ray / electron beam energy or nuclide, and ultrasound modes), as used in JJ1017 v3.0
123019	Caudal 10 degree distal-cranioproximal oblique	Caudal 10 degree distal-cranioproximal oblique radiographic projection, defined per Smallwood et al
123101	Neighborhood Analysis	Surface processing utilizing predefined weighting factors (i.e., kernels) applied to different data values depending on their location relative to other data values within the data domain. Includes Low Pass, High Pass, Gaussian, Laplacian, etc.
123102	Adaptive Filtering	Surface processing applied non-uniformly utilizing a priori knowledge of the system and/or relative locations of the data values within the data domain. Example: Neighborhood analysis where weighting factors are modified continuously based on predefined criteria
123103	Edge Detection	Surface processing through the exploitation of discontinuities in the data values within their domain. Includes Gradient filters
123104	Morphological Operations	Surface processing based on the connectivity of values based on the shape or structure of the data values within their domain. Includes erode, dilate, etc.
123105	Histogram Analysis	Surface processing applied to the distribution of the data values. Includes thresholding, Bayesian Classification, etc.
123106	Multi-Scale/Resolution Filtering	Surface processing accomplished through varying the data domain size. Include deformable models
123107	Cluster Analysis	Surface processing accomplished by combining data values based on their relative location within their domain or value distribution. Includes K- and C-means, Fuzzy Analysis, Watershed, Seed Growing, etc.
123108	Multispectral Processing	Surface processing accomplished through the weighted combination of multiple data sets. Includes Principle Component Analysis, linear and non-linear weighed combinations, etc.
123109	Manual Processing	Surface processing accomplished through human interaction. Region drawing
123110	Artificial Intelligence	Surface processing using Artificial Intelligence techniques, such as Machine Learning, Neural Networks, etc.
123111	Deformable Models	Surface processing using Deformable Model techniques, such as Point Distribution Models, Level Sets, Simplex Meshes, etc.
125000	OB-GYN Ultrasound Procedure Report	Document Title of OB-GYN procedure report
125001	Fetal Biometry Ratios	Report section for assessment of fetal growth using ratios and indexes
125002	Fetal Biometry	Report section for assessment of fetal growth
125003	Fetal Long Bones	Report section for assessment of fetal growth by long bone measurements
125004	Fetal Cranium	Report section for assessment of fetal cranium growth
125005	Biometry Group	Biometric assessment of
125006	Biophysical Profile	Report section for assessment of biophysical observations that evaluate fetal well-being according to Manning, Antepartum Fetal Evaluation: Development of a Fetal Biophysical Profile Score, Am. J Obstet Gynecol, 1980;136:787
125007	Measurement Group	A grouping of related measurements and calculations that share a common context
125008	Fetus Summary	Report section for fetus specific procedure summary observations
125009	Early Gestation	Report section for assessment of early gestation fetus
125010	Identifier	A name to differentiate between multiple instances of some item
125011	Pelvis and Uterus	Report section for assessment of pelvis and uterus
125012	Growth Percentile rank	The rank of a measured growth indicator relative to a normal distribution expressed as a percentage
125013	Growth Z-score	The rank of a measured growth indicator relative to a normal distribution expressed as the dimensionless quantity z = (x-m) /s where (x-m) is the deviation of the value x, from the distribution mean, m, and s is the standard deviation of the distribution
125015	Fetus Characteristics	Fetus characteristics (findings section title)
125016	Fetal Measurements	Fetal Measurements (findings section title)
125021	Frame of Reference Identity	There is a defined equivalence between the Frame of Reference of the Registration SOP instance and the Frame of Reference of the referenced images
125022	Fiducial Alignment	The registration is based on fiducials that represent patient or specimen features identified in each data set
125023	Acquisition Equipment Alignment	Registration based on a-priori knowledge of the acquisition geometry. This is not an object registration as in fiducial registration. Rather, it specifies a known spatial relationship
125024	Image Content-based Alignment	Computed registration based on global image information
125025	Visual Alignment	Registration by visually guided manipulation
125030	Inter-Hemispheric Plane	A plane fiducial that specifies the location of the plane separating the two hemispheres of the brain
125031	Right Hemisphere Most Anterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the right brain hemisphere
125032	Right Hemisphere Most Posterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the right brain hemisphere
125033	Right Hemisphere Most Superior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the right brain hemisphere
125034	Right Hemisphere Most Inferior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the Right brain hemisphere
125035	Left Hemisphere Most Anterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the left brain hemisphere
125036	Left Hemisphere Most Posterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the left brain hemisphere
125037	Left Hemisphere Most Superior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the left brain hemisphere
125038	Left Hemisphere Most Inferior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the left brain hemisphere
125040	Background	That which is not part of an object
125041	Registration Input	A segment for use as an input to an image registration process; e.g. to specify the bounding region for determining a Frame of Reference Transformation Matrix
125100	Vascular Ultrasound Procedure Report	Root Document Title for ultrasound vascular evidence reports (worksheets)
125101	Vessel Branch	The particular vessel branch, such as the inferior, medial or lateral
125102	Graft Type	A descriptor or elaboration of the type of graft
125105	Measurement Orientation	A modifier to a 2D distance measurement to describe its orientation; e.g. a vascular distance measurement for a vessel plague could have a modifier Transverse or Longitudinal
125106	Doppler Angle	The angle formed between the Doppler beam line and the direction of blood flow within a region of interest in the body defined by the sample volume
125107	Sample Volume Depth	The depth of the center of the Doppler sample volume measured from skin line along the Doppler line
125195	Pediatric Cardiac Ultrasound Report	Pediatric Cardiac Ultrasound Report (document title)
125196	Fetal Cardiac Ultrasound Report	Fetal Cardiac Ultrasound Report (document title)
125197	Adult Congenital Cardiac Ultrasound Report	Adult Congenital Cardiac Ultrasound Report (document title)
125200	Adult Echocardiography Procedure Report	Document title of adult echocardiography procedure (evidence) report
125201	Illustration of Finding	An image that is a pictorial representation of findings. The concept is typically used as a purpose of reference to an image, such as a depiction of myocardium segments depicting wall motion function
125202	LV Wall Motion Score Index	The average of all scored (non-zero) Left Ventricle segment wall motion scores
125203	Acquisition Protocol	A type of clinical acquisition protocol for creating images or image-derived measurements. Acquisition protocols may be specific to a manufacturer's product
125204	Area-length biplane	Method for calculating left ventricular volume from two orthogonal views containing the true long axis (usually the apical 4 and 2 chamber views). Volume = [pL1 / 6] * [(4A1) ÷ (pL1) ] * [(4A2) ÷ (pL2) ]
125205	Area-Length Single Plane	Method for calculating left ventricular volume from a view containing the true long axis (usually the apical 4-chamber view). Volume = [8(A)2]÷[3pL]
125206	Cube	Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) that estimates the volume as the cube of diameter
125207	Method of Disks, Biplane	Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis and using a disk diameter averaged from the two chamber and four chamber views
125208	Method of Disks, Single Plane	Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis with disk diameter taken from the four-chamber view
125209	Teichholz	Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) Volume = [7.0/(2.4+D) ]*D3
125210	Area by Pressure Half-Time	Mitral valve area (cm2) by Pressure Half-time = 220 (cm2.ms) / PHT (ms)
125211	Biplane Ellipse	Area = P/4 X d1 X d2 d1 = anterior/posterior axis d2 = medial/lateral axis Hagen-Ansert, Sandra L., Textbook of Diagnostic Ultrasound, ed. 3, The C.V.Mosby Co., 1989, p. 73.
125212	Continuity Equation	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the velocity
125213	Continuity Equation by Mean Velocity	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the mean velocity
125214	Continuity Equation by Peak Velocity	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the peak velocity
125215	Continuity Equation by Velocity Time Integral	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the velocity time integral
125216	Proximal Isovelocity Surface Area	Utilizes aliasing velocity (by color Doppler) of flow into an orifice (often regurgitant or stenotic) to measure instantaneous flow rate, orifice area, and flow volume. The instantaneous flow rate = (2πr2vav ) * (α / π) where vav is the constant velocity known as aliasing velocity at radius r, vp is the peak velocity at the orifice, and α is the angle in radians of the constant velocity surface. Estimated Orifice area = Flow rate / vp , where vp is the peak velocity at the orifice and the flow rate is the PISA peak flow rate. The volume flow is then the product of the orifice area and Velocity Time Integral
125217	Full Bernoulli	ΔP = 4*(V12 - V22)
125218	Simplified Bernoulli	ΔP = 4*V2
125219	Doppler Volume Flow	Volume flow = Conduit CSA * (Velocity Time Integral)
125220	Planimetry	Direct measurement of an area by tracing an irregular perimeter
125221	Left Ventricle Mass by M-mode	Mass = 1.04 * [(ST+LVID+PWT)3 - LVID3] * 0.8+ 0.6. Mass unit is grams and length in cm
125222	Left Ventricle Mass by Truncated Ellipse	Mass = 1.05P ((b + t)2 X (2/3 (a + t) + d - d3 /3(a + t)2) - b2 (2/3a + d - d3 /3a2)) a = Semi-major axis from widest minor axis radius to apex. b = Short axis radius calculated from short axis cavity area t = Myocardial thickness calculated from short axis epicardial and cavity areas d = Truncated semi-major axis from widest short axis diameter to plane of mitral annulus. Mass unit is grams and length in cm. Schiller NB et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography 2:364, 1989.
125223	4 Point Segment Finding Scale	A four point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125224	5 Point Segment Finding Scale	A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125225	5 Point Segment Finding Scale With Graded Hypokinesis	A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology, with severity of hypokinesis graded. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989
125226	Single Plane Ellipse	Method of estimating volume from a planar ellipse. Equivalent to Biplane Ellipse with an assumption that the ellipse in the orthogonal plane has identical major and minor diameters
125227	Modified Simpson	Modified Simpson's Method of estimating ventricular volume, based on the method of disks with paired apical views. Schiller NB, et al. "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms". J Am Soc Echocardiogr.1989 2(5):358-367. Sep-Oct
125228	Bullet Method	Bullet method of estimating ventricular volume. Volume = 5/6 * L * S L: Left ventricle long axis length S: Left ventricle area, SAX view at level of Mitral Valve
125230	Power Doppler	Color coded ultrasound images of blood flow, which depict the amplitude, or power, of Doppler signals	deprecated
125231	3D mode	Volumetric ultrasound imaging	deprecated
125233	Start of drug dose administration	Onset of administration of dose of a drug
125234	Start of contrast agent administration	Onset of contrast agent administration
125235	Destruction of microbubbles	Destruction of ultrasonic contrast microbubbles by a high-energy ultrasound pulse
125236	Onset of exercise	Instant at which exercise begins
125237	Cessation of exercise	Instant at which exercise ends
125238	Onset of stimulation	Instant at which stimulation begins
125239	Cessation of stimulation	Instant at which stimulation ends
125240	Line scan pattern	Ultrasound transducer scan pattern in which information is gathered along a line
125241	Plane scan pattern	Ultrasound transducer scan pattern in which information is gathered within a plane
125242	Volume scan pattern	Ultrasound transducer scan pattern in which information is gathered within a volume
125251	Non-imaging Doppler ultrasound transducer geometry	Ultrasound transducer geometry characterized by a single scan line used for PW or CW Doppler scanning
125252	Linear ultrasound transducer geometry	Ultrasonic transducer geometry characterized by parallel lines
125253	Curved linear ultrasound transducer geometry	Ultrasonic transducer geometry characterized by radial lines normal to the outside of a curved surface
125254	Sector ultrasound transducer geometry	Ultrasonic transducer geometry characterized by lines originating from a common apex
125255	Radial ultrasound transducer geometry	Ultrasonic transducer geometry characterized by lines emanating radially from a single point
125256	Ring ultrasound transducer geometry	Ultrasonic transducer geometry characterized by a circular ring of transducer elements
125257	Fixed beam direction	Ultrasonic steering technique consisting of a single beam normal to the transducer face steered by the orientation of the probe
125258	Mechanical beam steering	Ultrasonic steering technique consisting of mechanically directing the beam
125259	Phased beam steering	Ultrasonic steering technique consisting of electronically-steered beams
125261	External Transducer	Transducer is designed to be placed onto the surface of the subject
125262	Transesophageal Transducer	Transducer is designed for insertion into the esophagus
125263	Endovaginal Transducer	Transducer is designed for insertion into the vagina
125264	Endorectal Transducer	Transducer is designed for insertion into the rectum
125265	Intravascular Transducer	Transducer is designed for insertion via a catheter
125270	Left Ventricle Mass by Area Length	method to measure the mass of the Left Ventricle via the ASE area-length method at end diastole. LV Mass = 1.05(5/6(A1(L+t)) - 5/6(A2*L)) A1 = Left Ventricle epicardial SAX area at the level of the papillary muscle tips at end diastole. A2 = Left Ventricle endocardial SAX area cavity area at the level of the papillary muscle tips at end diastole. L = Left Ventricle apical view long axis length at end diastole. t = Myocardial thickness can be computed as: t = sqrt (A1/3.14) - sqrt (A2/3.14) Reference: 1) Schiller, N.B., et al. "Recommendations for Quantification of the LV by Two-dimensional Echocardiography." J Am Soc Echo, Vol. 2, No. 5: 358-367, Sep-Oct 1989. 2) Reichek, N., et al. "Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two-dimensional Echocardiography: Initial Results." Circulation, Vol. 67, No. 2: 348-52, February 1983
125271	Left Ventricle Mass by M-mode - adjusted by Height	Equation = Left Ventricle Mass by M-mode (in gram) / (Height (in meter)) ^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125272	Left Ventricle Mass by Truncated Ellipse - adjusted by Height	Equation = Left Ventricle Mass by Truncated Ellipse / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125273	Left Ventricle Mass by Area Length - adjusted by Height	Equation = Left Ventricle Mass by Area Length / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio
125901	CARDIOsphere	CARDIOsphere ultrasonic contrast agent produced by POINT Biomedical
125902	Echovist	Echovist® ultrasonic contrast agent produced by Schering AG
125903	Imagify	Imagify ultrasonic contrast agent produced by Accusphere Inc
125904	Levovist	Levovist® ultrasonic contrast agent produced by Schering AG
125905	Sonazoid	Sonazoid ultrasonic contrast agent produced by Daiichi Pharmaceutical / General Electric
125906	SonoVue	SonoVue ultrasonic contrast agent produced by Bracco Diagnostics
125907	Targestar-B	Targestar-B ultrasonic contrast agent produced by Targeson LLC
125908	Targestar-P	Targestar-P ultrasonic contrast agent produced by Targeson LLC
126000	Imaging Measurement Report	A structured report containing the quantitative results of human or machine analysis of images
126001	Oncology Measurement Report	A structured report containing the quantitative results of human or machine analysis of images for oncology evaluation
126002	Dynamic Contrast MR Measurement Report	A structured report containing the quantitative results of human or machine analysis of DCE-MR
126003	PET Measurement Report	A structured report containing the quantitative results of human or machine analysis of PET images
126010	Imaging Measurements	Measurements made on images
126011	Derived Imaging Measurements	Measurements derived from measurements made on images
126020	Multiparametric MRI	An MRI procedure in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126021	Multiparametric MRI of prostate	An MRI procedure of the prostate in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126022	Multiparametric MRI of whole body	An MRI procedure of the whole body in which multiple parameters including diffusion, dynamic contrast and T2 are measured
126030	Sum of segmented voxel volumes	The volume derived by summing the volumes of all the voxels (and partial voxels if the segment contains partially occupied voxels) included in the segment
126031	Peak Value Within ROI	Maximum average gray value that is calculated from a 1 cubic centimeter sphere placed within the region of interest. Reference Wahl et al PERCIST article
126032	Metabolic Volume	The volume of a lesion (e.g. a tumor) ascertained through information about its metabolic activity (e.g. SUV on PET). Abbreviated "MV". Synonymous with Metabolic Tumor Volume (MTV)
126033	Total Lesion Glycolysis	The total activity of a lesion obtained as the product of its volume and its glycolytic activity (on FDG-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in glucose metabolism. Abbreviated TLG. Synonymnous with "Tumor Lesion Glycolysis"
126034	Glycolysis	The amount glycolytic activity summed across all voxels in a defined region or within a defined range of SUV (on FDG-PET)
126035	Total Lesion Proliferation	The total activity of a lesion obtained as the product of its volume and its proliferative activity (on FLT-PET). The volume may be defined on the same modality (e.g. the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g. the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in cellular proliferation. Abbreviated TLP. Synonymnous with "Tumor Lesion Proliferation"
126036	Proliferative Activity	The amount proliferative activity summed across all voxels in a defined region or within a defined range of SUV (on FLT-PET)
126037	Standardized Added Metabolic Activity (SAM)	A background-corrected, partial volume independent version of TLG. SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126038	Standardized Added Metabolic Activity (SAM) Background	The background value (VOI2-VOI1) used to calculate Standardized Added Metabolic Activity (SAM). SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448
126039	Lesion to Background SUV Ratio	The ratio of the SUV within a tumor to the SUV of a pre-defined background region. Need reference(s). A more general concept than Tumor to Background Ratio (TBR)
126040	Background for Lesion to Background SUV Ratio	The SUV of a pre-defined background region used to compute Lesion to Background SUV Ratio. Need reference(s)
126050	Fractal Dimension	A statistical index of complexity comparing how detail in a fractal pattern changes with the scale at which it is measured; a ratio of the change in detail to the change in scale
126051	Skewness	Measure of the asymmetry of the probability distribution of a real-valued random variable about its mean
126052	Kurtosis	Measure of the peakedness of the probability distribution of a real-valued random variable
126060	Entropy of GLCM	The zero order entropy of a Gray Level Co-occurrence Matrix (GLCM). A measure of disorder. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126061	Energy of GLCM	The energy (uniformity) (square root of the Angular Second Moment (ASM)) of a Gray Level Co-occurrence Matrix (GLCM). A measure of orderliness. See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126062	Homogeneity of GLCM	The Inverse Difference Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126063	Contrast of GLCM	The sum of squares variance of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126064	Dissimilarity of GLCM	The dissimilarity of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126065	ASM of GLCM	The Angular Second Moment of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126066	Correlation of GLCM	A measure of the linear dependency of grey levels on those of neighbouring pixels of a Gray Level Co-occurrence Matrix (GLCM). See http://www.fp.ucalgary.ca/mhallbey/equations.htm
126067	Gray Level Co-occurrence Matrix (GLCM)	A tabulation of how often different combinations of pixel values (grey levels) occur in an image. See http://www.fp.ucalgary.ca/mhallbey/the_glcm.htm
126070	Subject Time Point Identifier	An identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point for a specific patient
126071	Protocol Time Point Identifier	An identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point "slot" within a treatment protocol using the same value for all patients in the protocol
126072	Time Point Type	A pre-defined type of a specific time point in a continuum
126073	Time Point Order	A number indicating the order of a time point relative to other time points in the same continuum
126074	Posttreatment	The time after the treatment of interest
126075	Eligibility	For the purpose of determining eligibility for a protocol
126080	RECIST 1.0	Response Evaluation Criteria in Solid Tumors version 1.0. See [RECIST] in Normative References
126081	RECIST 1.1	Response Evaluation Criteria in Solid Tumors Version 1.1. See Eisenhauer et al. "New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (version 1.1)." European Journal of Cancer 45, no. 2 (n.d.): 228-47. doi:10.1016/j.ejca.2008.10.026.
126100	Real World Value Map used for measurement	A reference to the Real World Value Map applied to the stored image pixel values before their use for a measurement
126200	Image Library Group	A container that groups common information about a set of images used as evidence to produce a report
126201	Acquisition Date	The date the acquisition of data started
126202	Acquisition Time	The time the acquisition of data started
126203	PET Radionuclide Incubation Time	The time between the start of injection of the PET radionuclide and the start of acquisition of the PET data
126220	R2-Coefficient	Coefficient of determination, R2. An indication of goodness of fit
126300	Perfusion analysis by Stable Xenon CT technique	Perfusion analysis by Stable Xenon CT technique
126301	Perfusion analysis by IV Iodinated Contrast CT technique	Perfusion analysis by IV Iodinated Contrast CT technique
126302	Perfusion analysis by Arterial Spin Labeling MR technique	Perfusion analysis by Arterial Spin Labeling (ASL) MR technique
126303	Perfusion analysis by Susceptibility MR technique	Perfusion analysis by Susceptibility (T2*) MR technique
126310	Least Mean Square (LMS) deconvolution	Least Mean Square (LMS) deconvolution
126311	Singular Value Decomposition (SVD) deconvolution	Singular Value Decomposition (SVD) deconvolution
126312	Ktrans	Ktrans, the volume transfer constant of a tracer diffusion kinetic model, specifically the volume transfer constant between blood plasma and extravascular extracellular space (EES) See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126313	kep	kep, the rate constant between extravascular extracellular space (EES) and blood plasma See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126314	ve	ve, the fractional (not absolute) volume of extravascular extracellular space (EES) per unit volume of tissue See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126320	IAUC	The intial area under the contrast agent concentration-time curve
126321	IAUC60	The intial area under the contrast agent concentration-time curve at 60 seconds after the onset time
126322	IAUC90	The intial area under the contrast agent concentration-time curve at 90 seconds after the onset time
126330	tau_m	τm. The mean intracellular water lifetime (τi). Used in the Shutter-Speed Model (SSM) of tracer kinetics
126331	vp	vp. The fractional (not absolute) blood plasma volume per unit volume of tissue. See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999
126340	Standard Tofts Model	A tracer diffusion kinetic model in which the permeability is assumed to be isodirectional. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126341	Extended Tofts Model	A tracer diffusion kinetic model in which the permeability is not assumed to be isodirectional, and which includes the contribution of tracer in the blood plasma to the total tissue concentration. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997
126342	Model-free concentration-time quantitification	A semiquantitative analysis of the contrast-enhancement concentration versus time curve that avoids the use of a pharmacokinetic model; e.g. integration to compute the initial area under the curve
126343	First Pass Leakage Profile (FPLP)	A tracer diffusion kinetic model that accounts for the tumor leakage profile during the first pass of contrast. See Li, Ka-Loh, Xiao Ping Zhu, John Waterton, and Alan Jackson. "Improved 3D Quantitative Mapping of Blood Volume and Endothelial Permeability in Brain Tumors." Journal of Magnetic Resonance Imaging 12, no. 2 (2000): 347-357. doi:10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7
126344	Shutter-Speed Model (SSM)	A tracer diffusion kinetic model that does not assume that intercompartmental water molecule exchange is infinitely fast. See Li, Xin, Wei Huang, Thomas E. Yankeelov, Alina Tudorica, William D. Rooney, and Charles S. Springer. "Shutter-Speed Analysis of Contrast Reagent Bolus-Tracking Data: Preliminary Observations in Benign and Malignant Breast Disease." Magnetic Resonance in Medicine 53, no. 3 (2005): 724-29. doi:10.1002/mrm.20405
126350	T1 by Multiple Flip Angles	T1 measurement by Multiple Flip Angles (MFA) (variable saturation) method
126351	T1 by Inversion Recovery	T1 measurement by Inversion Recovery (IR) method
126352	T1 by Fixed Value	Calculation was performed using a fixed value of T1 rather than a measured value. The value could be encoded as the value of (126353, DCM, "T1 Used For Calculation")
126353	T1 Used For Calculation	The fixed value of T1 used for a calculation
126360	AIF Ignored	No Arterial Input Function was used
126361	Population Averaged AIF	A population-averaged Arterial Input Function
126362	User-defined AIF ROI	An Arterial Input Function computed from a user-defined Region of Interest
126363	Automatically Detected AIF ROI	An Arterial Input Function computed from an automatically detected Region of Interest
126364	Blind Estimation of AIF	A data-driven blind source separation (BSS) algorithm that estimates AIF from individuals without any presumed AIF model and initialization. See Lin, Yu-Chun, Tsung-Han Chan, Chong-Yung Chi, Shu-Hang Ng, Hao-Li Liu, Kuo-Chen Wei, Yau-Yau Wai, Chun-Chieh Wang, and Jiun-Jie Wang. "Blind Estimation of the Arterial Input Function in Dynamic Contrast-Enhanced MRI Using Purity Maximization." Magnetic Resonance in Medicine 68, no. 5 (November 1, 2012): 1439-49. doi:10.1002/mrm.24144
126370	Time of Peak Concentration	The time at which the concentration-time curve achieves its peak for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126371	Bolus Arrival Time	The nominal time at which arrival of a contrast bolus is detected, which is used as a reference point for subsequent calculations. Used as a concept name for a value or as a method. No specific computational method is implied by this general definition. Abbreviated BAT
126372	Time of Leading Half-Peak Concentration	The time at which the concentration-time curve achieves half of its peak density for the first time. Used as a concept name for a value or as a method; e.g. used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126373	Temporal Derivative Exceeds Threshold	A method of determining BAT that involves computing the temporal derivative of the concentration-time curve and selecting the time when the temporal derivative exceeds a specified threshold. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126374	Temporal Derivative Threshold	A threshold applied to the temporal derivative of the concentration-time curve; e.g. used to establish BAT. See Shpilfoygel Med Phys 2008. doi: 10.1118/1.1288669
126375	Maximum Slope	The maximum rate of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126376	Maximum Difference	The maximum degree of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387
126377	Tracer Concentration	Tracer concentration in tissue; e.g. in a DCE-MR experiment, the concentration of contrast agent in mmol/l
126380	Contrast Longitudinal Relaxivity	The degree to which a paramagnetic contrast agent can enhance the proton longitudinal relaxation rate constant (R1, 1/T1), normalized to the concentration of the contrast agent. Also referred to as r1. Typically expressed in units of l/mmol/s
126390	Regional Blood Flow	The flow rate of blood perfusing a region as volume per mass per unit of time
126391	Regional Blood Volume	The volume of blood perfusing a region as volume per mass
126392	Oxygen Extraction Fraction	The percent of the oxygen removed from the blood by tissue during its passage through the capillary network. For example, as measured by blood oxygenation level dependent (BOLD) MR. See He, Xiang, and Dmitriy A. Yablonskiy. "Quantitative BOLD: Mapping of Human Cerebral Deoxygenated Blood Volume and Oxygen Extraction Fraction: Default State." Magnetic Resonance in Medicine 57, no. 1 (2007): 115-26
126393	R1	The longitiudinal relaxation rate constant. The inverse of longitudinal relaxation time, i.e., R1 = 1/T1
126394	R2	The transverse relaxation rate constant. The inverse of transverse relaxation time, i.e., R2 = 1/T2
126400	Standardized Uptake Value	A ratio of locally measured radioactivity concentration versus the injected radioactivity distributed evenly throughout the whole body. This general concept encompasses all specific methods of calculating the whole body volume of distribution, such as using body weight, lean body mass, body surface area, etc.
126401	SUVbw	Standardized Uptake Value calculated using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126402	SUVlbm	Standardized Uptake Value calculated using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126403	SUVbsa	Standardized Uptake Value calculated using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126404	SUVibw	Standardized Uptake Value calculated using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126410	SUV body weight calculation method	Method of calculating Standardized Uptake Value using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126411	SUV lean body mass calculation method	Method of calculating Standardized Uptake Value using lean body mass. The patient size correction factor for males is 1.10 * weight - 120 * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126412	SUV body surface area calculation method	Method of calculating Standardized Uptake Value using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126413	SUV ideal body weight calculation method	Method of calculating Standardized Uptake Value using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126500	Pittsburgh compound B C^11^	A beta-amyloid PET radiotracer that is an analog of thioflavin T
126501	Florbetaben F^18^	A beta-amyloid PET radiotracer
126502	T807 F^18^	A PHF-tau PET radiotracer
126503	Flubatine F^18^	A nicotinic α4β2 receptor (nAChR) PET radiotracer
126510	Monoclonal Antibody (mAb) ^64^Cu	A Cu 64 Monoclonal Antibody (mAb) PET Radiotracer
126511	Monoclonal Antibody (mAb) ^89^Zr	A Zr 89 Monoclonal Antibody (mAb) PET Radiotracer
126512	Trastuzumab ^89^Zr	A Zr 89 Trastuzumab PET Radiotracer
126513	Cetuximab ^89^Zr	A Zr 89 Cetuximab PET Radiotracer
126514	J591 ^89^Zr	A Zr 89 J591 PET Radiotracer
126515	cU36 ^89^Zr	A Zr 89 cU36 PET Radiotracer
126516	Bevacizumab ^89^Zr	A Zr 89 Bevacizumab PET Radiotracer
126517	cG250-F(ab')(2) ^89^Zr	A Zr 89 cG250-F(ab')(2) PET Radiotracer
126518	R1507 ^89^Zr	A Zr 89 R1507 PET Radiotracer
126519	E4G10 ^89^Zr	A Zr 89 E4G10 PET Radiotracer
126520	Df-CD45 ^89^Zr	A Zr 89 Df-CD45 PET Radiotracer
126600	^44^Scandium	^44^Scandium
126601	^51^Manganese	^51^Manganese
126602	^70^Arsenic	^70^Arsenic
126603	^90^Niobium	^90^Niobium
126604	^191m^Iridium	^191m^Iridium
126605	^43^Scandium	^43^Scandium
126606	^152^Terbium	^152^Terbium
126700	ATSM Cu^60^	A Cu 60 ATSM PET radiotracer
126701	ATSM Cu^61^	A Cu 61 ATSM PET radiotracer
126702	ATSM Cu^62^	A Cu 62 ATSM PET radiotracer
126703	Choline C^11^	A C 11 Choline PET radiotracer
126704	Fallypride C^11^	A C 11 Fallypride PET radiotracer
126705	Fallypride F^18^	An F 18 Fallypride PET radiotracer
126706	FLB 457 C^11^	A C 11 FLB 457 PET radiotracer
126707	Fluorotriopride F^18^	An F 18 Fluorotriopride PET radiotracer
126708	Fluoromisonidazole (FMISO) F^18^	An F 18 Fluoromisonidazole PET radiotracer
126709	Glutamine C^11^	A C 11 Glutamine PET radiotracer
126710	Glutamine C^14^	A C 14 Glutamine PET radiotracer
126711	Glutamine F^18^	An F 18 Glutamine PET radiotracer
126712	Flubatine F^18^	An F 18 Flubatine PET radiotracer
126713	2FA F^18^	An F 18 2FA PET radiotracer
126714	Nifene F^18^	An F 18 Nifene PET radiotracer
126715	CLR1404 I^124^	An I 124 cancer targeted phospholipid ether PET radiotracer
126716	CLR1404 I^131^	An I 131 cancer targeted phospholipid ether PET radiotracer
126801	IEC6127 Patient Support Continuous Angle	Patient Support Continuous Angle in IEC PATIENT SUPPORT Coordinate System [IEC 61217]
126802	IEC6127 Table Top Continuous Pitch Angle	Table Top Continuous Pitch Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126803	IEC6127 Table Top Continuous Roll Angle	Table Top Continuous Roll Angle in the direction of the IEC TABLE TOP Coordinate System [IEC 61217]
126804	IEC6127 Table Top Eccentric Axis Distance	Table Top Eccentric Axis Distance [IEC 61217]
126805	IEC6127 Table Top Continuous Eccentric Angle	Table Top Continuous Eccentric Angle in the direction of the IEC TABLE TOP ECCENTRIC Coordinate System [IEC 61217]
126806	IEC6127 Table Top Lateral Position	Table Top Lateral Position IEC TABLE TOP Coordinate System [IEC 61217]
126807	IEC6127 Table Top Longitudinal Position	Table Top Longitudinal Position IEC TABLE TOP Coordinate System [IEC 61217]
126808	IEC6127 Table Top Vertical Position	Table Top Vertical Position in IEC TABLE TOP Coordinate System [IEC 61217]
126809	IEC6127 Gantry Continuous Roll Angle	Gantry Continuous Roll Angle in degrees of the radiation source, i.e., the rotation about the Y-axis of the IEC GANTRY coordinate system [IEC 61217]
126810	IEC6127 Gantry Continuous Pitch Angle	Gantry Pitch Continuous Angle in degrees of the radiation source, i.e., the rotation about the X-axis of the IEC GANTRY coordinate system [IEC 61217]
126811	IEC6127 Gantry Continuous Yaw Angle	Gantry Yaw Continuous Angle in degrees of the radiation source, i.e., about the Z-axis of the IEC GANTRY coordinate system [IEC 61217]

See the full registry of code systems defined as part of FHIR.

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. See Code System for further information.

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code